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The study was designed to investigate the comparative efficacy
and specificity of action of finger temperature biofeedback, temporal
artery amplitude biofeedback and relaxation as treatments for migraine
headache. A heart rate feedback condition (placebo control) and a
waiting list control condition were also included. Patients' symptoms
were evaluated using a modified version of Waters Headache Questionnaire.
Dependent variables were finger temperature, temporal artery amplitude,
heart rate, frequency of headaches, intensity of headaches, duration
of headaches and an index of headache activity. An analgesic index,
frequency of vasoconstrictor drug use and amount of prophylactic
medication taken, were also recorded. Monthly records of headache
activity were taken for each patient over the period of a year. The
experimental patients were given a three month baseline, a three month
treatment period (consisting of ten one-hour treatment sessions) and
a six month follow-up period.
Group analysis of the physiological data provided little evidence
that biofeedback procedures enabled patients to gain control of the
relevant physiological parameters, although the clinical results
suggested the superiority of finger temperature and heart rate (placebo)
feedback in reducing headache activity. As a result of this anomaly
an investigation into the relationship between the clinical changes
and changes in physiological measures for each individual patient was
carried out. Of the physiological measures, a decrease in mean
temporal artery amplitude over all subjects accounted for the highest
proportion of the variance in clinical outcome. Implications are
drawn for current theories of migraine headache, and biofeedback
methodology is critically evaluated.
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Migraine is an ill defined, self limiting condition which takes
up much of the time of general practitioners. It involves no risk of
mortality hut can cause extreme distress to the sufferer, occuzrring
with little warning and at times which may he inconvenient and
socially embarrassing. Millac (1980) stated that headaches lead JO/o
of the British population to seek medical advice at some stage in
their lives. Phizacklea and Vilkins (1978) reported that in a
single handed urban practice of 3000 patients, headaches accounted
for 192 consultations in a six month period and that an estimated
25,000 patients are referred annually to hospital outpatient
departments with headache. DeLozier and Gagnon (1975) estimated
from an American survey of ambulatory patients, that 9UU.9 million
visits concerning headaches were paid to general practitioners between
May 1973 and. April 197U* Of the 60 most frequent patient problems,
headache was U+th and was the 8th most frequest symptom orientated
problem. Appenzeller (1979) estimated that at least i|C% of all North
Americans have experienced severe headaches at some point in their
lives.
Migraine is one of a variety of headache types. The following
classification is taken from Diamond (1975)?
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HEADACHE CLASSIFICATION
1. Traction and Inflammatory
Mass lesions (tumors, oedema, haematoma, etc).


















Migraine is a condition for which there are no signs that can
be objectively measured and doctors must rely solely on a subjective
description of symptoms by the patient in order to make a diagnosis.
The clinical definition of migraine has been a subject of dispute
- 3 -
for many centuries and remains so today. Friedman, Finley, Graham, Kunkle
Ostfield, Wolff (1962) recommended the following definition;
Yascular headache of the migraine type.
•Recurrent attacks of headache, widely varied in intensity, frequency
and duration. The attacks are commonly unilateral in onset; and
usually associated with anorexia and sometimes preceded "by, or
associated with, conspicuous sensory, motor and mood disturbances;
and are often familial'.
Nevertheless, it is often difficult to differentiate between
migraine and other types of headache, as there are no clear cut lines
whereby a headache can be diagnosed as migrainous or not.
Migraine may be divided into two main subgroups. First, classic
migraine where the headache is preceded or accompanied by visual aura,
sensory or speech disturbances, and second, nonclassic or common
migraine, which is not associated with the occurrence of sharply
defined focal neurological disturbances. In both of these types of
migraine headache, the pain is unilateral and may be associated with
nausea or vomiting. During the painful phase of the attack, patients
may also experience neurological symptoms such as numbness, 'pins and
needles', or giddiness.
The warning signs reported to precede the onset of a classic
migraine headache may be useful in helping the sufferer begin treat¬
ment at the earliest possible moment in the migraine attack. The






blindness, spots or lines,







Sensitivity to noise or light
Depression





Blotchy patches or rashes on the skin
Swelling of fingers, waist or breasts
Numbness
Elation





Increase in volume of urination
Unusual pallor
As well as the 'classic1 and 'common' migraine variants, other
less common types may occur. 'Hemiulegic' migraine and 'Opthalmoplegic'
migraine are vascular headaches characterised by sensory and motor
phenomena which persist during and after the headache (Priedman
et al, 1962). 'Facial' migraine, otherwise known as 'Lower half'
or 'facioplegic' migraine is a condition in which the headache is
followed by facial paralysis (Bickerstaff, 1977). In early life,
some migraineurs may experience the prodromal phase of classic
migraine but not the headache. The headache becomes a feature in
later life. It is however, uncommon for migraine to start this way
in adult life, or for this pattern to occur in patients with well-
established attacks (Bickerstaff, 1977).
- 5 -
'Cluster Migraine' (Periodic migrainous neuralgia) is a
condition which, although allied to migraine, is sufficiently-
different to warrant special attention. The symptoms include ciliary-
neuralgia; histamine cephalalgia, Horton's neuralgia; cluster headache;
autonomic cephalalgia; erythromelalgia of the head; greater superficial
petrosal neuralalgia and Harris's neuralalgia. It affects men six
times more often than women, occurs in bouts lasting 3-12 weeks or even
longer at intervals of six months to two years and usually starts in
the third or fourth decade. In each bout at least one attack and
sometimes several occur each day, with a characteristic predisposition
to occur between midnight and 3 s®1 (Bickerstaff, 1977)•
This brief introduction illustrates the diversity and magnitude
of the problem associated with the migraine headache and its variants.
Despite much clinical and research attention, it is still a relatively
little understood phenomenon and many myths have grown up about the
incidence of the condition and the characteristics of the sufferers.
As this project is concerned specifically with the classic migraine
headache, problems of definition for diagnostic purposes, establishing
prevalence rates and examining beliefs that surround the condition
will be covered in chapter 3-
AETIOLOGY AMD TREATMENT OP CLASSIC MIGRAINE
Current evidence supports the view that cranial arterial
distention and dilatation are implicated in the painful phase of the
headache, but cause no permanent changes in the involved vessels
(Friedman et al, 1962). Classic migraine headaches have long
been treated with medications designed to influence the observed
vasodysfunctions. Chapters k and 5 are concerned with physiological
and biochemical changes associated with classic migraine headaches.
Also, the merits of acute and prophylactic medication in the treat¬
ment and management of classic migraine is overviewed in chapter 6.
As mentioned, many of the available drug treatment regimes are
directed at the prevention or the re-establishing of biochemical and
calibre changes in the intra- and extra-cranial arteries; however
an editorial in Eemicrania (1971) stated that:
"It must be remembered that there are at least two causes of
a migraine attack. There is the primary cause, the often familiar but
still obscure diathesis or constitutional predisposition that loads
the gun, and the secondary cause that pulls the trigger".
Research is now being directed at both sets of causes, the
constitutional inadequacy and the numerous secondary factors that
trigger the headache and associated symptoms. The following trigger
factors have been reported as initiating migraine attacks:
Anxiety, worry, emotion, depression, Certain foods (fried food,
shock and excitement chocolate and cheese)
Over-exertion Oral contraceptives
Physical and mental fatigue Travel
Bending or stooping Use of sleeping tablets
Excess or sleep deprivation Change of routine
Changes of climate Loud noises
Artificial light Hot baths
Bright lights Lack of food
Penetrating smells Menstruation
Intense odours High blood pressure
Alcohol Toothache
(Thompson , 1978).
The variety of proprietary medications available for the
treatment of classic migraine have been considered to reflect the
lack of efficacy of any one particular treatment approach (Sargent,
Green and Walters , 1973b). Different modes of action of the various
medications may also indicate the absence of a single factor aetiology.
Given that dependence, side effects and rebound headaches are major
disadvantages of drug treatments, it is not surprising that alternative
treatments have been considered.
Thompson (1978) stated that 'treatment, consists in the first
place, of trying to avoid precipitating factors'. As has been shown,
there are various triggering factors and the avoidance of one does
not mean that other factors, perhaps unavoidable ones, may not also
be operative. Thompson (1978) also recommended that 'should an attack
threaten, the victim should immediately lie down' and that 'when an
attack is fully developed, rest in a bed, in a quiet darkened room is
essential*. Neither of these recommendations may be possible for many
sufferers, given specific situations at the onset of the headache, even
though obvious warning signs may precede the onset of the pain.
As the prevention of a migraine is more desirable than the
acute treatment of an attack (given the limitations and variable
effectiveness of drugs) a variety of alternative approaches has been
considered by clinicians. Although such approaches as insight
psychotherapy and problem orientated behaviour therapy have met with
some success, an increasingly popular approach to the management and





Biofeedback has been defined as: "any technique which increases
the ability of a person to control voluntary physiological activities
by providing information about those activities". (Olton and Noonberg,
1980).
It has long been accepted that biofeedback can effect the
skeletal musculature. Prior to 1969, little evidence existed to
support the notion that biofeedback could influence the autonomic
nervous system. Following experiments which appeared to demonstrate
the control of autonomic function by operant conditioning techniques
(Miller 1969), an increase in the diversity of biofeedback applications
has taken place. The application of biofeedback in clinical practice
has not been restricted by a lack of success in replicating Miller's
original findings. (Miller and Dworkin 1974)
The following is a theoretical representation of the nervous





















The diagram represents the parallel components of the external
biofeedback display and the internal self control aspects of biofeed¬
back. Within the subject, (1) efferent neurones stimulate the effector
system which alters the biological function under observation.
(2) These changes are registered on the biofeedback display via
transducers attached to the feedforward control system. (3) The
changes in the biological function are registered by internal
receptors and the information is sent through afferent nerves to the
brain. Simultaneously, (1+) the subject receives information concerning
the internal changes via the biofeedback display. This is a general
representation of the principles underlying the application of
biofeedback; the ultimate aim of biofeedback is that the information
received about internal responses will enable the subject to gain
volitional control over those responses.
The following is a brief overview of some of the clinical
applications of biofeedback.
CARDIOVASCULAR. TRAINING
Much of the original work in this area was conducted by Engel
and colleagues (summarised in Engel and Bleeker , 197U) working with
various cardiac disorders including atrial fibrillation, tachycardia
and premature ventricular contractions. Although these studies
provided promising evidence for the effects of biofeedback; even
with patients who had received little benefit from other treatments,
there were no controls for placebo effects and no extensive baseline
data were obtained. However, this work has been replicated by
Pickering and Miller (1977). Furthermore, other cardiac disorders
such as sinus tachycardia, supraventricular tachycardia and paroxysmal
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atrial tachycardia have been successfully treated, although more
evidence regarding transfer of control from the laboratory to every¬
day life and longer follow-up periods are required. Also the rationale
behind treating cardiac arrhythmias via control of heart rate remains
obscure. It has been suggested that gaining control over heart rate
modifies sympathetic and vagal tone to the heart, leading to reduction
in abnormalities, but this is highly speculative. It should also be
noted that little attention has been paid within biofeedback to the
role of psychological factors in cardiac disorders, although the
importance of such factors has long been recognised (Yates ,1980).
A final problem is that Benson, Alexander and Feldman (1975) reported
that training patients in progressive relaxation may be as effective
as biofeedback.
HYPERTENSION
Many attempts have been made to treat hypertension with
biofeedback. Benson, Shapiro, Tursky and Schwartz (1971) used
biofeedback to lower systolic blood pressure of seven hypertensive
patients. A marked improvement in five out of seven hypertensive
patients was reported, two of these patients bringing down their
blood pressure to within normal range. Over all patients the mean
systolic pressure was reduced from 165 to 11+8 mm Hg. This work has
been replicated by other workers, with generally consistent results;
although recently Surwit, Shapiro and Good (1978) were able to obtain
only very small, clinically non-significant changes. A further
problem is that long term follow-up suggests that these effects are
very short lived. Biofeedback for high blood pressure may therefore
not be particularly useful, especially since it is technically very
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complex. Further, Patel (1977) has shown in a number of studies
that passive relaxation and meditation seem to be superior to
biofeedback in reducing blood pressure. The complex technology of
biofeedback may therefore not be required.
ELECTRO-ENCTiPHALOGRAPHIC (EEG) FEEEBACK
There is now much evidence to show that subjects can be trained
to control EEG frequency, particularly they can be trained to increase
the proportion of alpha rhythm (8-12 hz). Alpha rhythm is typically
found during states of meditation and relaxation; during such states,
pain perception and anxiety are diminished. However, alpha feedback
is beset with methodological problems; whether the subjects keep
their eyes open or closed, the effects of ambient illumination, and
so on. In view of such problems, it would appear that alpha training
has little to offer in the way of clinical application. Melzack and
Perry (1975) found that alpha training had little effect in the
treatment of pain. However, it would appear that one promising area
of EEG training is that of sensory motor rhythm (SMR) training.
Sterman and Friar (1972) trained three epileptics to generate SMR
and found a reduction in abnormal slow-wave activity and polyspike
discharges. All three patients demonstrated a reduction in seizures.
Later Sterman (summarised in Sterman,1977) reported on five cases of
epilepsy, using an ABAB design. He found improvement in four out of
the five cases. The potential usefulness of this approach in
treating epilepsy has been confirmed by other workers (Lubar and
Shouse , 1977). However, the precise nature of SMR remains to be
elucidated, and in other studies it has been found that patients
improved without a concomitant change in SMR but with an associated
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change in other rhythms. It would therefore seem unlikely that
therapeutic effects are due to the production of a particular rhythm
hut a 'normalising1 of the EEG and hence the suppression of general
epileptic activity.
EIECTRO-MYOGRAPHIC (EMG) EEERBACK
EMG feedback differs from other methods of biofeedback in that
the biological response of interest is the activity of the striate
muscle, which is relatively under voluntary control. Typically the
electrical activity generated by muscle activity is transformed into
a noise, such that a high frequency click or high pitch noise is
indicative of tension, and a low frequency click or low pitch noise
is indicative of relaxation.
One of the most common disorders to which EMG feedback has
been applied is the so-called tension headache. Recent work however
has shown that the distinction between tension and migraine headache
is not so clear cut as was once believed (Martin and Mathews , 1978);
however, many biofeedback researchers have continued to assume that
they are entirely different clinical entities. Much of the original
work was reported by Budzynski, Stoyva and colleagues (Budzynski,
Stoyva, Adler and Mullaney ,1973). a series of essentially
uncontrolled reports, Budzynski et al (1973) observed that EMG from
the frontalis muscle was effective in reducing tension headache
activity. Unfortunately, as with the early migraine studies, the
effects of feedback were confounded with the effects of relaxation,
relaxation being given simultaneously with feedback. When the
relevant comparisons were made, it appeared that there was little
advantage in using EMG feedback (Cox, Freundlich and Meyer, 1975).
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Gray, Lyle, McGuire and Peck (1980) found that relaxation was
more effective than EMG feedback and that whether the electrodes
were placed on the painful site or elsewhere on the head, did not seem
to be crucial. There is now much evidence to suggest therefore that
simple training in progressive relaxation is just as effective as
EMG feedback treatment of tension headaches.
One of the most successful applications of EMG feedback to
clinical problems, is in the area of neuro-muscular disorders.
Andrews (196I4.) reported on a series of 20 patients with hemiparesis,
who had had no return of function in the year since onset. Seventeen
of these patients were able to develop well modulated action in a
previously paralysed aim in very few sessions. In a large scale but un¬
controlled study, Brundy, Korein, Grynbaum, Friedmarm, Weinstein,
Sachs-Frankel and Belandres (1976) used EMG feedback with 11L|. neuro¬
muscular disordered patients; the diagnoses included hemiparesis,
torticollis, dystonia and spinal cord and peripheral nerve injury.
All patients had had conventional therapy with little or no recovery.
The treatment took place over a period of eight weeks. Buring the
follow-up period of three years, 5CP/o of the patients had significant
clinical improvement. Wooldridge and Russell (1976) trained twelve
spastic children in the control of head position. Movement of the
child's head to the right produced a sound in the right ear, and a
movement to the left produced a sound in the left ear. The children
were thus trained to control head position during a variety of
everyday activities. All the children responded to some degree and
this control generalised to other areas of functioning.
Other EMG applications have also produced clinically impressive
results. Engel, Nickoomanesh and Schuster (197U) trained six patients
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who had been incontinent of faeces for five years from a variety of
causes including diabetic neuropathy and gastrointestinal surgery.
They were trained to produce external sphincter contractions in
synchrony with internal sphincter relaxation. During the follow-up
period of five years, four of the patients were completely continent
and there was improvement in the other two. This application is
particularly impressive because it would appear that there is no
viable alternative treatment to this very debilitating condition.
EEG feedback has also been used to teach pregnant women
appropriate muscle control during labour. Gregg (1978) gave EMG
feedback to 100 women during pregnancy and found a significant
reduction in the duration of the first stage of labour; in addition,
less pain was reported and less sedative medication was requested.
Vebb (197U) has also used EMG feedback as an aid for the blind
in appropriately portraying emotional state and thus enhancing
interpersonal interactions.
Other areas where EMG feedback appears to be useful include
the treatment of blepharospasms (Peck ,1977), writers cramp (Reavley,
1975), and severe tremors (LeBoeuf , 197&).
SKDJ TEMPERATURE FEEDBACK
Skin temperature training has been one of the most popular
methods of biofeedback, possibly because it is comparatively straight¬
forward from a technological point of view. Skin temperature bears a
close correspondence to blood flow in the underlying tissue.
Accordingly, it is possible that skin temperature training may be
useful in the treatment of disorders of peripheral blood flow.
One of the major disorders of peripheral blood flow is
Raynaud's Disease, a predominantly female disorder characterised by
decreased blood flow, frequent vaso-spastic attacks and increased
susceptibility to frostbite in the hands and feet. Taub and Emurian
(1976) treated four patients with Raynaud's Disease, training them
to increase hand temperature. All patients kept records of the fre¬
quency of vaso-spastic attacks, and reported a significant decrease.
Success rates of $1 - 95^ have been reported but typically studies
reporting such figures were not well controlled and had small numbers.
Keefe, Surwit and Pilon (1980) gave 21 female subjects either auto¬
genic training, progressive relaxation training, or a combination of
autogenic training and temperature feedback. All of the patients
improved irrespective of the method of treatment. It would appear
therefore that there is little advantage in using temperature
biofeedback; equal therapeutic success may be obtained by using
relaxation.
The most common clinical application of finger temperature
training has been in the treatment of migraine headaches. The
pioneers in this area are Sargent, Green and Walters (1972). They
used differential temperature training whereby patients were trained
to increase the temperature difference between finger and forehead.
Initial success rates were claimed to be around JCP/o using large
numbers of patients. However this work has been severely criticised
on the grounds that no control groups were used, little baseline data
were reported and there was an inadequate statistical evaluation of
the results. Most crucially, biofeedback was given at the same time
as autogenic training, thus one cannot determine which was the crucial
ingredient producing therapeutic change. Despite these inadequacies,
the work of Sargent et al (1972) has stimulated considerable further
research; A detailed summary of the application of finger temperature
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biofeedback for migraine is included in chapter 7.
CEKEBBAL VASO-MOTOR RESPONSE (CVMR) ITEEIiBACK
Snyder and Noble (1968) demonstrated that subjects could be
trained to decrease arterial pulse amplitude in the finger, when
given direct feedback of the amplitude. Christie and Kotses (1973)
demonstrated that increases and decreases in cephalic vasomotor
responses could also be achieved, although the changes were small
and there was no difference from baseline levels. However these
initial findings have stimulated researchers to apply C"VMR feedback
clinically. The superficial temporal artery is the vessel most
closely associated with the alleged cerebral vascular abnormality
in migraine headache; it may therefore be possible to train migraine
patients to control temporal artery amplitude and thereby gain control
over their headaches. Although initial clinical findings are
encouraging, a clear relationship between clinical and vasomotor
changes has yet to be reported. Also, the rationale for CVMR feedback
does not appear to be consistent with the rationale for finger temp¬
erature feedback. The former involving vasoconstriction of the
temporal artery, is associated with increased sympathetic activity;
but finger temperature feedback is associated with decreased
sympathetic activity. However, both claim to be successful procedures
in the alleviation of migraine headaches. This question will be
addressed in greater detail in chapter 7.
CONCLUSION
In the area of biofeedback, claims of general effectiveness
and of wide applicability have gone beyond the available date. Much
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more carefully designed research is required, using appropriate
control groups as the extravagant speculations pervading this area
have done biofeedback a disservice (Brown, 197U). Yates (1980)
stated that biofeedback may have only an ancillary or minor role to
play in some treatment methods. Nevertheless, that role may be an
important one in both practical terms and, in some cases, in
suggesting new treatment approaches.
Hiebert (1976) stated that the popularity of biofeedback has
increased to the point where serious investigation into the ther¬
apeutic claims and treatment methodologies is warranted. Engel-
Sittenfeld and Engel (1978) suggested that the treatment of migraine
through biofeedback methods is probably one of the best examples of
how biofeedback has been used in a clinical context without explicit
diagnostic procedures and without deep knowledge of the mechanisms
underlying effects. Adams, Feuerstein and Fowler (1980) stated that
although biofeedback provides promising leads in the development of
t
effective physiological treatments for migraine headaches, the claims
of these techniques must be substantiated by well-designed treatment
outcome studies. They concluded that the most reasonable research
tactic would be to conduct a clinical trial including a variety of
treatment groups, a placebo group and a no-treatment waiting list
control group. The clinical trial should also examine the active
components and mechanisms proposed to be responsible for the thera¬
peutic effects. The clinical research criteria specified by Adams
et al (1980) emerge from a detailed critical appraisal of the use of
biofeedback (included in chapter 7) anh have been incorporated in
the design of the present research.
CHAPTER 3
EPIDEMIOLOGICAL ASPECTS OF MIGRAINE HEADACHES
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EPIDEMIOLOGICAL ASPECTS OF MIGRAINE HEADACHE
This review will "be concerned with four areas relevant to
determining the prevalence of migraine in the community. Firstly,
an overview of clinical impressions will be outlined; secondly, the
problems of diagnosis and its implications for epidemiological studies
will be considered. Thirdly, a brief overview of contemporary
epidemiological studies will be given and the concluding part of the
chapter will outline current impressions on the epidemiology of
migraine.
According to a survey by DeLozier and Gagnon (1975)> headaches
(undifferentiated) was among the top 1lj. principle problems reported
by out-patients attending office-based general practitioners in the
one year period between May 1973 and- April 197^-4-. This symptom alone
accounted for over 12 million office visits in the U.S.A.;
categorising these patients by sex indicated that 29% were male and
71% female.
Prevalence rates for migraine as distinct from other forms of
headpain is a matter of debate, the definition of migraine, which is
obviously central to the issue, having led to much controversy.
Critchley (1962) stated that the only criterion necessary to establish
a diagnosis of migraine is "the presence of recurrent headache,
irrespective of any preceding, accompanying or subsequent phenomenon".
This statement reflects the lack of specificity employed by some
clinicians in the definition of migraine.
Although the definition of migraine as used by Critchley (1962) may
be considered 'overinclusive1, more frequently employed definitions
(Gowers , 1888 ; Friedman, Finley, Graham, Kunkle, Ostfield and
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Wolff, 1962) are also deficient. The description given by Gowers
(1888) includes the features accepted as essential parts of the
diagnosis. He wrote "migraine is an affection characterised by
paroxysmal nervous disturbance of which headache is the most constant
element. The pain is seldom absent and may exist alone, but is
commonly accompanied by nausea and is often preceded by some sensory
disturbance, especially by some disorder of the sense of sight.
The symptoms are frequently one sided and from this character of the
headache the name is derived".
This definition, as can be seen, is limited by the use of such
adverbs as 'usually® and 1 frequently*, and the Friedman et
al (1962) definition, although essentially the same as the above,
has the following qualifying phrase; 'all characteristics are not
necessarily present in each attack or in each patient*. Hence the
determination of prevalence rates is subject to interrater
variability.
As stated, sex differences in migraine have been an area of interest,
and as indicated by DeLozier and Gagnon (1975)* females appear to be
most vulnerable. Selby and Lance (i960) reported that 6C% of 500
vascular headache cases from an Australian sample were women, whereas
Ziegler, Hassanein and Hassanein (1972), in an American study,
reported no differences between males and females. More recently,
Waters and O'Connor (1975) reported an 8% higher incidence rate
among women. Adams, Feuerstein and Fowler (1980), stated that since
the majority of epidemiological studies have been conducted in
Britain or Australia, cross cultural factors may account for some of
the variance in reported incidents.
- 20 -
Social class has been implicated as being a significant
feature in the incidence of migraine headaches. A Research Committee
of the Council of General Practitioners (19^2) found a higher
incidence of migraine in professional classes and that a social
gradient in recorded prevalence of consultations was evident; a
decrease in consultation rates was associated with decreasing social
class.
It has been hypothesised that the increased prevalence of
migraine in professional persons may be associated with occular
disorders caused by continued close work. Williams (1966) stated
that prolonged eye strain, especially in the presence of uncorrected
errors of refraction is considered to precipitate migraine attacks.
Walker (1909)» reported that in 300 consecutive patients over
the age of i+0 years, the prevalence of migraine rose as blood
pressure increased. However, Robinson (1969), found that certain
symptoms, and in particular headache, made general practitioners more
likely to measure a patient's blood pressure. This would give an
underestimate of the incidence of high blood pressure in non-headache
patients.
Familial prevalence is also an area of considerable interest.
Liveing (1873) was the first to state that migraine was a familial
condition, subsequent studies have strengthened this impression;
(Lennox , 191+1 ; Walker , 1959 ; Childs and Sweetnam , 1961).
However, methods used to verify the hypothesis are suspect, as some
authors include a family history as part of their diagnosis. Hence
if borderline cases are diagnosed as migrainous or not according to
family history, it could be possible to provide a tautological
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demonstration that migraine is a familial trait.
An alternative to using clinical information f°r investigating
migraine prevalence rates is to conduct epidemiological studies.
Epidemiological studies are important because the population from
which the cases come is known, a factor uncontrolled in clinical
studies. Waters (1970) used an epidemiological approach in an
attempt to resolve the basic difficulty of diagnosis. He used a
questionnaire to determine the prevalence of the three cardinal
migraine symptoms; unilateral headache, warning signs and nausea,
without introducing the term migraine. It was found that of subjects
diagnosed of migraine based on questionnaire responses, there was
a 3<y/o agreement with independent clinical rates. (Waters and
O'Connor, 1970).
Waters and O'Connor (1971) employed the questionnaire to
investigate 2933 females aged 20-61+ years. Subjects with the three
migrainous features were identified and the prevalence of migraine
was estimated as 19%. In this study, 117 women kept diaries of
headache features. Of the 289 headaches reported from the migraine
group, all had at least two of the three cardinal features, whereas
none of the 21+3 headaches experienced by the non-migrainous group
had any of the three features. Waters and O'Connor (1971)
discovered that the incidence of both migraine and non-migrainous
features was significantly higher during the menstrual period.
Interestingly, 81+migraines occurred within the seven day period
after menstruation and 52 occurred in the seven days before
menstruation, contradicting the theory that migraine is common
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before menstruation. On examining patients who displayed migraine
features, patients who did not have migrainous headaches and subjects
free of headaches, no evidence of systolic or diastolic blood pressure
differences, no social class or intelligence differences or proportion
with visual acuity difficulties was found. Waters and O'Connor (1971)
interviewed first degree relatives of randomly selected probands with
migraine, non-migraine headaches and without headache and found that
although first degree relatives of migraineurs did have a higher
preponderance of migraine symptomatology, the difference was not
statistically significant.
Results from community studies raise the question as to whether
the observed migraine symptoms do constitute a distinct clinical
entity or whether it is a point on a headache continuum. Current
literature has considered migraine as a syndrome of three symptoms
and from the respondents of a later study (Waters, 1973)s the number
of subjects displaying unilateral headache, warning signs and nausea,
and the incidence of each feature alone on the basis of chance were
calculated. The results suggested that for the combinations of
two and three symptoms there was an excess of 'observed' over
'expected' values. However the information was period prevalent
data taken over twelve months, and did not indicate the extent to
which the features occurred together during one attack. The information
did however enable Waters (1973) to compare two theories
of migraine in an attempt to account for observed prevalence
figures and examine implications for diagnosis. The first
of these theories would state that the three
- 23 -
features of migraine may frequently be associated with any types of
headaches and hence occur in one subject by chance, migraine may
then be observed in the small additional group with three features
that cannot be explained by chance occurrence. On this basis,
prevalence rates of 1.3% both males and females would be expected.
The alternative theory would state that subjects displaying any of
the three features may be considered as having migraine. With this
second hypothesis, prevalence rates of 38.3% men and. 57.5% for
women would be expected. The prevalence rates obtained in community
studies would suggest that neither of these theories adequately
account for the observed figures. A third theory was considered by
Waters (1973) which stated that the more severs the headache, the
greater the probability of occurrence of the three migrainous
features. Using this model, it was found that although prevalence
rates were not as high as those observed, they were higher than would
be expected by chance. In conclusion this study provides evidence to
support the concept that migraine might be more appropriately
considered as the extreme of a headache continuum, rather than a
distinct clinical entity.
This overview of epidemiological methodology, gives an
indication of the difficulties involved in attempting to establish
prevalence rates for migraine headache. However, given the above
difficulties, similar questionnaire studies have been used to examine
conventional ideas concerning migraine headache.
Clarke and Waters (197U) investigated prevalence rates in
General Practice in Britain. Of 3500 patients sent questionnaires,
88.1% of males and 93.3% females responded. Results indicated that
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prevalence of headaches was higher with women than men and declined
with age in "both. There was also a tendency for the prevalence of
headaches to be slightly, but not significantly higher in the 'better'
off areas, especially with male respondents. Although it was reported
that the average severity of the male responders was not as great as
the females, it was determined that within the year prior to
questionnaire, an average of a quarter of a working day per man was
lost. Thus, for every man aged between 1S—61+ years, a total of 7U5
male replies, approximately 186 days were lost due to migraine
headaches. Clarke and Waters (197U) calculated that 28.7% of all
females and 19.5% of all male patients had migraine.
Clinical studies would indicate that pressure and tension may
be significant factors in the precipitation of a migraine attack.
On this basis, the prevalence of migraine may be greater in
industrialised than rural areas. Mills and Waters (197U) examined
this hypothesis by comparing the prevalence of migraine symptoms in
the five Isles of Scilly. Of the five, St Mary's is the largest,
with the largest population. The results indicated that headaches
were more problematical on St Mary's than the smaller islands;
however, the authors stress that because of the small populations,
the results may be due to chance. A comparison of prevalence rates
between the Scilly Isles and London indicated that the Scilly Isles
had slightly lower rates although differences were small and not
consistent across age groups. Thus the information may be regarded
as inconclusive given the differences in population sizes.
An increasing area of concern with migraine, is the effect of
oral contraception. Phillips (1971) conducted a study of 57 females
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and found a significantly increased incidence of headaches amongst
women taking oral contraceptive preparations. The headaches were
frequently of a type indistinguishable from classical migraine in
that prodromal features, lateralised pain, vomiting and photophobia
were present. In others, headaches were accompanied by depressive
symptoms and had no features of migraine. Patients with true
migraine were generally worse whilst taking oral contraceptives and
the headaches often assumed a cyclical pattern in that the commonest
time of occurrence was between courses of pills. Kudrow (1975)
found that in 7C% of cases where oral contraception was discontinued,
a reduction in headache frequency occurred.
There have been few epidemiological studies with Schoolchildren,
although the area of childhood migraine is of considerable interest,
not least from the treatment aspect of the disorder, where potent
and potentially addictive drugs are to be avoided.
In a study conducted in a Girls Grammar School, Moss and Waters
(197U) found that 93« 1% of the students recorded headaches within the
previous year, fewest headaches being reported in the 11-12 yeaisage
group. Migraine features were also found to be very common, 92.2%
of respondents experienced one or two or all three migrainous features
within the previous year. No clinical validation of the questionnaire
was attempted although a prevalence rate of 28.!$> was estimated.
Interestingly, the results contradict the notion that the menarch
precipitates migraine as a majority of the girls aged 11-12 years who
had not reached the menarche were already experiencing headaches.
Small and Waters (197U) conducted a similar study in a mixed
sex Comprehensive School. They found that 96.8% of the girls and 91%
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of the boys had experienced at least one migraine feature in the
previous year.
Although the studies concerning schoolchildren have not been
clinically validated, the fact remains that there is a high morbidity
from a migrainous type of headache in schoolchildren, prevalence
rates being estimated at 31.5% f°r girls and 26.1% for boys.
Heredity as a feature of migraine has been a major feature of
clinical and epidemiological research. Waters (1971) and Adams,
Feuerstein and Fowler (1980) have questioned the role of genetic
factors in the aetiology of migraine headaches. Although concordance
rates of 2&/o and J\y/o have been found for monozygotic and dizygotic
twins respectively, no shared patterns of precipitants and character¬
istics of attacks could be found between pairs of twins (Lucas , 1977).
Adams et al (1980) concluded that because minimal data
are available and contradictory findings as well as methodological
inadequacies characterise most of the studies, genetic assumptions
are at best tentative.
In summary, this chapter has emphasised;
a. The unsatisfactory nature of present definitions of migraine.
b. That individuals with headache but without migrainous features
at any time, are relatively uncommon in the general population,
indicating that migraine may not be a completely separate entity
from other forms of headache.
c. That using a clinical validation technique, prevalence rates
have been found to be fairly uniform across studies, ranging
from 15 - 19% in males and 21+ - 29/o in females.
d. The prevalence of migraine depends mainly on sex and age and
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appears independent of social class.
e. Comparable prevalence rates found in Grammar and Comprehensive
schoolchildren indicate a lack of association between migraine
and intelligence.
f. Migraine does not appear to be associated with occular disorders.
g. Although there appears to be an association between migraine
and hormone levels, the exact nature of the relationship has
yet to be determined.
h. It appears that the heredity factor in migraine is still an
unresolved area.
CHAPTER h
CEREBRAL AMD PERIPHERAL BLOOD PLOW STUDIES
IN RELATION TO MIGRAINE HEADACHES.
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CEREBRAL AND PERIPHERAL BLOOD ELOW STUDIES PI RELATION TO MIGRAINE
HEALACEES
INTRODUCTION
This chapter will assess the rationales underlying the use of
temporal artery amplitude and finger temperature biofeedback as
treatments for classic migraine.
CEREBRAL BLOOD FLOW IN RELATION TO MIGRAINE HEADACHES
The use of temporal artery amplitude biofeedback as a treatment
for migraine is based upon observations that the painful phase is
associated with increased temporal artery amplitude pulsations.
Reducing the amplitude of the temporal artery is considered to be a
method of affecting direct control on the pain producing mechanisms
involved in the migraine headache. This section will firstly review
physiological experiments that have examined cerebral blood flow
changes that occur during the prodromal and painful phases of
migraine headaches. The concluding part of the section will briefly
examine the relationship between temporal artery vasoreactivity and
temporal artery plethysmography.
PERIPHERAL CIRCULATION IN RELATION TO MIGRAINE
The use of finger temperature biofeedback as a treatment for
migraine is based on observations that changes in finger blood flow
are associated with changes in sympathetic nervous system arousal.
A decrease in finger blood flow (and thus finger temperature) is
associated with an increase in autonomic arousal and conversely an
increase in finger blood flow (and an increase in finger temperature)
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with a decrease in autonomic arousal. Learning to increase finger
temperature is considered to be an indirect method of decreasing
sympathetic arousal and controlling migraine pathology. The first
part of the section will examine the relationship between finger temp¬
erature and sympathetic arousal. The final part of the section will
assess claims that migraine is part of a general dysfunction linked
to nervous system difficulties.
CEREBRAL BLOOD FLOW CHANGES IN RELATION TO MIGRAINE •
While a primary cause of migraine is still elusive, there is
evidence to suggest that the pre-headache phase and the headache
itself is associated with changes in intra and extra-cranial arteries.
This 'vascular' theory of migraine proposes that the aura phase of
the migraine headache is due to constriction of one of the major
cerebral arteries and the headache is caused by excessive pulsations
of the extra-cranial arteries, specifically the suprorbital, super¬
ficial temporal or occipital vessels. (Wolff,1963).
Apart from the extensive observations by Wolff (summarised
by Dalessio , 1972), the vascular theory has received support from
Goltman (1936) who observed that a skull defect in a migrainous
patient was depressed during the prodromal phase of an attack and
bulged during the headache phase. Graham and Wolff (1938) found that
an injection of a powerful vasodilator (histamine) immediately after
a severe migraine had been eliminated by ergotamine tartrate, caused
a transient recurrence of the pain. The headache was observed to be
most acute on the side that had been previously involved in the
migraine attack and was associated with an increase in amplitude of
the temporal artery. Tunis and Wolff (1953) proposed that the pain
- 30 -
during a migraine headache resulted from increased tension within
pain sensitive cranial artery walls. They recorded cranial artery
pulse waves at intervals prior to, during and after migraine attacks.
The artery pulsations were found to be larger during the headache
than the non-headache phase and much larger than in subjects with no
history of migraine.
Dalessio (1972) observed that although mechanical distension
of cranial vessels caused pain, vigorous constriction of arterial
walls after local application of adrenaline was unaccompanied by pain.
These results would concur with the theory that vasoconstriction is
unaccompanied by pain and that vasodilatation is associated with pain.
To further strengthen this position, Skinh^j and Paulson (19^9)
reported details of a case in which cerebral blood flow was measured
unilaterally during the prodromal phase of a migraine attack. A mean
reduction in blood flow of $1% was recorded, the greatest reduction
was found in the area corresponding to the aura symptoms. Patients
examined during the prodromal and headache phases displayed reduced
cortical perfusion; in some areas to levels known to be critical
for adequate oxygenation.
In conclusion, the above studies support the vascular theory of
migraine which proposes that intracerebral vasoconstriction causes
hypoxia and isch .ernia thus precipitating prodromal symptoms, whilst
the rebound vasodilatory phase causes the headache. Recent
experimental evidence however, would question the simplicity of this
picture.
O'Brien (1971) examined patients who experienced pre-headache
symptoms during the painful phase of their migraine attacks.
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Bilateral measurements indicated that the aura phase of the migraine
was associated with reduced cortical perfusion, hut as a general and
not a local finding. The headache phase was found to he associated
with a small increase in cortical perfusion characteristic of
reactive hyperaemia. O'Brien (1973) determined that although the
aura phase is associated with generalised cerebral vasoconstriction,
the degree may he closely associated with, hut is probably not the
cause of the phase and that an unidentified third factor may he
influential. O'Brien (1973) also stated that vasoconstriction occurs
in the preheadache phase of both classic and common migraine and may
thus be asymptomatic as regards classification, hut an accidental
clinical expression of a more widespread process. Ext;ra-cranial
dilatation was also observed to he a feature of headaches in patients
who did not display prodromal symptoms prior to the onset of the pain.
O'Brien (1973) therefore concluded that attacks of migraine are
probably biphasic in relation to blood flow changes but that in only
a proportion is vasoconstriction associated with symptomatology.
The classification of migraine into 'classical' and 'common' varieties,
depending on the presence of aura symptoms may thus have no patho¬
physiological correlate.
Norris, Hachinski and Cooper (1975) observed global decreases
of cerebral blood flow in the carotid artery territory during the
aura phase of a migraine and considerable perfusion in the headache
phase of the same attack. Unexpectedly, ergotamine tartrate
administered intra-muscularly, brought definite relief of symptoms
with no accompanying change in cerebral blood flow.
Although, as the above studies would indicate, there appears
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to be considerable evidence for vasomotor disturbance being associated
with migraine headaches, the exact mechanisms and the temporal and
spacial aspects of blood flow disturbances remain unresolved.
Attention has been centred upon the increased pulsations
and dilatation of proximal parts of the temporal artery because of
the association between pain and observed changes in cerebral
vasculature. Heyck (1970), however, noted that the 'vascular' theory
would not account for the paleness often displayed by patients
suffering from migraine headaches. Further, he stated that gross
oedema is rarely associated with the painful phase but that it is
common to have laxity of tone characterised by sagging soft flesh
around the forehead and temples and also a dulled appearance of the
cornea. These features would indicate a filling defect in the
peripheral vessels and a diminished capillary blood flow, notwith¬
standing the increased pulsation and prominence of the "temporal artery
which seems paradoxical.
Whilst observing one patient during a migraine attack, it was
noticed that blood extracted from the swollen frontal vein was bright
red and indistinguishable from arterial blood. Secondly, the vein
could hardly be collapsed despite continual withdrawal of blood,
suggesting continual replenishment. On the basis of the above
observations, Heyck (1970) suspected the existence of a transient
arteriovenous 'shunt' network to be responsible for the pain.
To test the 'shunt' hypothesis, seven migraine and seven non-
migraine controls were investigated; arterio-venous oxygen saturation
differences between arterial and venous blood flow in cerebral
vessels were compared with arterial blood from the arm as a control.
Comparisons were made both during the after headaches. The results
suggested that most of the circulating blood being withdrawn from
capillary beds had been excluded from metabolic exchange. The scalp
blood flow was therefore in excess of its metabolic requirements,
being increased in the scalp during a migraine attack even though
skin capillaries were constricted. Heyck (1970) proposed that the
'shunt' hypothesis would be the most plausible explanation for this
phenomenon since it accounts for the rise in total blood flow assoc¬
iated with the increased pulsation of the temporal artery and the
distension of larger veins.
The increase in total blood flow would lead to increased
pulsation and distension of the feeding artery as well as to
distension of the veins because of abnormally high pressures trans¬
mitted through the 'shunt'. At the same time it would produce
ischaemia over a wide area of the neighbouring capillary network.
No evidence of 'shunts' were found during attack free periods
and Heyck (1970) proposed that a large number of bridging vessels,
normally closed, become patent when an attack of migraine is
initiated. The opening of arterio-venous 'shunts' in the scalp and
possibly in the meninges causes higher arterial pressure and an
increase in pulse amplitude, not only in larger arteries (where Heyck
(1970) stated it does little harm) but also in thin walled arteries
lying in front of the 'shunts'. Thin walled arterioles are thus
subject to severe distension, which together with capillary ischemia ,
pain threshold lowering hypoxia and acidosis, could be sufficient
cause of pain.
In all of the above studies, migraine headaches have been the
exclusive focus of attention. Mathew, Hrastnik and Meyer (197&)
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investigated patients with different types of headaches and found
that regional "blood flow varied with clinical phase in migraine
headache patients alone, and that such variations did not characterise
non-migrainous headaches. During the prodrome, "blood flow was reduced
and during the headache phase, increased cortical perfusion was
noted. Those patients who continued to show neurologic signs
during the headache phase did not display standard cerebrovascular
changes as mixed patterns of reduced and increased blood flow were
observed.
Friedman (197 6) stated that vasodilatation alone cannot explain
the painful phase of migraine as the headache is aggravated by
coughing, and the valsalva test, which would infer that a venous
component is involved. Edmeads (1977) measured cerebral blood flow
during attacks of migraine and observed decreases in flow during the
aura phase and increased flow during the headache phase. However, the
distribution in time and space of blood flow changes did not always
correlate with the clinical features of the attack.
This complex clinical picture was reviewed by Blau (1978) who
concluded that the extra-cranial hypothesis was an oversimplification
of the mechanisms involved in migraine headache. Blau's main
criticism centred around the observation that when the patient is
symptom free, arterial pulsations are of the same magnitude as when
the headache is graded 7 on a 1-10 scale of headache severity.
Although neglecting the possibility that the abruptness of the
dilatation may be the precipitant of the pain, Blau (1978) concluded
that the symptoms emerge from calibre variation in the lepromeningeal
circulation. Vasoreactivity of the pial vessels excite or inhibit
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the cortex locally to produce sensory symptoms, this is then
succeeded by a phase of more diffuse alteration in the meningeal
blood flow arteries, capillaries and dural sinuses.
Although the pattern of events as conceptualised by Blau (1978)
differs from Wolff's original hypothesis as to the site of the pain
mechanism; meningeal compared to extracranial vessels, experimental
support for Blau's position is lacking.
In the light of the above evidence it would appear that
focusing exclusively on extracranial vessels as the site of pain
production during a migraine attack may be unwarranted. Certainly,
before conclusions regarding the therapeutic mechanisms of temporal
artery biofeedback can be reached, more should be known about vaso-
reactivity characteristics of extracranial vessels. At present there
is a dearth of information. Sokolov (19&3) reported that when a
volume plethysmograph is placed over the temporal artery, increases
in blood volume were observed when novel or alerting stimuli were
presented and decreases when the stimuli were painful or threatening.
Although plethysmography recordings are a popular method of
investigating vascular activity, difficulties in interpretation arise
from the fact that both venous and arterial sides of the vascular bed
are both under sympathetic control. The plethysmograph therefore
provides a measure of sympathetic nervous system activity without
discriminating between the relative influences of different component
vessels in the vascular bed. Ideally, a measure of arteriolar tone,
venous tone, and the distribution of blood between the true capillaries
and other vessels would be required in order to relate these variables
to the behaviour and psychological state of the subject (Cook , ^^rJbr),
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In conclusion, the vascular theory of migraine would appear
unable to account for the spatial and temporal aspects of cerebral
blood flow in relation to the aura and pain phases of migraine.
The site and pain mechanisms involved in migraine are also questioned,
an important point when considering the rationale underlying temporal
artery biofeedback. Given the lack of knowledge concerning cerebral
vasoreactivity and the indication that plethysmographic recording
provides information regarding gross sympathetic change, evidence
about the mechanisms underlying temporal artery biofeedback is
lacking.
PERIPHERAL CIRCULATION AND MIGRAINE HEADACHES
A considerable amount of psychophysiological research has been
conducted upon peripheral circulation as an index of sympathetic
nervous system activity. Although later chapters will deal in detail
with parametric studies and the clinical application of finger
temperature biofeedback, an evaluation of the rationale underlying
this therapeutic approach will be undertaken.
Much research has been carried out on peripheral blood flow
because it is a system responsive to many stimuli; because of its
activity varying over a wide normal range without danger to the
organism, and because it is a convenient model for the study of
autonomic learning (Lynch and Schuri , 1978). Specific interest
with respect to migraine was suggested by Sargent, Green and Walters
(1972) who observed that in a migraine headache patient, the spontaneous
recovery from a migraine attack coincided with a considerable flushing
in her hands, resulting in a 10°P rise in finger temperature in two
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minutes. Further studies using finger temperature control for the
alleviation of migraine headaches have met with varying success
(details in Chapter 7).
The rationale employed by Sargent, Green and Walters (1973b)
for the use of finger temperature biofeedback in the treatment of
migraine is based upon the limbic system as being the major responder
to psychologic stress (Papez ,1937). Psychosomatic problems are
considered to become chronic somatic processes through the numerous
interconnections between the limbic system and autonomic control
centres of the mid-brain. The chain of events may be conceptualised
as follows: psychologic response - limbic response - hypothalamic
response - autonomic response, leading to a somatic response. In the
case of migraine (which would appear to be part of a stress related
syndrome) the somatic response is a dysfunction of vascular behaviour
in the head related to intense sympathetic overactivation. Vaso¬
constriction in the hands is a function of sympathetic activity and
vasodilatation is a one variable indication of decreased sympathetic
outflow. Sargent, Green and Walters (1973b)thus concluded that
fingerwarming is effective in the amelioration of migraine because
patients are learning to 'turn off' excessive sympathetic outflow.
Much of the research on peripheral circulation with respect to
migraine has taken two lines of enquiry; firstly, whether peripheral
blood flow does provide an adequate index of sympathetic nervous
system activity and secondly, whether migraine is part of a general
vascular dysfunction.
Lynch and Schuri (1978) stated that peripheral circulation
includes two distinct regions, the skin and skeletal musculature.
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The primary function of the muscle circulation is to supply essential
nutrients to the working muscle and remove waste products and heat
resulting from the work. The skin circulation has the primary role
of dissipating and conserving heat in order to maintain a constant
internal temperature.
The vascular structures concerned with heating the skin
consist of an extensive subcutaneous venous plexus, which holds large
quantities of blood that can heat the surface of the skin, and in some
skin areas, arteriovenous anastomoses, which are large vascular
communications directly between the arteries and venous plexuses.
When constricted, the anastomoses reduce blood flow into the venous
plexuses and when dilated they allow extremely rapid blood flow into
the plexuses (Guyton ,1971). The arteriovenous anastomoses do not
appear to be under metabolic control but seem to be governed chiefly
by the central nervous system and reflex influences from temperature
receptors (Detweiler , 1973). Abrahamson (19&7) stated that
vascularity in the fingers is developed beyond the degree necessary
for nutrition of the comparatively thin epidermis, indicating its role
in the control of thermal states. Plutchik (1956) stated that using
finger temperature as 31 index of sympathetic arousal is justifiable
as although the exchange of heat between the body and the environment
occurs over the entire surface, measures of skin temperature of the
fingers and toes serve as the most sensitive indices of blood flow
changes in superficial vessels. Cook (197U) concluded that many studies
confirm that the vasomotor control of the fingers is achieved by the
release of vasoconstrictor tone and in none has any evidence for
vasodilator control been found. Reduced sympathetic tone can in fact
- 39 -
induce vasodilatation equivalent to that produced by a complete nerve
block.
In conclusion it would appear that the circulation of the
fingers does provide a sensitive indication of the level of activation
of the sympathetic nervous system.
Investigations into whether migraine is part of a generalised
disturbance of the peripheral circulation, however, are less conclusive.
As previously stated, the common conception of migraine headache
is that it is due to dilation of the extra-cerebral arteries of the
dura mater and scalp. Schumacher and Volff (19U1) stated that the
therapeutic effect of ergotamine tartrate is thought to be through
its vasoconstrictive effects on cerebral vessels. It has also been
considered that the characteristic vascular changes associated with
migraine might not be limited to the cranial circulation but perhaps
be a generalised dysfunction linked to sympathetic nervous system
difficulties.
Initially, Kerslake and Cooper (1950) observed that blood flow
to the extremities increases when the body trunk is heated; a
response to control internal temperature. The hypothesis under
consideration is that if migraineurs have deficient vasomotor control
then they will exhibit abnormal responses when compared with a
control group under experimental conditions. Appenzeller, Davison
and Marshall (19&3) placed a heat cradle containing six 100 watt
bulbs over the chests of ten migraineurs and ten non-migraine control
subjects. A venous occlusion plethysmograph placed around the right
arm of the subjects monitored vascular responses. Although eight of
the ten migraine subjects did not exhibit responses comparable with
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those observed in the non-migraine controls, an unequal sex distribution
between the groups is considered to have influenced the results
(Morley , 1977). Downey and Frewin (1972) measured the responses of
migraine patients and normal controls to cooling one hand. Apart
from the mean resting blood flow in the hands of migraineurs being
higher than in the non-migraine controls, the cold stimulus test
indicated a diminished level of reactivity in the vessels of migraine
patients. Elliot, Frewin and Downey (197U) recorded the response of
oral temperature and hand heat elimination in a group of normal
females, normal females on oral contraceptives and a group of female
migraine sufferers, to placing one arm in a bath of warm water. It
was noted that older migraine patients had a diminished vascular
response, although the remaining migraine patients displayed normal
vasodilator responses to heating. Morley (1977) concluded that
investigations of generalised vasodysfunction in migraine patients
were characterised by several methodological shortcomings. The lack
of controlled subject selectivity with respect to age, sex, duration
of migraine, medication and menstrual cycle; unclear specification
of diagnostic criteria, inadequate statistical treatment of results,
and a failure to define the experimental phenomenon under invest¬
igation, render the results equivocal.
In conclusion, although there is substantial agreement that
finger temperature is a sensitive indicator of sympathetic nervous
arousal, it remains unclear if migraine is part of a general
dysfunction linked to sympathetic nervous system activities. Until
more is known about vasomotor function in migraine, it is not possible
to conclude whether increased sympathetic nervous system activity is
the cause of a migraine or a result of the discomfort experienced.
CHAPTER 5
BIOCHEMICAL BASIS OP MIGRAINE HEADACHES.
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BIOCHEMICAL BASIS OF MIGRAINE HEADACHE
INTRODUCTION
Prom the previous chapter reviewing the role of cerebral
blood flow changes in migraine headache, there is strong evidence to
suggest a biphasic phenomenon associated with the Classical Migraine
crisis. Prodromal and painful phases of the headache correlate with
cerebrovascular vasoconstriction and vasodilatation respectively.
It would also appear that the vasoconstriction associated with the
aura phase manifests not only in intra and extracranial vessels, but
also in sympathetically innervated peripheral vessels, producing cold
extremities such as fingers and toes. Hence, observed physiological
changes associated with a migraine crisis have implied the existence
of a link between the sympathetic nervous system and migraine headaches.
The types of aura and the site of the pain experienced by
migraineurs would, however, appear to have little patho-physiological
correlation with the temporal and spatial aspects of observed blood
flow changes. It has thus been concluded that generalised
cerebrovasodilatation may be associated with, but is probably not
the cause of, the painful phase and that a third and as yet
unidentified factor may be influential (O'Brien ,1973).
When the variety of triggering mechanisms thought able to
precipitate a migrainous headache is considered, including hormonal
and dietary factors, it is not surprising that biochemical theories
for migraine are prevalent. Support for a biochemical component in
the pathogenesis of migraine is offered by Sicuteri (1979) who stated
that spontaneous vasodilatation and scalp muscle contraction, even if
intense and long lasting, are in themselves incapable of producing
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pain in normal subjects. Vasodilating drugs such as papaverine and
amyl nitrite may provoke intense relaxation and pulsation of arteries
but not induce pain. Only those drugs capable of acting on both
receptors of pain and the smooth muscle of vessels, such as histamine,
kinin and prostaglandin, can provoke vasodilatation and induce pain.
These drugs lower pain thresholds which locally render otherwise
silent pulsations painful.
Evidence for biochemical factors in migraine headache is
available from both clinical and experimental sources. This chapter
will deal with some studies representative of the prevalent areas of
research in an attempt to outline current trends in biochemical
investigation of migraine headaches.
DIETARY FACTORS
In approximately 2%% of 339 migraineurs, dietary factors such
as fats, fried foods, chocolates and oranges have been implicated as
precipitants of migraine headaches, (Selby and Lance ,1960).
Hanington (1967) stated that 30^ of migraine headaches were associated
with the ingestion of chocolate, cheese and alcohol, all of which
contain tyramine. However, Adams, Eeuerstein and Fowler (1980)
reported that the percentage said to be precipitated by these factors
seems excessive and has not been reported by other researchers.
ORAL CONTRACEPTION
Oral contraceptives, pregnancy and the menstrual cycle have
received considerable attention as precipitants of migraine (Selby
and Lance ,1960 ; Kudrow ,1975). The use of oral contraceptives
apparently increases the frequency of migraine headaches (Carroll
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197*1) and- relief from migrainous headaches has been associated with
the cessation of oral contraception and the decrease of maintenance
oestrogen (Kudrow , 1975) .
Lance and Anthony (1966) reported that during pregnancy, 6h%
of those women whose headaches had previously occurred during menses
and 148% of those women whose headache occurred throughout the menstrual
cycle experienced relief from their headaches. In general, various
studies indicate a 60-8C^ remission or improvement in migraine
headaches during pregnancy (Lance , 19&9 » Epstein, Hockaday and
Hockaday , 1975). Among the changes that accompany pregnancy,
intrinsic oestrogen levels increase. As the above studies report
that decreases in oestrogen levels are associated with decreases in
migraine headaches, the results render the role of oestrogen levels
unclear. Further research is thus required to determine the
specific role that changes in intrinsic and extrinsic oestrogen
levels play in migraine.
SEROTONIN
It has been hypothesised that a variety of vasoactive
substances including plasmakinin, serotonin and histamine, play
critical roles in the aetiology of migraine (Fanchamps , 197U)»
fluctuations in the levels of these agents perhaps initiating vaso¬
motor changes characteristic of the migraine attack. Of the
substances mentioned above, serotonin has received the most attention
and, because of serotonin's vasoconstrictive action, it has been
suggested that a release of platelet serotonin results in the vaso¬
constriction associated with the prodromal phase of migraine. The
subsequent depletion of platelet serotonin, decreasing the normal
-in¬
tone of the arteries, would precipitate a passive distention of the
arterial walls. In conjunction with the activity of serotonin,
plasmakinin is thought to be synthesised, and this would reduce the
pain threshold of the receptors in the affected vessels (Fanchamps,
1971+).
The importance of the role of serotonin has been inferred
from a number of studies. Dalessio (1972) reported on a series of
studies conducted in a New York Hospital where a programme monitoring
variations in fluid and electrolyte excretion in association with
vascular headaches of the migrainous type was undertaken. The results
indicated that there was a decreased rate of water, sodium, potassium
and creatinine excretion prior to and during the early phases of the
headache. Increased excretion of water, sodium and potassium were
usual with the subsidence of the headache. These observations were
linked to the action and influence of serotonin, as it not only causes
vasoconstriction but also has antidiuretic and emetic effects.
Slight rises in plasma serotonin levels have been found at the start
of migraine attacks, but more convincing marked falls have been
noted at the onset of the headache phase (Curran, Hinterberger and
Lance ,1965). These changes appear specifically with migraine
headaches and have not been observed in other equally severe but non-
migrainous headaches.
Further support for the role of serotonin in migraine has
been provided by the observed action of reserpine, known to lower
plasma serotonin concentration and found to precipitate attacks in
those liable to migraine. Phenelzine on the other hand is a monoamine
oxidase inhibitor which increases endogenous serotonin production and
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is claimed to reduce frequency and severity of attacks. Serotonin
given intravenously has also been observed to alleviate migraine
attacks (Kimball, Friedman and Vallejo , i960). Dexter and Riley
(*1975) observed decreased plasma serotonin levels at the onset of
migraine pain in three patients reporting nocturnal migraine.
Although elevated serotonin levels result in vasoconstriction and
possible initiation of the prodromal phase, consistent reductions
(60-809^) in platelet serotonin have been reported during the actual
headache phase (Curran, Hinterberger and Lance , 1967). Observations
have also shown that patients with vascular headache have abnormal¬
ities in platelet serotonin content (Deshmukh and Meyer , 1977), and
metabolism (Hilton and Cuming , 1972) , and it has been demonstrated
that platelet monoamine oxidase activity during migraine is
temporarily defective (Sandler, Youdim and Eanington , 197U). These
data, with clinical findings that methysergide (a serotonin antagonist)
tends to reduce the frequency of migraine attacks, provide support
for the role of serotonin in migraine activity.
In an attempt to explain why only some patients should
experience migraine headaches, Sicuteri (1979) described three cate¬
gories of person; hypnoceptors, eunoceptors and hypernoceptors.
Hypnoceptors are characterised by high pain thresholds whilst hyperno¬
ceptors experience pain on slight stimulation and to a degree in
excess of that experienced by the eunoceptor category of patient.
Sicuteri (1979)> however, does not attempt to test the validity of
these conceptual categories, but apparently relies upon the precipi¬
tation of migraine as a defining feature.
Awakening in the early morning with a headache is one of the
commonest modes of migraine onset (Williams ,1966). Hsu, Crisp,
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Kalucy, Koval, Chen, Carruthers and Zilkha (1978) studied
plasma levels of noradrenaline and adrenaline, the serotonin
precursor tryptophan, glucose, insulin and free fatty acid levels in
19 patients who frequently experienced migraine on wakening. Results
showed that plasma total and free tryptophan, glucose, insulin and
free fatty acid levels were not significantly different in the
migraine group compared with a non migraine control group. However,
raised catecholamine levels in the three hours preceding awakening with
migraine were considered to indicate the presence of an as yet unidenti¬
fied stress factor pervading sleep. Sicuteri's (1967) finding that
urinary excretion of 3 Methoxy - I). Hydroxy Mandelic Acid (VMA) was
increased during a migraine attack would he consistent with these
findings. Failure to find any correlation between plasma tryptophan
levels, whether free or bound, and migraine suggests that the role of
tryptophan, if any, in the genesis of migraine is unlikely to be a
direct one; a conclusion contradictory to studies implicating the
role of serotonin in migraine.
The studies considered so far have concentrated mainly upon
assays of excreted serotonin metabolites^ for information about bio¬
chemical activity associated with migraine headaches. Poloni, Nappi,
Arrigo and Savoldi (197U) measured cerebro-spinal fluid 5-h.ydroxy-
indolacetic acid (5-HIAA) levels in patients during spontaneous
migraine attacks, headache free periods and following treatment with
L-tryptophan. The results showed no differences in 5-HIAA levels
between migraine patients in headache free periods and the controls.
Although the values obtained during a spontaneous migraine attack
appeared to be lower than directly preceding the attack, the decreases
did not attain statistical significance. Moreover, all values
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recorded were found to "be within normal limits. Clinical results
however indicated that prolonged L-tryptophan treatment was found to
prevent migraine attacks in three out of five migraineurs. It was
concluded that the therapeutic results could not be explained merely
on the basis of tryptophan administration and its ability to increase
the synthesis of brain 5-HT. These findings may thus illustrate
the existence of a third factor, combining locally with serotonin at
the site of the pain or even acting independently directly upon
dilated vessels in an inflammatory fashion.
PLASMA. KPTIN
Wolff (1963) and colleagues attempted to identify such a third
factor. They collected fluid from subsurface tissue at the site of
local pain of a patient experiencing a migraine attack. A kinin was
identified which induced vasodilatation, lowered pain threshold,
increased capillary permeability and increased vulnerability of the
tissue to injury. Later experiments showed that this kinin was also
liberated during neuronal excitation, although such observations could
not be accomplished with ease in the average patient. When kinin
specimens were obtained, Dalessio (1976) was unable to identify other
mediators which he considered were undoubtedly operative at the
inflammatory sites.
In conclusion, it appears that although the painful phase of
migraine is characterised by vasodilatation, this in itself does not
produce the painful experience. Experiments such as the above suggest
that a variety of vasoactive substances precipitate vasodilatation and
combine locally around distended blood vessels, this combination of
vasodilatation and sterile inflammation producing a migraine headache.
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In all of the above studies, psychological disposition has received
scant attention as a mediator or precipitant of biochemical change.
Given the importance of stress, anxiety and various other emotional
states purporting to be potent triggering mechanisms for the
precipitation of migraine headaches (Pearce , 1971) , the biochemical
picture may be considered incomplete.
CHAPTER 6
PHARMACOLOGICAL ASPECTS OP THE TREATMENT AND
MANAGEMENT OP MIGRAINE HEALACHES.
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PHARMACOLOGICAL ASPECTS OF THE MANAGEMENT AND TREATMENT OF MIGRAINE
HEADACHES
INTRODUCTION
According to conventional theories (Volff 1963)» migraine
headache is considered to "be a peripheral disorder, provoked by
noxious agents in the vessels of the scalp, meninges and extra and
intra-cranial tissues. Thus, painful stimuli are considered to be
mechanical: sphygmic waves on an otherwise distended extra-cranial
artery. Later studies provided evidence for the involvement of
other pain producing substances, such as neurokinin and serotonin,
of which the latter has received considerable attention. (Sicuteri,
1979).
Previous chapters have included reviews of these theories, and
although a considerable amount of empirical data is available, a
unitary theory explaining the occurrence of migraine is still elusive.
However, the major types of drugs used in the control of migraine
reflect the importance attached to the mechanical and serotonin
theories.
This chapter will not attempt to provide an exhaustive review
of the relative merits of different drug therapies, but is designed
to draw attention to the disadvantages of managing migraine with
drugs.
Migraine is characterised by severe headache so one might
assume that analgesics would play an important role in its treatment.
Panchamps (1979) however, states that the effect of analgesics upon
conventional migraine attacks is in fact very poor. As a consequence
of this, the following most frequently administered drugs will be
described in terms of their proposed mode of action, their effective-
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ness in clinical trials, and their side effects. These drugs are:
ergotamine tartrate, methysergide, propranolol, clonidine and
pizotifen.
ERGOTAMINE TARTRATE
Ergotamine tartrate is the compound which, so far, has given
the best results in the treatment of migraine attacks. It is an open
question whether its therapeutic effects are due solely to its vaso¬
constrictor action or whether other pharmacological actions are
involved (Sicuteri, 1959). On testing the compound on 18 patients,
Sicuteri (1959) considered it to have considerable therapeutic and
prophylactic potential. Ryan (1970) stated that ergotamine tartrate
is not habit forming, and when it is administered with caffeine
(itself a vasoconstrictor), vasoconstrictor effects appear to be
increased with lowered doses of ergotamine. Hence, Ryan (1970)
considered its mode of action to be vasoconstrictive, restoring
cerebral vascular tone and thus interrupting the pain producing
mechanism. The side effects noted by Ryan (1970) consisted almost
entirely of gastrointestinal disturbances, including nausea, vomiting
and stomach cramps.
Although Waters (1970) found that ergotamine tartrate was not
as effective as a placebo, Wilkinson and Wall (1973) stated that in
acute attacks, intra-muscular injections of ergotamine tartrate are
effective in over "JCP/o of patients. This study indicated that an
excess of ergotamine could produce ill effects, which went against
the original recommendation by Sicuteri (1959) that the use of ergo¬
tamine administered prophylactically would be beneficial. Side effects
observed through over-administration of ergotamine included nausea,
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vomiting and listlessness. Another feature of excess ergotamine
tartrate is, paradoxically, the precipitation of migrainous type
headaches which can only be relieved by further doses of ergotamine
tartrate. Termination of ergctamine tartrate therapy also causes
withdrawal headaches which are again indistinguishable from migraines
and can last up to 72 hours (Lucas and Falkowski , 1973).
Prolonged arteriospasm after overadministration of ergotamine
tartrate has also been observed (Byrne-Quinn ,19614.), In this case,
12 mg Migril tablets consumed daily for six weeks caused a patient's
feet to become numb and discoloured with no pulse evident below the
femcrals. Cyanosed fingers and toes have also been observed.
Bross, Cisek, Czereda and Kozminski (1963) described the case
of a patient who developed gangrenous ulcers on the feet after taking
ergometrine for abnormal bleeding after the birth of a child.
Arterial insufficiency cleared after ergometrine had been withdrawn
and the patient had been bed rested for three months. Patients
displaying ergotism have also been found to have a higher incidence
of other disorders, particularly diabetes and collagen diseases
(Hbkkanen, Kallansanta and Waltimo ,19714-).
MBTHYSERGIBE
Methysergide is prescribed as a prophylactic medication in the
management of migraine. Although methysergide is classed as a drug
which inhibits the action of serotonin on receptor sites and not as a
vasoconstrictor (Bakal , 1975), there are reports of vascular
complications (Rackley, Mengel, Pomerantz and Mcintosh , 1966). Acute
ischaemia of the lower extremities due to severe arterial constriction
has been reported (Johnson, 1966), and retroperitoneal fibrosis and
- 52 -
tolerance leading to a steadily increasing consumption of the drug
have also been observed (Lucas and Falkowski , 1973)*
Rackley, Mengel, Pomerantz and Mcintosh (1966) reported
unusual side effects with two patients using methysergide. The
patients developed chest pains and vasospasm of the lower limbs, the
chest pains being relieved by administration of nitroglycerine
and carotid massage. Discontinuing methysergide caused the disappear¬
ance of the chest pains and a return of the pulses in the lower
extremities. Johnson (1966) observed that the side effects of
methysergide were usually mild and transient: they included nausea,
giddiness, dizziness, epigastric distress, insomnia, difficulty in
concentrating, limb pains and intermittent claudication accompanied
by cramping extremity pains. On cessation of the drug, acute
peripheral ischaemic reactions required five or more days to subside,
and rebound headaches complicated the patient*s recovery. Lucas and
Falkowski (1973) reported on five patients who displayed cyanosed
fingers and weak peripheral pulses, pruritis of the hands, burning
and watering of the eyes and a continual urge to defecate. One
patient gave clear signs of developing withdrawal headaches on
termination of methysergide therapy, after tolerance to the drug had
necessitated increased dosage.
PROPRANOLOL
Propranolol is classified as a drug whose action is to block
beta-adrenergic receptor sites in blood vessels and therefore prevent
vasodilatation. It is considered to be most effective when used
prophylactically. Wideroe and Vigander (197U) compared propranolol
with a placebo in a double blind clinical trial and found that
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propranolol reduced headache frequency to a significantly greater
extent than the placebo. Borgensen, Lanng and Eckart-Moller (197U)
employed a double-blind, single cross-over trial to compare propranolol
with a placebo. The results indicated that propranolol was slightly
better in reducing mean number of attacks than the placebo: a reduction
to 75% of the pretreatment level with the placebo compared with a
reduction to 66% of the pretreatment level with propranolol. However
nine of the thirty subjects using propranolol were made worse.
CLONIDINE
Clonidine was originally used as a hypotensive drug as it was
thought to act on the central sympathetic outflow (Wilkinson, Neylan
and Rowsell , 1972). Later it was found to have a direct effect on
reducing the responsiveness of peripheral blood vessels (Heathfield
and Ralman , 1972). It was first used as a prophylactic treatment
for migraine in 19^9 (Wilkinson et al, 1972) . Studies have
shown that 70% of those patients whose migraine is precipitated by
the ingestion of tyramine-containing foodstuffs are helped by this
drug (Wilkinson et al, 1972). Although encouraging results .
regarding the therapeutic efficacy of the drug have been reported
(Sjaastad ,1972), subsequent findings have cast doubt on it. Shaw
and Saunders (1972) used a double blind, cross-over trial to evaluate
the efficacy of clonidine compared with a placebo, the results of
which failed to attribute any therapeutic benefits to clonidine.
Neither frequency nor duration of attacks diminished and the authors
were at pains to point out that any potential benefits were not obscured
by inclusion in the trial of patients whose excessively frequent and
prolonged attacks might be attributed to emotional factors. It was
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however concluded that "many patients improved with the passage of
time regardless of treatment, perhaps due to the special interest
that had been taken in them, the opportunity to discuss problems and
the hope that the cure was just around the corner".
PIZOTIPEN
Pizotifen is used as a prophylactic medication. Initial
pharmacological reports suggest that it has a marked anti-serotonin
activity and a powerful antihistamine effect. Unlike methysergide
it has no effect on pain produced by the synergistic action of
serotonin and bradykinin on vessels. Side effects include drowsiness,
weight gain and mental depression, which constitute the commonest
causes of subjects defaulting in clinical trials. All controlled
studies have shown pizotifen to be a significantly more effective
therapeutic agent than placebo, but less effective than methysergide.
In other forms of headache - tension, post traumatic, inflammatory
and trigeminal neuralgia - pizotifen has generally had little effect
(Speight and Avery , 1972).
CONCLUSION
This brief review is an outline of some of the most popularly
recommended and administered drugs in the acute treatment and
prophylactic management of migraine headaches. As yet, no effective
treatment has been developed that does not have significant side
effects and risks that seriously affect the patients' acceptance.
The plethora of drugs available, of which the above are a sample, is
evidence of the lack of a truly successful treatment of migraine
(Sargent, Green and Walters ,1973b). Although some are effective in
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some respects; such as the vasoconstrictor and serotonin inhibitory
effects of ergotamine and methysergide, dependence, side effects,
withdrawal headaches and peripheral arterial complications made
continued use inadvisable. Bakal (1975) would contend that the
pharmacological prevention of headache is only successful for as long
as the patient continues to use it. Given the disadvantages and
limitations of drug therapies as outlined above, and the fact that
pain relief may be a 'green light' for some patients to undergo
further those stresses that originally precipitated the headache, an
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Wide public interest has been aroused over the past ten years
by the development of biofeedback techniques. It not only offers a
method of investigation into the control of internal physiological
processes, but also suggests the potential benefit in applying these
techniques for the amelioration of certain disorders of physiological
functioning.
This review will be confined to two major aspects of the
biofeedback literature:
Section 1. An appraisal of the empirical studies concerned with
demonstration of volitional peripheral temperature control
(finger and differential earlobe temperature), temporal
artery amplitude and digital pulse amplitude control.
Section 2. An appraisal of the literature relating the clinical
application of volitional finger temperature control,
temporal artery amplitude control and relaxation techniques
in the amelioration of migraine headaches.
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A. Biofeedback ; Methodological Issues
Although this review will consider both peripheral temperature
and temporal artery amplitude biofeedback studies, the relatively
extensive empirical literature available on finger temperature control
lends itself to highlighting methodological and procedural aspects
of biofeedback research. This is not to say that temporal artery
amplitude studies are not subject to the same issues, merely that
they are still to be reported extensively in the literature.
Finger temperature is a variable of considerable interest to
biofeedback researchers since peripheral temperature cannot only be
measured with near perfect validity and reliability, but the changes
which do occur are slow and hence 'noisef relative to 'signal* is low.
Although it would seem to be a straight forward matter to determine
whether finger temperature can be brought under voluntary control
given the complexity and sensitivity of the biofeedback equipment
available, there are difficulties inherent in such investigative
procedures. The following section will outline some of the procedural
and methodological factors.
One of the most important independent variables in biofeedback
research is the display of the function under investigation. Display
modalities are visual, auditory, digital and occasionally tactual;
within each modality there is a wide variety of possible feedback
displays. An appreciation of the complexity of possible feedback
combinations can be acquired by considering a simple taxonomy of
feedback displays which could be applied across the four modalites
mentioned (visual, auditory, digital and tactual);
Within versus end of trial feedback : information presented
'within' the trial period to monitor ongoing progress, or
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presented on conclusion of the trial period as an assessment
of overall performance.
Proportional versus binary change : presentation of a signal
whose value is analogous to the activity level of the function
under investigation (often referred to as 'analogue1 feedback).
Proportional feedback is a quantitative measure of change
whereas binary feedback is a qualitative measure giving
information that change is apparent, but not the amount of
change.
Continuous versus non continuous feedback : information
presented instantaneously may be considered as being continuous;
information presented at discrete intervals representing the
state of activity since the last reading was presented, may
be considered to be non continuous information.
The aim of biofeedback is to present clear and potentially
useable information to the subject. Continuous1 feedback of a
rapidly fluctuating physiological function may not provide meaningful
information to the subject, even though the information may be detailed
and accurate. Similarly, 'Binary1 feedback may provide sufficient
information if a set criterion of change is desired, (e.g. to increase
or decrease finger temperature) but not if quantitative aspects of
the subjects1 performance are under observation. Hence it is
important to consider the purpose of biofeedback in determining the
type of biofeedback display to be used.
There is a dearth of information regarding the empirical merits
of the above displays and parameters. Information that is available
covers a diversity of physiological functions; E.E.G., (Lubar and
Bahler ,1976) ; Frontalis muscle activity (Budzynski and Stoyva
- 60 -
1969) ; Heart rate increases and decreases (Blanchard, Scott, Young
and Haynes , 197U Colgan , 1977) . Yates (1980), in a review of
the literature regarding the efficacy of different types of feedback,
states that unsystematic approaches to the problem have not enabled
any clear results to emerge. Certainly, an unsatisfactory situation
arises when biofeedback from a specific system is presented to a
subject, and little is known about the reactive effects of measurement
devices on that system, and of other possible counfounding factors.
Before further considering methodological issues related to
biofeedback and especially finger temperature control studies, it
should be made clear that measures of finger temperature are not
linearly related to finger blood volume. At lower finger temperatures,
relatively small increases in blood volume can cause large increases
in temperature. When skin temperature has reached around 3i|°C,
further considerable increases in blood flow are accompanied by small
rises in temperature (Pelder, Russ, Montgomery, and Horowitz , 195U).
Given that finger temperature cannot be used to measure absolute
blood flow changes in the finger and that ' thermal lag' effects delay
indications of change, skin temperature recordings may still give
valuable information regarding peripheral circulation when changes
are constant over several minutes (Lynch and Schuri , 1978).
Although skin temperature changes constant over several minutes
may give information about peripheral circulation,methodological issues
regarding the acquisition and interpretation of this information
should be considered. One important and influential variable is the
phenomenon of naturally occurring variation or the 'drift' effect.
In peripheral blood flow studies, drift is often observed as a
gradual decrease in temperature, especially obvious in the fingers.
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It has been noted that ambient temperature has a differential effect
upon the rate of drift in finger temperature studies; the lower the
ambient temperature, the faster the rate of drift. The phenomenon
of drift is investigated in a pilot study included in this thesis.
The importance of drift effects when interpreting physiological
information is obvious. Differential influences of drift on the
voluntary control of finger temperature could lead to situations
where decrease values are accentuated and increase values are
minimised; hence the importance of control and baseline information.
Yates (1980) recommends two methods for countering the effects of
drift. The first controls for the effects of room temperature,
outside variations in temperature and the effects of activity prior
to the subject entering the baseline phase by allowing the subject
to sit in the experimental room, held at a constant temperature, for
half an hour before starting the experiment. The second method is
to use no-feedback intertrial intervals as discrete baselines within
the feedback session. No-feedback intertrial intervals have however
been shown to contaminate succeeding trial periods. Blankstein,
Zimmerman and Egner (1976) proposed that this is because subjects are
continuing to plan strategies for the next trial period rather than
resting. Peper (1976) concluded that poor control is obtained during
the trial periods because rapid switching from control to rest
periods does not give subjects an opportunity to adequately test con¬
trol strategies. Yates (1980) also suggested that a major disadvan¬
tage of employing intertrial intervals as a means of controlling
for drift is that a reverse effect or upward drift can be demonstrated.
Sex differences in finger temperature values have also been
observed; not only do females tend to have lower starting temperatures
but they also drift downwards faster (Yates ,1980).
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As well as the above methodological and physiological factors,
Taub, Emurian and Howell (197U) claimed that 'person factors' are also
influential in biofeedback. Taub et al (1971+) stated that
peripheral response control is facilitated by an informal, warm and
friendly approach by the experimenter to the subject. However, no
information was given about the type or nature of the feedback task,
nor of the instructions administered. Given the absence of such
information and the inability to replicate these findings, Lynch and
Schuri (1978), the results should be treated as equivocal.
In conclusion, this selective review has considered some
aspects of the methodology of biofeedback research. A pilot study
specifically concerned with 'drift', its implications for baseline
administration and physiological response interpretation is presented
later in the study. It is however clear that a multitude of complex
methodological issues make biofeedback a fruitful area of research.
The following is a review of empirical studies concerning the
biofeedback control of peripheral blood flow. It is not a definitive
analysis of all methodological issues in biofeedback, but is rather
an attempt to evaluate the empirical findings within the context of
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AUTHOR INDEPENDENT DESIGN DEPENDENT SUBJECT/SESSION OUTCOME
VARIABLE VARIABLE
GARDNER Instructions Groups Temperature 40 subjects. Changes in temp in
and to increase of right 12 x 30 minute specified direction.
Keef e 7s decrease index finger training sessions After 4 sessions -
(1976) temperature on 12 consecutive subjects vho knew that
and days. information was
information Tone & visual related to finger
vs no centre needle temp showed superior
information biofeedback performance.
regarding After 12 sessions, no
temperature difference.
Gillespie Group A Controlled Finger 12 Biofeedback
(1981) Finger temp temp 6 females. Superior finger temp
feedback 6 males. elevation than
Group B 5 training imagery arid
Task relevant sessions. suggestion.
imagery and Session Reliable differences
explicit 10 x 80 second in performance
verbal trials within four sessions
suggestion 9 x 10 second
intertrial
intervals
Herzfeld Neutral vs Group Whole hand 5 normal subs. Small but reliable
and thermal temp change. 3 to decrease differences in whole
Taub suggestions From five 2 to increase hand temp in 4 of 5
(1976) and locations on 2 or 3 baseline subj ects.
instructions the hand days. Greater temp changes
to increase 10 training days on suggestion than
and decrease non-suggestion days
finger temp
Hunter, Consistent Group Finger temp 60, 6-9 yr old Average increase of
Russell, vs mixed children. 0.38°F.
Russell reinforcement 30 learning Consistent reinforcemei
and and disabled better than mixed.
Zimmerman presence vs 30 matched Learning disordered
(1976) absence of normals, children better than
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AUTHOR INDEPENDENT DESIGN DEPENDENT SUBJECT/SESSION OUTCOME
VARIABLE VARIABLE































































in baseline period .





King Experiment 1 Group Finger temp 24 subjects No difference in
and Instructions to 5 sessions finger temp across
Montgomery increase finger all groups










AUTHOR INDEPENDENT DESIGN DEPENDENT SUBJECT/SESSION OUTCOME
VARIABLE VARIABLE
King Experiment II Group Finger temp 32 subjects Group IV, greater
















Koppman, Instructions to Single Cephalic 9 migraineurs Acquired control for
McDonald increase vs group vasomotor 6 oV dilation & constriction
and decrease response 3 $ of superficial temporal
Kunzel blood volume (CVMR), 2-4 weeks artery amplitude.
(1974) pulse (BVP) of EMG Zygomatic 2 to 3 sessions Only 'blood volume
temporal artery process , per week pulse' (BVP) modulated.
EMG Trapezius, Independent of other
Finger pulse responses thus specific
volume « cerebral control
Chest
respirometer#
lynch, Experiment 1 Group Experiment 1 4 children Experiment 1
Hama, Differential hand temp (9-11 years) Three out of four
Kohn hand - hand differences successful in complying
and temperature
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Simpson Finger pulse Group Finger pulse 20 subjects
and volume volume. 2 sessions
Nelson biofeedback Respiration







Finger pulse volume is
significantly higher
in the feedback group




Snyder Digital Control Digital
and vasoconstriction vaso-

































































Survit Simple vs Group Digital 15 subjects (Simple: Analogue
(1977) complex temperature 2 sessions meter feedback
feedback Complex: Above, with
binary feedback with
lights and tones)
Both groups - significant
increase but complexity














































































































The role of relaxation in volitional finger temperature control studies
As Engstrom (1976) suggested that some degree of mental and
physical passivity is important during the performance of biofeedback
tasks, it is important to determine whether changes in finger
temperature are a function of the feedback or a consequence of the
passive state of the subject.
Thompson and Russell(l976) and Attfield and Peck (1979) have
found that feedback of finger temperature with instructions to
increase finger temperature, facilitated vasodilatation to a
significantly greater extent than progressive relaxation alone.
Price and Tursky (1976) found no incremental utility in the use of
feedback over relaxation exercises in producing finger temperature
increases. However, these findings may have been a function of the
single session design employed by Price et al (1976) rather than the
subjects responsiveness.
Ohno, Tanaka, Tayeka and Ikemi (1977) trained independent
groups of subjects to raise and lower finger temperature. Although
the increase and decrease groups differed significantly after
training, neither succeeded in obtaining a significant change from
its own baseline level. Two control groups (no feedback and false
feedback) produced results which indicated that very little success
had been achieved in this study. The subjects of this experiment
were however uninformed about the nature of the task and thus no
conclusive evidence about the effects of feedback upon finger
temperature can be drawn.
Although these findings may question the sensitivity of
finger temperature as an index of relaxation, a comparison of high
and low arousal states provides a different impression of peripheral
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blood flow sensitivity. Boudewyns (1976) monitored finger temperature
during relaxation periods and periods during which electric shocks
were threatened and administered. The electric shock or 'stress'
periods, corresponded with a decrease in temperature whereas
relaxation periods were characterised by an increase in finger
temperature. Crawford, Friesen and Tomlinson-Keasey (1977) observed
decreases in finger temperature in subjects allowed to discuss
anxiety provoking topics, but no increases in peripheral temperature
when pleasureable topics were discussed; rather there appeared to
be a return to baseline levels. The three minute trial periods used
in this study may not have provided sufficient time for the 'passive'
vasodilatory response to develop fully, carry over effects and
thermal lag masking potential vasodilatory responses. Butschek and
Miller (1980) repeated this experiment incorporating a nine minute
trial period (3x3 minute periods) with Anxiety and Pleasure topic
groups. Both groups showed a decrease in finger temperature;
however the anxiety topic groups displayed a significantly greater
decrease, a result supporting that of Crawford et al (1977).
In conclusion it appears that 'stress' responses are associated
with peripheral vasoconstriction and that relaxation may cause a slow
return to baseline measures. Evidence also suggests that biofeedback
induced finger temperature changes may be significantly greater than
those associated with relaxation. These conclusions are equivocal
as confounded designs and the lack of adequate controls confuse the
issue.
The role of information display in volitional finger temperature
control studies
Fundamental to biofeedback experiments is the presentation of
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a physiological response or an analogue of that response, so that
control can be acquired. Methods of presenting the information
should therefore be investigated to determine their relative efficacy
in enabling subjects to acquire feedback skills.
Thompson and Russell (1976) administered counter-balanced
presentations of auditory, visual and no feedback to subjects
instructed to raise their finger temperature. Financial reward and
reinforcement are confounded in this design, financial reward being
based on performance although rate of reward was yolked to no-feedback
and relaxation training groups as controls. Although the type of
feedback is not adequately described and the effects of financial
reward upon feedback performance is yet to be determined (Hume
1977) > the authors concluded that feedback is necessary and a
training effect is evident within I), x 15 minute periods.
Surwit (1977) examined 'complexity* of presentation and found
that analogue meter feedback representing 'simple* feedback produced
as effective results as 'complex* feedback using binary feedback
with lights and tones. The single effect of any component was however
not investigated.
The use of 'consistent* (contingent) and 'mixed' reinforcement
for finger temperature elevation was studied by Hunter, Russell,
Russell, and Zimmerman (1976). In this experiment 30 learning
disabled 6-9 year old children were age matched with 30 normal
children. Feedback consisted of a complex arrangement of moving toy
trains and variable intensity lights. Hunter et al (1976)
found that learning was demonstrated only for the contingently
reinforced group. An incidental finding that the learning disabled
children were superior in performance to the normal children
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indicates grounds for further research.
Given that "biofeedback equipment is relatively expensive, it
would appear logical to investigate the simplest and most economical
displays. This does not seem to "be a consideration in the above
experiments. Keen and Montgomery (1978) further complicate the issue
in comparing Interoceptive reinforcement (IR) with Elicited operant
paradigm (EOP) for dominant and non-dominant hands using meter feed¬
back and a no-feedback control. IR is the presentation of an overall
subtle sensation of warmth and a soft red light contingent on finger
temperature elevation, the monitored hand shielded to prevent effects
on the transducer. EOP is the emersion of the non-monitored hand in
alternating cool and warm baths to capitalise upon vasomotor reflexes.
Although EOP appeared to be most effective in eliciting temperature
increases the greatest increases were found during the baseline
period across all groups. The results from this experiment may have
been influenced by a number of factors including drift effects.
Laterality of vasomotor responses in the EOP condition may have
caused a 'consensual reaction* (Lynch and Schuri , 1978) which would
indicate that temperature changes were due to the external thermal
conditions rather than internal operant control. Also the effects of
changing ambient temperature; albeit minimal as in the IR condition,
may also have led to a consensual reaction.
The role of instruction in volitional finger temperature control studies
The presentation of biofeedback is usually accompanied by
instructions regarding demands of the task. Ohno, Tanaka, Tayeka and
Ikemi (1977) provided no formal instruction with a temperature
increase and a temperature decrease group; the presence or absence
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of a light was the only form of information the groups received. A
no-feedback and a false-feedback group were included as controls.
The results indicated that temperature changes during the three
sessions significantly differed between the increase and decrease
groups but neither group differed from their own baseline. The results
could indicate the redundancy of 'instructions', although very
different results may have been observed had instructions been used.
Also, considering that only three sessions were used and that binary
visual feedback provides limited specific- information about the amount
of control achieved, the results are supportive of a biofeedback
effect.
In the typical biofeedback experiment, increase and decrease
instructions have been used as control conditions without using a
control group instructed to maintain finger temperature stability.
It is therefore often difficult to determine whether 'increase' and
'decrease' control has been established independently, or whether
significant differences are due to one function changing more than
the other. This question will be approached in more detail in the
pilot study section.
Gardner and Keefe (1976) reported significant differences
between groups instructed to 'increase' and then 'decrease' finger
temperature. An 'information' and a 'no-information' condition
regarding the meaning of the feedback information, was employed across
both experimental conditions. After four sessions, subjects in the
'information' condition showed superior performances in both of the
instructed directions. After twelve sessions, however, no difference
in the ability to increase and decrease finger temperature was evident
between the two information groups. It would therefore appear that
- 77 -
instructional set is not essential to the subjects overall performance
and skill acquisition.
Surwit, Shapiro and Feld (1976) observed that temperature
differences with opposing instructional 'sets' was primarily due to
a change in the decrease direction. In contrast, Keefe (1975)
compared increase and decrease instructions with subjects given
differential finger-forehead temperature feedback; absolute finger
temperature changes were also monitored. Visual and auditory analogue
feedback were presented over 12 15-minute sessions. It was found that
finger temperature changed in the specified direction and that
differential finger temperature correlated highly with absolute finger
temperature, validating earlier observations of Sargent, Green and
Walters (19736). Keefe and Gardner (1979) extended the above study
which had used 12 sessions to investigate the effect of a larger
number of experimental sessions. Results of the first part of the
study indicated highly significant finger temperature differences
after five sessions, the second part of the study employed 20 sessions
and although a significant effect was noted after three sessions, the
opportunity for further practice did not enhance the effect.
Instructions given to subjects in biofeedback experiments may
include suggestions regarding mental strategies which might be
employed to gain volitional control. King and Montgomery (1980)
suggested that increases in finger temperature can only be obtained
by skeletal mediation, independent of instructions. Comparing an
autogenic instruction, a contingent feedback, a non-contingent feed—
back and a financial incentives group (without feedback), no
differences in finger temperatures were noted. When, in a second
experiment, the financial incentive group was replaced by another
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contingent feedback group allowed to use a range of specific physical
methods for elevating finger temperature, an increase was noted for
this group.
Although acceptable somatic exercises included isometric
tension and changes in respiration, no controls for the influence of
limb movement were applied. King and Montgomery (1980) admit the
absence of constraints to prevent subjects positioning their fingers
towards their body, palms of the hands or other heat sources. As
Lynch and Schuri (1978) have observed that isometric exercises of
the shoulders and trunk and a variety of respiratory manoeuvres
succeed in decreasing finger temperature, it may be that the finger
temperature increases reported were achieved by uncontrolled
strategies.
In conclusion, it appears that instructions are not critically
important in the acquisition of finger temperature control providing
feedback is available. It has also been suggested that the minimum
number of feedback sessions required to achieve finger temperature
control is three and that additional sessions do not increase the
subject8s ability to further increase finger temperature (Keefe and
Gardner , 1979). King and Montgomery (1980) concluded that the role
of somatic mediation was a more important factor in achieving finger
temperature control than instructions, contingent, non-contingent
feedback and financial incentives. However, lack of adequate controls
render the evidence equivocal.
The role of suggestion in volitional finger temperature control studies
Instructions are a set of directives given by the experimenter
to their subjects in an effort to orientate them towards the task
characteristics in the feedback situation. Instructions may include
- 79 -
proscriptive and prescriptive statements regarding the acceptability
of certain types of behaviour during the feedback session. Extending
or supplementing instructions with proposals regarding cognitive
strategies that may influence a subject's ability to effect desired
changes may be construed as introducing the element of 'suggestion1.
Suggestion need not always be verbal and explicit; financial
incentives based upon performance, thermally related autogenic phrases
and hypnosis may all have an effect upon performance of feedback tasks,
hue to the often abstract and individual nature of suggestion,
investigations into its effects are fraught with methodological
difficulties. Largely as a consequence of these factors, the role of
suggestion in biofeedback is seldom controlled for in experimental
studies.
Herzfeld and Taub (1976) compared neutral and thermal suggestions
for subjects instructed to increase and decrease whole hand temperature.
Temperature changes were taken from five locations on the hand and it
was found that four out of five subjects were able to produce small
but reliable changes in whole hand temperature; the greatest changes
occurring on days thermal suggestions consistent with instructed
temperature changes were administered. More recently, Herzfeld and
Taub (1977) found that a combination of externally imposed (as
compared with internally generated) thermal suggestions and biofeedback
is more successful in eliciting temperature changes than biofeedback
alone. Again temperature elevation and depression instructions were
used as comparisons. Keefe (1978) compared the effects of thermal
suggestion, response-specific instruction and instructions to rest;
with and without finger temperature biofeedback. Although response-
specific instructions plus biofeedback and thermal suggestions plus
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biofeedback produced significant increases in finger temperature,
thermal suggestions without biofeedback also produced significant
finger temperature increases. These effects were maintained over a
two week follow-up period, indicating that the subjects who received
thermal suggestions were able to increase finger temperature without
the aid of feedback. This was not the case with subjects who received
response-specific instructions but were not provided with feedback.
These findings have not however been replicated; Gillespie (1981)
found that thermal suggestions presented visually and verbally,
relevant to increasing finger temperature, were not as effective as
feedback alone.
In conclusion it would seem that the role of suggestion in
finger temperature control is of considerable interest. Quantitative
evidence implies that the combined effects of thermal suggestion and
feedback are superior to the effects of feedback alone. However, the
lack of conclusive evidence may be a result of the poorly designed
experiments that characterise the area, hence it would seem a vital
area for further research.
The role of imagery in volitional finger temperature control studies
Richardson (1969) stated that two types of imagery have been
used in biofeedback, memory imagery (self induced images of warm and
cold conditions) and imagination imagery which is a term covering a
wide variety of cognitive strategies. Imagination imagery is
distinguished from memory imagery mainly by its lack of personal
experiential reference, by its being more vivid than memory imagery
and by its tendency to occur in unusual states of consciousness.
The importance of imagination imagery lies in its potential link with
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the subjective states alleged to be associated with some kinds of
biofeedback training and the possibility that these states may act,
via imagination imagery, as links with the somatic changes which
biofeedback produced.
Maslach, Marshall and Zimbardo (1972) reported that induced
hypnotic imagery was capable of creating controlled peripheral skin
temperature changes. Although the results show substantial bi¬
directional changes between two hands in experimental compared to
control subjects, there was no information regarding ambient tempera¬
ture or method of temperature recording. Most importantly, it is
not clear whether the temperature changes were absolute or differential
changes due to decreases in one hand relative to the other; a
phenomenon reported by Surwit, Shapiro and Feld (1976). Clark and
Forgione (197U) found that gingival and digital responses to thermal
images did not correspond in any systematic way, and that 'cold' and
'warm' memory image instructions produced the same digital vascular
responses; initial constriction followed by progressive dilatation.
Blizard, Cowings and Miller (1975) taught subjects to imagine heaviness
and warmth or coolness and lightness in their hands. Significant
increases in heart rate and respiration rate accompanied the induction
of coolness and lightness but the reverse was not the case for the
induction of heaviness and warmth and no differences in finger
temperature resulted from differential induction of the two states.
Dugan and Sheridan (1976) found that subjects instructed to imagine
their hands in very warm water or in ice cold water (but with no
feedback) produced significant increases and decreases in peripheral
finger temperature respectively. All ten subjects using cooling
imagery showed a significant change in one hand while six showed
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corresponding changes in the other hand as well. These results were
however well within the range of temperature changes that would be
expected for drift effects (Yates , 1980).
It has been suggested that peripheral blood flow changes and
the ability to influence and control physiological responses may not
only vary with levels of arousal (Boudewyns , 1976 ; Crawford,
Friesen and Tomlinson Keasey , 1977 and Butschek and Miller , 1980),
but also as a function of personality variables. Roberts, Schuler,
Bacon, Zimmerman and Patterson (1975) investigated the ability to
produce differential hand temperature changes with high and low
scoring subjects cn 'hypnotic susceptibility' and 'absorbed imaginative
attention' scales. Large and reliable performance and learning
effects were found to be unrelated to hypnotic susceptibility or
capacity for absorbed imaginative attention. As no instruction as to
the use of imagery was given, the results should be treated as
equivocal.
In conclusion, the relative significance of feedback and imagery
instructions has been poorly researched. The results render any
comparative evaluation regarding the importance of imagery and bio¬
feedback as undetermined.
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D. Pulse amplitude response studies
Compared with finger temperature feedback, there is a dearth
of information about the conditionability of vasomotor pulse activity.
Vasomotor activity in the skin is under sympathetic control, the
vessels are therefore capable of active vasoconstriction but passive
vasodilatation (Cook , 197U). The mechanism underlying vascular pulse
conditioning is similar to that underlying finger temperature feedback;
in that vasolability of peripheral pulsations is related to the arousal
level of the sympathetic nervous system.
Snyder and Noble (1968) reinforced subjects for decreasing
finger pulse volume, using binary-visual feedback. A group of subjects
reinforced for maintaining vasomotor stability, also given binary-
visual feedback, and a no-reinforcement group, were used as controls.
A significant increase in the number of vasoconstrictions during the
acquisition phase of the experiment was observed for the contingently
reinforced group. Stern and Pavloski (197U) replicated the Snyder and
Noble (1968) study using 30 experimental subjects and 60 yolked
controls, half of whom received reinforcement identical in time and
number to the experimental group (true yolking) and half who received
the same number of reinforcements per minute but never for vaso-
constricting (partial yolking). Highly significant group differences
between the contingently reinforced, true and partially yolked groups
were found. Hence it would appear that there is evidence to suggest
that biofeedback conditioning of digital vasoconstriction is possible.
Simpson (1973) and. Simpson and Nelson (1976) found that vasodilatation
of the digital pulse could be elicited to an extent greater than that
observed for false feedback or for progressive relaxation groups.
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These findings appear consistent with the observations recorded
during finger temperature feedback experiments although Yates (1980)
stated that the results of Simpson (1973) Simpson and Nelson
(1976) were influenced by drift effects.
Increasing interest has developed in the biofeedback control
of cephalic vasomotor responses, the reason being that direct
modification is obtained at the alleged site of the primary 'pain
mechanism1 responsible for migraine headaches (Wolff , 1963). Two
studies of particular interest were conducted by Christie and Kotses
(1973) and. Koppman, McDonald and Kunzel (197U). Christie and Kotses
(1973) gave instructions to dilate or constrict cephalic vasomotor
responses using red and green lights to signal the onset of the
dilatation and constriction periods respectively. Success was
reinforced by the avoidance of aversive white noise. A similar 'white
noise avoidance* paradigm was used by Koppman, McDonald and Kunzel
(1971;) both experiments using number of pulse beats above or below inter-trial
criteria and not an initial baseline criterion as a measure of success.
Christie and Kotses (1973) found that although there were significant
differences in pulse amplitude between the trial and inter-trial
periods, differences were not significantly different from baseline
recordings. Koppman, McDonald and Kunzel (197U) analysed time on
target as the index of activity without including measures of
amplitude change. Given these methodological and statistical short¬
comings, Koppman, McDonald and Kunzel (1971;) stated that it is
premature to conclude 'that acquired control of temporal artery
constriction and dilatation is demonstrated independent of other
responses and that the control is a specifically cerebral phenomenon'.
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E. Summary : Volitional peripheral temperature control, temporal
artery amplitude control and digital pulse amplitude control.
Experimental evidence regarding volitional control of finger
temperature, temporal artery amplitude and digital pulse control has
been found deficient on a number of methodological, procedural and
physiological grounds.
Major criticisms include:
a. The interpretation of physiological responses in terms of
volitional control whilst neglecting other possible influences
(i.e. 'Drift').
b. The inclusion of multiple independent variable designs such as
'consistent versus mixed reinforcement (contingent versus non-
contingent) for finger temperature elevation with learning
disordered versus non-learning disordered child subjects'
(Hunter, Russell, Russell and Zimmerman ,1976) . 'Verbal
instructions versus analogue feedback for increases and decreases
in digital pulse amplitude in dominant versus non-dominant hands'
(Johnston ,1977)• 'Binary analogue feedback for increases in
finger temperature versus yolked false feedback versus relaxation
with autogenic phrases versus a neutral information condition
with migraine and non-migraine patients (Price and Tursky , 1976).
c. Few studies have controlled for the effects of feedback by using
a no-feedback group or a feedback group instructed to maintain
baseline levels of responding.
d. There is a tendency to draw conclusions about the subject's
ability to control physiological responses based on the use of
widely differing displays, combinations of displays and the
presentation of feedback from multiple sites.
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e. Prior to the administration of feedback, a stabilisation period
of at least half an hour has been suggested (Yates, 1980). In
general, researchers have neglected to include details of
stabilisation periods.
f. Changes in temporal artery amplitude measures were obtained using
'time on target' scores, where feedback was contingent upon a
proportion of the temporal artery pulsations occurring below a
specific amplitude criterion. The criterion was adjusted at
inter-trial intervals and although inter-trial intervals overcome
the exaggerated effects of downward drift, a reverse (upward)
drift effect appears to occur (Yates ,1980). Given that amplitude
measures were not obtained, it is difficult to assess the exact
nature of the changes.
g. A variety of experimental feedback periods have been used in
different studies. Herzfeld and Taub (1976) used 50 second trials
and 10 second inter-trial no-feedback intervals, ^urwit (1977)
and Surwit, Shapiro and Feld (1976) used 75 second trials and 10
second inter-trial no-feedback intervals. Given that thermal
changes may be slow (due to thermal lag and to sympathetic nervous
system dynamics) it is difficult to determine how far conclusions
from these results can be generalised.
As most of the studies display the above deficits as single or
multiple features in their methodology, the question of whether
volitional control can be achieved remains equivocal although evidence
strongly suggests that it is possible. Steptoe, Mathews and Johnston
(197U) investigated voluntary control of differential temperature
changes in the ear lobes. They chose the ear lobes, primarily because
of the absence of active skeletal musculature and the specificity of
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the response which could be obtained. Although the task proved
difficult for the subjects, results showed temperature change in the
instructed direction, which would be consistent with an ability to
control peripheral vascular responses. The striking feature was the
specificity of control given the unusual feedback location. ¥hether
this result is relevant to finger temperature or temporal artery
amplitude changes where different types of vessels are involved,
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Clinical studies of the treatment of migraine headaches have
been assessed in the following terms:
1. Independent variables : treatment procedures.
2. Design ; to be discussed below.
3. Dependent variables : measures of treatment effects,
i;. Subjects : number and diagnosis.
5. Diagnostic criteria : for patient selection.
6. Treatment : frequency, duration and type of feedback given.
7. Concurrent Treatments : other than dependent variables.
8. Bioelectric responses : reported physiological findings.
9. Follow-up : duration and procedure used to obtain information.
10. Clinical response.
DESIGN
The demonstration of treatment specific effects depends on
sound research design. The research designs in the studies reviewed
are placed in four general classes. The classes are based on the
degree to which each design can isolate treatment specific effects,
and on the practice of other reviewers (Jessup, Neufeld and Merskey ,
1979).
Anecdotal case study
This type of report usually describes a patient, the treatment
procedure and the apparent clinical benefit. It lacks control over
the many non-treatment variables that can account for patient improvement.
Systematic case study
In this design a target response is repeatedly and systematically
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measured both during a pretreatment baseline (A) and during treatment
(B) (A-B design), ^upport for treatment effectiveness increases if
the baseline is long and improvement occurs when the treatment is
introduced. A stronger version of the systematic case study is
where the treatment is followed by a second no treatment baseline
(A-B-A design). The treatment effectiveness gains support if the
target symptom changes during the treatment phase and reverts during
the second baseline. The major problem with the A-B-A design in
applied clinical work is the difficulty in concluding an experiment
with a baseline phase if some improvement had occurred during the
treatment phase. This concern has led to the greater use of the
A-B-A-B design where the treatment is reintroduced after having once
been withdrawn (Barlow, Blanchard, Hayes, and Epstein ,1977).
However, the generalisability of systematic case study results to
other subjects and to other settings sometimes appears questionable.
Carry over effects and appropriate statistical analyses are also
issues.
Group outcome study
The target symptom is measured pre and post treatment in a group
of similar patients. Often two or more groups receiving different
treatments are included in the same group outcome study. However any
report classed as a group outcome study will always lack a true control
group who receive the non specific aspects of treatment such as
attention, suggestion and assessment. Multiple group outcome studies
are comparisons of different treatments; consequently group outcome
studies cannot isolate treatment specific effects. Additional rigour
may be gained by taking exrfcended baseline measures, thus making the
group outcome design similar to a set of systematic case studies.
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Control group study
This design permits the clearest isolation of treatment specific
effects. A control group study requires at least two groups of
comparable patients, a treatment group and a no-treatment group who
are assessed at the same time. This procedure controls for the
passage of time and for the variety of non-treatment effects that have
come to be labelled 'spontaneous remission'. The inclusion of an
attention placebo group separates the effects of attention and
expectancy from the treatment of interest, and is hence the most
powerful design.
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For evaluation purposes, each of the above studies is placed
into one of the following six categories.
1. Finger temperature feedback as a single independent variable.
2. Finger temperature feedback and other strategies as a composite
independent variable.
3. Temporal artery amplitude feedback.
1+. Temporal artery amplitude feedback and other strategies as a
composite independent variable.
5. Progressive relaxation as a treatment procedure.
6. Other treatment approaches.
I
Category 1. : Finger temperature feedback as a single independent
variable.
Of the eight experiments using finger temperature feedback as
a single treatment strategy, two utilised group controlled designs
(Beasley ,1976 and Mullinix, Norton, Hack and Fishman ,1978).
Beasley (1976) found that finger temperature biofeedback alone
was not as effective in reducing headache frequency and intensity as
a combination of autogenic phrases, relaxation, Electromyograph feed¬
back (EMG) and finger temperature biofeedback. A combination of auto¬
genic phrases and relaxation was however found to be ineffective in
reducing headache frequency and intensity. As the single effect of
EMG biofeedback was not controlled for, conclusions regarding the
comparative effects of finger temperature and EMG biofeedback cannot
be reached.
Mullinix, Norton, Hack and Fishman (1978) is the only experiment
to employ a placebo control group. They reported that an improvement
in migraine symptoms was not correlated with finger temperature
increases as improvement was similar between a 'true' finger temperature
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feedback group who showed an increase in finger temperature and a
•false' finger temperature feedback group who did not. The authors
concluded that the study supports the growing notion that raised
finger temperature is not correlated with positive therapeutic
responses in migraine patients.
Of the remaining studies in category 1, four employed group
designs: (Alvin , 197U > Reading and Mohr , 1976 ; Graham , 197U. and.
Peck , 1980). Alvin (197U) reported 'impressionistic' findings of
the effects of finger temperature control with ten patients. Claims
that two thirds of the patients improved should be treated with
caution since dependent variables, diagnostic criterion, duration of
follow-up and details of temperature changes were not reported.
Reading and Mohr (1976) reported an improvement in frequency, intensity
and duration of headaches in six patients over an eight week follow-up
period. Successful elevation of finger temperature was defined as a
rise of 0.1°C or more, but given that a short stabilisation period of
two minutes preceded the treatment phase, drift may have contaminated
the results. The uncontrolled nature of this study makes it unlikely
that the elimination of placebo and expectancy effects was achieved.
Graham (197U) reported that a 2°P rise in finger temperature could be
achieved through hypnotic induction without the aid of feedback. A
finger temperature biofeedback group and a hypnosis plus feedback
group also achieved finger temperature increases of similar magnitude.
As improvement was uniform across the groups, no conclusions can be
drawn regarding the superiority of finger temperature control.
Andreychuk and Skriver (1975) compared finger temperature feedback,
alpha EEG feedback and self hypnosis. Although all groups showed a
significant improvement, the 79% reduction in headache 'density'
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achieved by the finger temperature feedback group compared with the
and 36% reductions as shown by the EEG and hypnosis groups
respectively, would indicate the comparative superiority of finger
temperature feedback. Peck ( 1980) was unable to demonstrate a
differential effect with EMG feedback and finger temperature biofeed¬
back. Even though no temperature increases were observed and EMG
changes were minimal (less than 1 microvolt) a decrease in frequency
of headaches was reported at a 2I4. week follow-up. A second follow-up
at 73 weeks found that all dependent variables reverted to baseline.
Category 2 : Finger temperature feedback and other strategies as a
composite independent variable.
In this category there is one control group study, twelve group
design studies, one systematic case study and four anecdotal case
studies.
The main feature of these studies is the inclusion of strategies
designed to enhance the ability of the patient to elevate finger
temperature. As Graham (197U) has shown with hypnotically induced
finger temperature elevation without feedback, such strategies
themselves may be potent modifiers; thus the addition of such
strategies should be accompanied by control procedures to investigate
their individual roles in the achievement of any change. Most commonly,
autogenic phrases (Schultz and Luthe ,19^9) have been used as an
aid to finger temperature elevation (Blanchard, Theobald, Williamson,
Silver and Brown , 1978 ; Sargent, Green and Walters , 1972 ; Sargent,
Green and Walters , 1973a.; Sargent, Green and Walters , 1973b; Solbach
and Sargent , 1977 and Mitch, McGrady and Iannone , 1976). The studies
by Sargent, Green and Walters 1972, 1973aand 1973b, Solbach and
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Sargent (1977) and Mitch, McGrady and Iannone (1976) all report the
combined effect of autogenic phrases and finger temperature control
on migraine activity, although experimental design deficiencies,
poor diagnostic assessment and follow-up procedures prevent clear
conclusions from being drawn. In the controlled study by
Blanchard et al (1978), it was found that progressive relaxation
training was as effective, or slightly more effective than autogenic
finger temperature control training, but the effectiveness of finger
temperature feedback alone as a treatment remains unclear. Verder
(1978) found that three out of four child patients improved with a
combination of finger temperature control, autogenic phrases and
relaxation exercises and Medina, Diamond and Franklin (1976) reported
positive findings when Tension and Migraine patients were treated
with EMG feedback as an aid to relaxation in a complicated study
including finger temperature control with autogenic phrases.
EMG feedback has been used in combination with finger temperature
feedback when symptoms of both migraine and tension headaches have been
reported by patients (Diamond and Franklin , 1976 and Diamond,
Diamond-Falk and DeYeno , 1978). However, due to lack of control
groups, conclusions about the comparative effectiveness of the
treatments cannot be made. Crosson, Andreychuk, Tiemann and Phillips
(1978) compared finger temperature feedback plus autogenic phrases
with finger temperature feedback plus hypnosis plus autogenic phrases.
The absence of follow-up information regarding headache activity
pre-empts any conclusions from being reached. Adler and Adler (1976)
compared interpretive psychotherapy plus EMG feedback plus passive
concentration plus finger temperature control with a group receiving
the same treatments minus finger temperature biofeedback. Although
an overall 81% improvement was reported, the importance of finger
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temperature alone was not discussed. A lack of information regarding
finger temperature changes, the inclusion of a heterogeneous group
of headache sufferers (tension, migraine, mixed and cluster headaches)
without diagnostic information further confuse the issue.
Gainer (1978) combined assertive training, systematic
desensitisation, finger temperature biofeedback and temperature
discrimination training. Although the patient was able to raise
finger temperature during the feedback sessions, it was beneficial
only after she was taught to become aware of the peripheral coolness
that preceded the migraine attack. Such mastery enabled the subject
to raise finger temperature at a critical time in the headache cycle
and avert the onset of the painful phase. This procedure however,
does not necessarily indicate that finger temperature elevation is
the reason for headache aleviation, but rather raises the question as
to whether attentional divertion is the major feature of the strategy.
Kentsmith, Strider, Copenhaver and Jacques (1976) monitored dopamine-
b-mono oxygenase blood levels whilst using meditation and relaxation
to supplement finger temperature biofeedback. The authors speculate
that the relief of migraine by biofeedback is related to the
suppression of autonomic activity rather than to the direct modification
of the pathogenesis of migraine. Again confounding treatment
strategies render the results equivocal.
In conclusion these studies are characterised by the inclusion
of different headache types without clear diagnostic differentiation,
short follow-up periods with unspecified methods of information
collection and a lack of control for placebo and expectancy effects.
Although in general, positive therapeutic results are reported, given
the deficiencies concerning physiological and methodological issues,
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these studies fail to provide unequivocal support for the effective¬
ness of finger temperature biofeedback in the treatment of migraine.
Category 3: Temporal artery amplitude control as a single independent
variable.
Of the four studies using temporal artery amplitude feedback,
only one employed a control condition (Bild ,1976). Friar and Beatty
(1976), Koppman, McDonald and Kunzel (197U) and Zamani (197^+) all
employed group studies. Bild (1976) found that temporal artery
amplitude biofeedback 'seemed* more effective than EMG feedback which
in turn was more effective than no-treatment in reducing migraine
activity. However, there were no differences in the intensity of
headaches between the two treatment groups.
Friar and Beatty (1976) found that temporal artery amplitude
feedback reduced the incidence of major attacks over a 30 day follow-
up period compared with patients given vasoconstrictive finger pulse
feedback. This study failed to indicate the precise placement of
the temporal artery plethysmograph stating that a ramification of the
superficial temporal artery was used as the monitored site. This is
an important point as the rationale for this procedure rests on the
assumption that a modification of the pain mechanism is taking place.
Friar and Beatty (1976) also used positive response to ergotamine
tartrate as a diagnostic criterion for migraine headache, reasoning that it
provided pharmacological evidence that induced decreases in pulse
amplitude relieved migraine. However, Alvin (197U) and Morley (1977)
statedthat as vasolability may be impaired by the chronic use of
vasoactive drugs, care should be taken if using this as a major
diagnostic feature.
- 113 -
Koppman, McDonald and Kunzel (197U) and Zamani (197U) concluded
that temporal artery "biofeedback is effective in reducing migraine
headache activity, but as control conditions were lacking and the
follow-up periods were short (Zamani employs a six week follow-up
period, Koppman, McDonald and Kunzels (197U) is unspecified), these
results are equivocal.
Category h : Temporal artery amplitude feedback and other strategies
as a composite independent yariable.
This category contains one group study (Sturgis, Tollison and
Adams , 1978), and two systematic case studies (Feuerstein, Adams and
Beiman ,1976 and Feuerstein and Adams , 1977)•
Sturgis, Tollison and Adams (1978) used Blood Volume Pulse
(BVP) feedback and EMG feedback in a counterbalanced design with two
subjects suffering from combined migraine and muscle tension headaches.
It was concluded that BVP and EMG relieved the respective migraine and
tension components of the headaches. However it was found that the
subjects were unable to demonstrate a decrease in BVP during the
feedback phase but could during the post feedback voluntary control
phase. If a decrease in BVP had been demonstrated during the feedback
phase and continued during the no-feedback voluntary control phase,
it would have suggested that a biofeedback skill had been acquired.
These results however suggest that a decrease in blood pulse volume
was associated with unspecified factors related to the cessation of
feedback.
The two systematic case studies by Feuerstein, Adams and Beiman
(1976) and Feuerstein and Adams (1977) also suffer from methodological
inadequacies. Both studies included patients with mixed headaches
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without adequate diagnostic specification, and include three types of
vasomotor activity as indices of change ("blood pulse volume (BVP),
"blood volume (BV) and number of vasospasms). The authors conclude
that 'idiosyncratic patterns of activity emerge during biofeedback
training' but are unable to relate the significance of any pattern to
apparent changes in headache activity.
In conclusion, lack of diagnostic criteria, inconsistent
positioning of piethysmographs and inclusion of idiosyncratic patterns
of activity as evidence of vasomotor change render the results
equivocal.
Category 5 : Relaxation as a treatment procedure.
Of the seven studies in this category, two incorporated
relaxation as a single treatment variable (Mitchell and Mitchell,
1971 and Warner and Lance , 1975)• In the first part of a two part
study, Mitchell and Mitchell (1971) compared the effects of relaxation
with combined desensitisation (including relaxation) and a no-treatment
control. Although the no-treatment group improved significantly more
than the relaxation group in this first part of the study, results
from the second part of the study indicated that combined desensitisation
was more effective at reducing headache activity than a single model
(relaxation) approach or providing no treatment. Warner and Lance
(1975) used relaxation as a treatment with mixed, migraine and tension
headache patients. Relaxation was found to reduce headache activity
in eight of the twelve migraine patients although the design did not
control for non specific treatment effects.
The remaining studies supplemented relaxation exercises with a
variety of other treatment strategies includinggpoup discussions (Hay
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and Madders ,1971)» mental passivity concentrated upon decreasing
pressure build up (Lutker , 1971)• EEG and alpha feedback (Montgomery
and Ehrisman , 1976) and EMG with autogenic phrases and hypnosis
(Stambaugh and House »1977)• The complexity of the designs and poor
control of dependent variables make any conclusion regarding the
comparative efficacy of relaxation as a treatment for migraine
tentative.
Category 6 : Other treatment approaches.
Benson, KHemchuk and Graham (197U) found that transcendental
meditation appeared to be of limited usefulness in the treatment of
migraine headaches. Less than one third of the 17 migraine and four
cluster headache patients were rated as showing improvement in headache
activity. Mitchell and White (1976) conducted a study designed to
determine whether self help management was superior to symptom
orientated interventions. The patient was involved in an intensive
two stage study for over a year and although a complete cessation of
headaches was reported, no conclusions regarding the comparative
efficacy of any part of the treatment package can be made. Ansell
(1977) used auto-suggestion of handwarming with one patient and
reports a positive therapeutic effect without including temperature
change information. Lambley (1978) used an »anti-reductionist1
approach to the treatment of migraine in three patients. The treatment
package included drug and behaviour therapies combined with psycho-
dynamic bioenergetics and affect modifying behaviour therapy. Clinical
responses included statements such as 'patient feels happier about
their relationship' but reports on changes in migraine pathology are
limited.
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In conclusion, the-use of uncontrolled multi-strategy inter¬
ventions renders any judgement regarding the comparative efficacy of
the treatments or components of the treatment as tentative.
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I. SUMMARY
The experiments concerning finger temperature biofeedback have
failed to demonstrate a relationship between increases in finger
temperature and decreases in migraine pathology. Those experiments
which infer such a relationship may be considered inconclusive due
to design deficiencies and a lack of adequate controls. On this basis,
expectancy and placebo effects may have contaminated the results.
Blanchard, Andrasik, Ahles, Teders and O'Keefe (1980) used a meta¬
analysis procedure to determine the relative efficacy of finger
temperature feedback, finger temperature feedback with autogenic
phrases and relaxation exercices compared with medication placebo
treatments. Blanchard et al (1980) concluded that the superiority
of the behavioural treatments over the medication placebos was an
indication of their therapeutic potential. However until controlled
studies attempting to relate treatment interventions with hypothetical
pain mechanisms are carried out, finger temperature biofeedback remains
of unproven value.
Although temporal artery biofeedback is considered to be a
promising treatment approach for migraine headache (Jessup, Neufeld
and Mersky , 1979)> there are a number of criticisms which are
evident as features of the above studies. Firstly, E.M.G. feedback
has been used as a control for temporal artery amplitude feedback
with heterogeneous groups of headache sufferers (Bild , 1976 ;
Feuerstein, Adams and Beiman , 1976 ; Feuerstein and Adams , 1977 »
Sturgis, Tollison and Adams ,1978). It would seem preferable to
use a homogenous group of migraine patients and compare temporal
artery amplitude feedback with the other most frequently used biofeed-
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back approach, that of finger temperature control, especially as
positive therapeutic outcomes have been reported for both. The
second major criticism is the lack of detailed infomation regarding
changes in temporal artery pulse activity that take place during
biofeedback. When detailed information is given regarding changes
in temporal artery pulse activity, the number of subjects is small
and 'idiosyncratic responses' have been observed.
In conclusion, any study attempting to overcome the above
methodological deficits and assess comparative effectiveness of
biofeedback approaches in the treatment of migraine headaches, should
incorporate the following features:
\
1. A homogeneous group of classic migraine headache sufferers should
be selected on the basis of carefully defined diagnostic criteria.
2. The independent variables (treatments) should be chosen on the
basis of experimental evidence showing that they are of potential
benefit in the treatment of migraine.
3. The independent variables (treatments) should be unitary and
unconfounded by other treatment strategies.
l+. The independent variables (treatments) should be related to
hypothetical pain mechanisms.
5. Dependent variables should include physiological responses, indices
of headache activity, and concurrent treatments (medication).
6. Attention placebo and waiting list control groups should be used.
7. Changes in headache activity and medication consumption should
be recorded over a baseline and a follow-up phase of adequate
duration.







The objective of biofeedback is to enable an individual to
gain voluntary control over otherwise relatively involuntary processes.
Before biofeedback is presented, a stable level of responding is
established during a pre-experimental or pre-trial baseline phase.
Experimental results are then based on the assumption that this stable
level of responding would otherwise be maintained during the experi¬
mental period if biofeedback was absent. The sophistry of this
assumption was illustrated by Yates (1980) who monitored finger
temperature changes in two groups of male and female subjects seated
for a period of 90 minutes in rooms with ambient temperatures of 20°
and 25°C. The results that were obtained from the group seated in
the lower ambient temperature room could have been interpreted as
showing successful control in a downward direction, as although no
feedback or instructions were provided, a significant decrease in
temperature was observed. Although the decrease displayed by the
higher temperature group was less evident, it was still obvious. This
change in responding, Yates (1980) labelled as 'drift'. Before the
concept of drift had been described, consistently small magnitude
changes which characterised biofeedback peripheral vasodilatation
experiments (summarised by King and Montgomery , 1980) had not been
adequately explained. Surwit, Shapiro and Peld (1976) proposed that
the 'arousal-like' reflexes produced during biofeedback experiments
explained the ease of conditioning vasoconstriction compared to vaso¬
dilatation. Dugan and Sheridan (1976) proposed that vasodilatation
may be due to the biofeedback stimulus creating orientational
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responses (Sokolov , 19&3) competitive with target behaviour.
Given that biofeedback experiments may be contaminated by
uncontrolled influences, it was considered a pre-requisite of the
clinical application of biofeedback treatments to investigate the
effects of experimental procedures and ambient temperature upon the
two target responses under investigation in this study: finger
temperature and temporal artery amplitude.
This study was conducted to determine whether finger temperature
or temporal artery amplitude changes could be observed during rest,
relaxation and concentration tasks, in the absence of biofeedback.
As respiratory manoevres are known to be associated with decreases
in finger temperature (Lynch and Schuri , 1978), respiration patterns
were monitored to investigate covariance between respiration rate and
depth, temporal artery amplitude and finger temperature.
EDCFEBTMENT 1
THE EFFECTS OF AMBIENT 'i'liuyiJb'ilLKATIJHE!„ REST, BET.AXATIQN AND A G0NCEHTRATI0N
TASK ON EINGER TEMLERATTJRE, TEMPORAL ARTERY AMPLITUDE /RESPIRATION RATE
AMD DEPTH.
The first experiment was designed to investigate the effects of
an extended baseline period on finger temperature and temporal artery
amplitude. Respiration rate and depth were also monitored to determine
the extent of covariation between the physiological responses.
METHOD
Subjects
Eight volunteer subjects, four male and four female, took part
in the experiment; there were two males and two females in each of
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two groups. Ages ranged from 20-32 years, (mean 21;.7 years). All
subjects were technical or secretarial staff from a university
department and were free of peripheral vascular abnormalities.
Physiological Measures
The subjects were seated in a dimly lit, sound attenuated room
kept at a constant temperature of 22l 1°C. An adjacent room contained
a Devices MX6 Recorder, on which was recorded finger temperature,
temporal artery pulse amplitude and respiration depth and rate.
Finger temperature was obtained using an NiCr/NiAl thermocouple probe
sensitive to q°C, attached to the volar aspect on the third phalange
of the third finger on the right hand, and connected to a Comark
Electronic Thermometer (Type 1608) and thence to the MX6 Recorder.
A Devices Light Reflectance plethysmograph was used to detect temporal
artery pulse amplitude, which was also recorded on the MX6 Recorder.
All recordings of temporal artery amplitude were made on intensity 'Dl
to enable objective evaluation of change. All subjects wore Beyer
Dynamic Headphones during the session; in addition to providing a
means of communicating, they helped to protect the photo-plethysmograph
from extraneous light. The body of the headphones was placed over
the ear; only the light sponge outer rim overlapped the plethysmograph
so as not to disturb its placement. A second thermocouple was placed
immediately under the nostril to record temperature fluctuations of
inhaled and expired air. The thermocouple lead was securely fixed
to spectacle frames, which were taped in position. From the air
temperature changes, rate and relative depth of respiration were
recorded.
Procedure
Each subject attended for one session which consisted of five
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phases: (a) rest periods (3 phases); (b) a concentration task (l
phase); (c) a relaxation procedure (1 phase).
In sessions for group 1, the phase order was (a) (b) (a) (c)
(a); in sessions for group 2, the phase order was (a) (c) (a) (b) (a).
Groups were treated similarly in all other respects. Each phase in
each session was of 15 minutes duration with an additional interval
between each phase to permit re-establishment of temperature stability
point. Prior to the start of the session, all subjects were given an
adaptation period of 20 minutes.
(1) General Instructions: Subjects were given the following general
instructions:-
!T want you to sit quietly for a few minutes before the experiment
begins. When you are relaxed the experiment will start. During the
experiment there will be two tasks I will ask you to complete, each
task taking 15 minutes, and between each task there will be a rest
period of a similar length. The experiment will take a little over an
hour and a half. Do you feel comfortable? If you feel the need to
move, do so quickly, but do not move excessively or fall asleep. Please
do not breath through your mouth at all. Any questions?"
At the end of each phase, the experimenter outlined the
conditions of the next phase.
(2) Concentration Task; Instructions for the concentration task were
as follows
"I am going to play you a news item; I want you to listen to
it carefully. This will be played five times during this fifteen
minute period. I want you to remember as much of what is played as
possible. At the end of the 15 minutes I will ask you one or two
questions about it. Sit quietly and relax, and concentrate on the tape."
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The following tape of one minute duration was then presented
at minutes 1, 1+, 7> 10 and 13 of the phase:-
"How often are young male deaths due to road accidents?
According to a briefing paper published by the Office of Health
Economics, in the 15-19 age range, accidents accounted for 62% of
deaths among males. Women, on the other hand, are far more likely
to fall down stairs when they are 80 than to kill themselves on a
motorbike at 17; 16% of all accidental deaths to females happen at
this age. Accidents cause I4.O deaths a day in England and Wales, a
total of 15j069 in 1976; a number which has not increased this
century but the death rate expressed in the context of population
growth has fallen by about 36% since the beginning of the century to
a level of 306 per million of the population in 1976; that is, 2.5%
of all deaths, although this proportion is considerably higher in
children than adults."
(3) Progressive Relaxation: Subjects were given instruction in
progressive relaxation exercises (abbreviated from Jacobson , 1938).
The instructions were presented over the headphones by the experimenter
and subjects were asked to remain as still as possible for the duration
of the phase.
(U) Rest Phase: Subjects were simply asked to make themselves
comfortable and sit quietly.
Data Reduction and Analysis
Finger temperature stability was considered to have been achieved
when temperature remained within 0.2°G for four consecutive minutes
with a minimum of 10 minutes and a maximum of 20 minutes. All subjects
were allowed to acclimatise to the experimental environment for 15
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minutes prior to the administration of the "baseline period-
Baseline temperature was calculated, as the mean of the last
four minutes of the stabilisation phase. During training sessions,
finger temperature was examined every 30 seconds and the mean
deviation from the established baseline was calculated; this procedure
provided a conservative assessment of the degree of temperature
change, since it incorporated data from all stages of the training
session. Temperature was allowed to restabilise to the above
criterion between each phase. Temporal artery pulse amplitude was
examined at the same intervals and was averaged over a five second
period. Respiration depth was also sampled every 30 seconds, time
linked to the finger temperature and temporal artery amplitude
measures. Respiration rate was assessed every minute. (See Appendix
2.1).
Results
Two Way (order x trials) split plot Analyses of Variance were
used to examine temporal artery pulse amplitude and finger temperature
variations. No significant differences were found across the 'order1
or 'trial* factors for temporal artery pulse amplitude recordings.
For finger temperature, no significant difference between the 'order'
factors was found, but a significant difference between 'trial*
factors was obtained (F = 8.65, p>0.0l).
The significance of the linear component of the 'trial' sum
of squares (F = 33.57> p>0.0l) indicates that the trend in finger
temperature was due to the temporal aspects of the experiment
irrespective of experimental conditions (see Figure 1).
- 125 -
MEAN CHANGES IN TEMPORAL ARTERY AMPLITUOE
RESPIRATION DEPTH RESPIRATION RATE AND FINGER































Pearson Product moment correlation coefficients between finger
temperature, temporal artery pulse amplitude and respiration measures




Finger temperature decreased consistently throughout the
session; however this was not related to the specific tasks and
instructions presented. Temporal artery pulse amplitude, respiration
depth and respiration rate remained constant throughout experimental
conditions. No consistent relationships were found between finger
temperature, temporal artery pulse amplitude and the respiration
measures. It would appear therefore that over the extended no-
feedback baseline period, finger temperature showed drift in a down¬
ward direction (negative drift) at an ambient temperature of 22±1°C,
when a pre-experimental reference point is used. These findings
validate Yates (1980) suggestion as the drift was independent of the
conditions provided.
The consistent 'negative drift1 observed in finger temperature
is clearly antagonistic to the usual clinical goal of temperature
increase as incorporated in the clinical application of biofeedback
for migraine headaches.
EXPEBTlvrFTNFP 2
THE EFFECTS OF RELAXATION, A CONCENTRATION TASK AND FINGER TEMPERATURE
BIOFEEDBACK UPON FINGER TEMPERATURE.
The first experiment showed that, over a number of conditions
presented in a single session, finger temperature gradually decreased.
The decrease was independent of the presented conditions but was
consistent over time, indicating a temporal, rather than task related
phenomenon.
The second experiment was designed to investigate this further,
over a larger number of sessions, by examining the effects of adding
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biofeedback and instructions to raise finger temperature. This
condition was compared with finger temperature changes obtained
under near identical conditions but without instructions to raise
finger temperature, and with task demands which would deny the
opportunity of using thermally related imagery. The effects of
progressive relaxation on temperature were also examined.
METHOD
Subjects
There were six subjects, three male and three female; age
ranged from 27-32 years (mean 29.6 years). All were from university
technical and secretarial staff and all were free of peripheral
vascular abnormalities. None of the subjects had participated in
Experiment 1.
Procedure
This experiment comprised six weekly sessions; each session
consisted of a relaxation phase, a concentration task phase (resembling
finger temperature biofeedback) and a true biofeedback phase. The
phases were fully counter-balanced within sessions to control for the
effects of order and of carry-over from one phase to another. Thus
all subjects received all possible combinations of experimental
conditions over the sessions. Each phase within the session was of
10 minutes duration and between each phase was an interval of varying
duration during which finger temperature restabilised to a criterion
of no more than 0.2°C change over four consecutive minutes. Prior to
the start of the sessions all subjects were given a baseline period to
permit temperature stabilisation as in Experiment 1.
(1) Progressive Relaxation: Instructions were given as in Experiment 1.
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(2) Temperature Feedback: Finger temperature was recorded as in
Experiment 1, except that the output from the Comark thermometer was
fed into a Solatron 7055 Micro-processor Digital Yoltmeter (DVM).
The EED display of the DYM was transmitted by a Pye FET Lynx automatic
camera to a TY monitor in the subject's room; this continuous
numerical display functioned as the feedback stimulus, presenting
updated finger temperature every second, accurate to -^qq°0.
(3) Concentration Task: The stimuli presented in this phase were
identical to those used in the biofeedback phase but differed in that
the display was not related to subject changes; and in that subjects
were instructed to memorise aspects of the LED display (see below for
details). The task was arranged as follows:-
When the DYM is in operation, small internal currents are shown on
the LED display. Changes in the display were obtained by manually
switching between DC and AC measurement. The maximum figures
(+15.00 and -15*00) were displayed after the DYM had been left on for
several minutes. The DYM was programmed to display the change at 1
second intervals, the same intervals as used with the biofeedback
display.
(I4.) Instructions: The following basic instructions were presented to
all subjects with appropriate modifications for the counterbalancing
of the phase orders:-
"This experiment consists of three phases:- Phase 1: You will be
played a set of relaxation instructions which will last for six
minutes. On completion of the exercises there will be a short time
interval for you to maintain a state of mental and physical tranquility.
The phase will last for ten minutes. Phase 2: This display has
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nothing to do with your finger temperature; in fact it has nothing
to do with any measurement of you at all. You will see that the
display will alter at 1 second intervals in either an upward or down¬
ward direction, as indicated by the sign in front of the figures, one
sign indicating a positive number and another sign indicating a
negative number. The numbers over the next ten minutes will change
continuously. Please watch them carefully and try to remember the
highest positive number and the lowest negative number registered
throughout the ten minute period. It is not important to remember
the whole number, but I would prefer it if you could remember at
least the first two digits. I will then ask you to recall them at
the end of the ten minute period. Phase 3: You will have presented
to you your finger temperature changes at intervals of 1 second. I
want you to raise your finger temperature; use any means but physical
ones. Do not touch the thermometer probe or use any bodily movement
in any way. Sit quietly and concentrate upon making your finger
temperature warmer. Please do not fall asleep. Do you have any
questions?"
At every change of phase the experimenter entered the subject's room
and informed them of the next experimental phase. When the subjects
were confident of the nature of the next task, they were left to
prepare themselves.
Results
As in Experiment 1, finger temperature was examined every 30
seconds and the mean deviation from the pre-experiment phase baseline
was calculated. (Appendix 2.1). A repeated measure, Analysis of
Variance of the three conditions over the six sessions revealed
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significant differences. (F=6.9l;, p>0.0l). A Post Hoc analysis of
significance (Scheffe Test) revealed a significant difference between
the relaxation and concentration task conditions (t=3.12, p>0.0l)
between the concentration task and biofeedback conditions (t=3«55j
P>0.01), but no difference was found between the biofeedback and
relaxation conditions (t=0.1fl .n.s.). Figure 2 shows the mean
temperature changes across subjects for each session separately.
The apparent close correspondence between temperature variations in
the relaxation and biofeedback phases (r = +0.797) is just short of
statistical significance (t=2.6ij., p< 0.058).
FIGURE 2.
MEAN FINGER TEMPERArURE CHANGES
OVER SIX WEEKLY SESSIONS
+0-3-1
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Experiment 1 showed that during an extended period of maintained
passive attention, a significant decrease in finger temperature was
observed. The decrease was not associated with a change in temporal
artery pulse activity, respiration rate or respiration depth and was
independent of experimental conditions. As temperature did not
restabilise to the baseline level after each experimental condition,
as would be expected if orientation had occurred (Sokolov ,19&3),
the results would appear to be consistent with the drift hypothesis.
Experiment 2 further investigated the decrease in finger temperature
and found that it was counteracted when biofeedback was provided.
In Experiment 2 a close correspondence between the temperature
variations in relaxation was noted, but failed to reach significance.
This correspondence may reflect a common mechanism between finger
temperature and relaxation, associated with similar autonomic changes.
This would be consistent with previous reports indicating a positive
relationship between relaxation and skin temperature (Boudewyns , 1977).
However, conclusions regarding the correspondence in temperature
between the relaxation and feedback groups must be tentative especially
as a decrease in temperature during relaxation was evident in
Experiment 1.
One implication of these data is that when biofeedback is
provided, small changes (or even no change) in finger temperature may
still be a demonstration of control, since under comparable




1. Experiment 1 showed that finger temperature decreases in the
passive attentive subjects are independent of temporal artery-
amplitude changes, respiration changes and experimental
conditions. It is proposed that the decrease in temperature
is most appropriately explained in terms of drift.
2. The presentation of finger temperature biofeedback militates
against the negative drift in finger temperature.
3. Small finger temperature increases obtained during biofeedback
may still be a demonstration of control, given that a
temperature decrease may occur in the absence of feedback.
CHAPTER 9
MAIN STUDY:
A CONTROLLED COMPARISON OP BIOPEEDBACK METHODS





The rationale for a controlled clinical group outcome study
emerges from the previous chapters which reviewed the theoretical,
empirical and clinical status of finger temperature biofeedback,
temporal artery pulse amplitude biofeedback and progressive relaxation.
It is indicated that there are possible therapeutic benefits to these
treatment approaches, however future studies should seek unequivocally
to demonstrate such benefits. The aim of this study was to evaluate
the relative contributions of finger temperature biofeedback, temporal
artery pulse biofeedback and progressive relaxation training in the
treatment of classic migraine headaches. An attention placebo
condition (biofeedback mediated heart rate decrease) and a waiting
list control group were incorporated to fulfil Paul's (1966)
stringent criteria for control groups.
HYPOTHESES
1. Finger temperature for the finger temperature biofeedback
group will be significantly higher than in the other treatment
conditions.
2. Temporal artery amplitude pulsations will be significantly
reduced in the temporal artery feedback group as compared with the
other treatment conditions.
3. Heart rate decreases for the heart rate biofeedback group
will be significantly greater than in the other treatment conditions.
1;. In the progressive relaxation group, heart rate would
decrease, temporal artery amplitude pulsations will remain stable
- 131+ -
(evidence from pilot study) and finger temperature will decrease. A
decrease in finger temperature is anticipated due to the effects of
'drift1 (evidence from the pilot study), which is contrary to other
findings (Boudewyns ,1966).
5. That increases in finger temperature and decreases in
temporal artery pulse amplitude will be associated with a decrease in
headache activity and medication.
6. The therapeutic value of finger temperature and temporal
artery amplitude biofeedback will be greater than for progressive
relaxation exercises. Patients in the attention placebo and waiting
list control conditions will show no clinical benefit over the
experimental period.
PATIENTS
The patients were collected from two sources, the out-patient
department of a general hospital, and a community general practice.
The collection and assessment of the patients was carried out over
the period of one year (January 1979 to January 1980). All patients
had histories of headaches and had received neurological investigation.
67 patients were assessed over the one year period of which 13 were
rejected on the basis of their diagnosis. The remaining 5U patients
were included in the project. Six patients withdrew from the project
prior to the treatment period. The remaining I4.8 patients were
randomly assigned across the five experimental conditions. The
randomisation procedure was based upon random number tables, thus the
allocation of a patient to a particular condition was independent of
patient characteristics. There were 38 female and 10 male patients;
the mean age was 38.02 years (standard deviation 13.1+ years) and the
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length of illness ranged from 3 years to 35 years. Of the 1+8 patients,
8 were in Social Class i+, 16 in Social Class 3» 13 in Social Class 2
and 9 in Social Class 1. (2 were unclassified.)
Allocation to the experimental conditions was as follows:
Finger temperature control condition
10 patients, 7 female and 3 male. Mean age 37.7 years (SB 15»5)•
Length of illness ranged from 6 to 28 years. 1 patient dropped out
during the treatment period.
Tem-poral artery pulse amplitude control condition
10 patients, 8 female and 2 male. Mean age 31.6 years (SD 114..I4.).
Length of illness ranged from 8 to 31 years. 2 patients dropped out
during the treatment period.
Progressive relaxation condition
9 patients, 7 female and 2 male. Mean age 3l+«9 years (SD 11.]+).
Length of illness ranged from 1+ to 20 years. 2 patients dropped out
during the treatment period.
Heart rate control condition
10 patients, 9 female and 1 male. Mean age 1+3-9 years (S3) 13.6).
Length of illness ranged from 3 "to U5 years. 1 patient died and
1 patient dropped out during the treatment period.
Waiting list control condition
9 patients, 7 female and 2 male. Mean age 1+1.9 years (SD 9.6).
Length of illness ranged from 5 "to 19 years. 2 patients received
treatment at the end of the waiting list period. 6 patients declined
to reply to the offer of treatment and 1 patient deferred the offer
of treatment indefinitely.
Of the 39 patients in the four treatment conditions, 1 died
and 6 withdrew during the treatment period of the project. There was
a treatment attrition rate of 1 tyo.
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DIAGNOSIS OF CLASSIC MIGRAINE HEADACHE
The diagnosis of classic migraine has been a topic of
considerable debate, as reviewed in chapter 3« This project
incorporated a modified version of the Waters (1970) headache
questionnaire for diagnostic purposes. The major difficulties
underlying the diagnosis of classic migraine for the purpose of
clinical evaluation studies are as follows:
1. Factor analysis of questionnaires from clinically diagnosed
migraine headache sufferers has failed to reveal a single factor
which encompasses the three migraine features. (Zeigler, Hassanein
and Hassanein , 1972 and Peck and Attfield , 1981). However Peck and
Attfield (1981) did observe a factor which comprised of two of the
three classic features, a criterion which would be considered to
indicate the presence of migraine using the diagnostic guidelines of
Friedman, Finley, Graham, Kunkle, Ostfield and Wolff (1962).
2. There is considerable overlap in the pathophysiology of migraine
and muscle tension headache (Bakal and Kaganov , 1977) to the extent
that 'mixed' headaches have been considered a variant of migraine
in clinical evaluation studies (Adams, Feuerstein and Fowler, 1980).
It was intended that the above difficulties would be minimised
given that the Waters (1970) questionnaire has shown a 90% agreement
with independent clinical raters for the diagnosis of migraine.
Further, that the questionnaire was supplemented with questions
designed to identify patients displaying predominantly migraine
features in the relative absence of tension headache symptoms
(Bickerstaff , 1977) and cluster headache symptoms (Ekbom 1970)
In this way, it was intended that a homogenous group of predominantly
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classic migraine headache patients would emerge.
The questions were divided into two categories:
Category 1, identifying the symptoms of classic migraine (7 questions)
Category 2, identifying symptoms of tension and cluster headache
(14. questions).
Category 1 (see questionnaire. Appendix 1.1 )
The patient scored 1 point per question if:
Question lit. Headache is usually or always unilateral (symptom 1)
Question 16a. Sensory/Motor disturbance is present in aura phase
(symptom 2).
Question 16b. Sensory/Motor disturbance is present in aura phase
(symptom 2).
Question 13. Other pre-headache warning symptoms during the aura
phase (symptom 2).
Question 19. Visual disturbance is present in aura phase (symptom 2).
Question 20. Loss of appetite accompanies headache (symptom 3)«
Question 21. The patient ever/usually or always vomits during the
headache (symptom 3).
Category 2
The patient scored 1 point per question if the following were absent:
Question 11. The headache usually or always has a tight band quality
to the pain.
Question 9. The headache can be relieved by movement or walking
around.
Question 10. The patient experiences unilateral nasal congestion,
watering eyes or rhinorrhea as a regular feature of
their headaches.
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Question 18. The headaches occur in 'clusters' over a short period
of time with periods of six months or more separating
the 'clusters'.
To constitute a diagnosis of classic migraine, each patient
scored at least I4. points from category 1, of which two of the three
major symptoms were included, and 1+ points in category 2. If a score
of 5 points was obtained in category 1, a minimum of 3 points were
obtained in category 2 for the patient to be diagnosed as suffering
from classic migraine. However, those patients who scored more than
2 points in category 2, irrespective of the category 1 score were
excluded from the project on the basis that significant pathology of
another headache type was apparent. The minimum 'point' score to
constitute a diagnosis of migraine was therefore 8. Of the 67
patients assessed, 13 scored less than 8 points, 20 scored 8 points,
21+ scored 9 points, 6 scored 10 points and 1+ patients scored 11 points.
Information from the 67 questionnaires obtained during this
study was incorporated in a statistical analysis of the Waters
Headache Questionnaire. The results of this study, 'Migraine symptoms
on the Waters Headache Questionnaire : A Statistical Analysis' (Peck
and Attfield ,1981) are included in Appendix 1.2.
APPARATUS
The patients were seated in a dimly lit sound attenuated room
+ o
kept at a constant temperature of 22_1 C. An adjacent room contained
the following:
A heated stylus, Devices MX6 Recorder (MX6) containing a DC
(3U61) preamplifier and two pulsemonitor (3^11) preamplifiers.
One 3611 preamplifier was set on AC mode and the other on
DC mode.
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A Solatron 7055 Microprocessor Digital Voltmeter (DVM)
A Solatron Data Transfer Unit (DTU)
A Devices Instantaneous Ratemeter type 2751 (ratemeter)
A Comark Electronic Thermometer type 1608 (thermometer)
A Pye Lynx: Antomatic Camera (camera)
A Sony Stereo Cassette-corder TC-158SD (tape recorder).
Finger temperature was obtained using a NiCr/NiAl thermocouple
probe sensitive "to-jQQ °C, attached to the volar aspect of the third
phalange on the third finger on the patient's right hand. A Devices
light reflectance plethysmograph was placed above the zygomatic arch
on the external superficial temporal artery at the point of maximum
engorgement. The placement of the plethysmograph was on the side of
the patient's head that was associated with the painful phase of
the migraine. The patients wore Beyer Dynamic headphones which, in
addition to providing a means of communication, helped to protect the
plethysmograph from extraneous light. The body of the headphones
were placed over the ear, only the light sponge outer rim overlapped
the plethysmograph so as not to disturb its placement.
Finger temperature monitored by the thermocouple probe was fed
into the thermometer and thence to the 3611 preamplifier (DC mode) in
the MX6; a second thermocouple probe was fed directly into the DVM
via the DPU. Signals from the light reflectance plethysmograph were
fed into the 3&11 preamplifier (AC mode) of the MX6, whereby a wave
trace of temporal artery pulsations was obtained. Output from the
3611 preamplifier (AC mode) was also transmitted to the ratemeter
whereby a calibrated heart rate signal (beats per minute) were fed
into the 3U61 preamplifier in the MX6. In this way permanent records
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of finger temperature changes, temporal artery pulse amplitude and
heart rate could be obtained for every patient on every session.
DIAGRAMATIC REPRESENTATION OF THE BIOFEEDBACK EQUIPMENT
Recording Room Experimental Room
. « » « Finger Temperature Information
Heart Rate Information
Temporal Artery Amplitude Information
—»• • • Combined Heart Rate/Temporal Artery
Amplitude Information
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FEEDBACK ; MICROPROCESSOR PROGRAMMES AMD PROGRAMME DESCRIPTIONS
Finger temperature, temporal artery amplitude and heart rate
information was fed into the ITU which was linked to the DVM. All
operations were measured as dc voltage: 'the results being the average
value of the input during a selected period'.








Enables measurements to be displayed
directly in °C.
For the NiCr/NiAl thermocouple.
Ambient temperature is entered into the
programme and the measurement is
linearised and displayed in °C.
This measurement does not carry out
measurement processing, but brings the
measurement and processing under the
control of the voltmeters built in clock.
When a time is selected, the voltmeter
presents the answer at the end of the
run without regard to the results of
the previous one.
The patient was presented with a display of finger temperature
accurate to
^ C. The feedback was updated at 1 second intervals.
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The programme can determine the maxirrmm-to-date,
the minimum-to-date or the peak-to-peak; value of a
long series of measurements.
The peak-to-peak value. This option gives an
algebraic subtraction of the minimum from the maximum.
Calculates trends; mean, variance, and standard
deviation, all statistical analysis calculations;
also root-mean-square values. The option selected
governs what is displayed during the running of the
programme; the user can recall all results from
memory at the end of a run.
Gives the average to date value, subject to
continuous updating while the programme is running.
At the end of each measurement run the average value
of the measurements is displayed.
As with the finger temperature biofeedback condition.
This programme is regarded as particularly useful
when used with programme 7 (statistics) as it allows
measurements to be made over a fixed time period and
an average reading to be obtained. When a run time
is selected, the voltmeter will present an answer at
the end of the run, then restart a further run with¬
out regard to the results of the previous one.
The patient was presented with a value analogous to variations
in the mean size of the temporal artery pulsations. These values were
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the updated average of the measurements, presented at 1$ second
intervals. The slight variations in pulse amplitude found across
subjects and within subjects across sessions meant that pulse
amplitude readings had to be taken at different plethysmograph light
intensities, to gain clear signals. Although the same patient may
have shown varying size of pulse amplitudes across sessions, within
session recordings were all obtained on the same light intensity.
The presentation of updated signals at 15 second intervals provided
a method of overcoming the following deficiencies:
1. presenting the patient with rapidly fluctuating and thus
potentially confusing feedback;
2. of not being able to monitor magnitude of change, as would be the
case if binary feedback was given (Koppman, McDonald and Kunzel , 197i+
and Feuerstein, Adams and Bieman ,1975)j or of having 'idiosyncratic
responses' (such as simultaneous changes in blood pulse volume,
blood volume and frequency of vasospasms) interfere with the feedback
signal (Feuerstein and Adams »1977)-
Friar and Beatty (1976) presented feedback after every 20 pulse
beats: thus the 15 second intervals used in this study would





7 (statistics) As with temporal artery amplitude feedback.
Option 1 Gives a continuous updating while the
programme is running. At the end of each
measurement run the average value of the
measurements is displayed.
9 (time) As with the finger temperature and temporal
artery amplitude biofeedback conditions.
When a run time is selected, the voltmeter
will present an answer at the end of the
run, then restart a further run without
regard to the results of the previous one.
The patient was presented with a value representing the average
heart rate (in beats per minute). The feedback was updated and
presented at 1$ second intervals.
Heart rate biofeedback was chosen as a placebo treatment in
this project as it was considered to fulfil the following criterion:
"A placebo is a procedure with no intrinsic therapeutic
value, performed in controlled studies to determine the
efficacy of other clinical procedures".
(Borland1s Medical Dictionary ,1977).
The reasons for the choice of heart rate decrease biofeedback
are as follows:
1. No study has attempted to develop control of heart rate as a
method of treating migraine and there is no evidence to suggest
that it would be of therapeutic value.
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2. Heart rate biofeedback did not require the placement of extra
transducers and did not produce any direct physiological effect
upon finger temperature or pulse amplitude responses.
3. Heart rate biofeedback studies would suggest that there is no
difference between types of biofeedback display (Blanchard, Scott,
Young and Haynes , 1971+) or schedules of display (Hatch , 1980),
in eliciting heart rate decreases. It was therefore considered
unnecessary to construct a separate means of display for heart
rate biofeedback.
]+. The pulsatile nature of the pain often associated with migraine
headaches gives a credible association between heart rate and
migraine headaches.
5. A decrease in heart rate indicated a decrease in arousal; thus
a biofeedback task consistent with lowering arousal may be
construed by patients as a relevant treatment approach.
6. As it is possible to produce heart rate decelerations comparable
with those accepted as significant with biofeedback by instructing
subjects to lower heart rate (Lang and Twentyman ,1976), some
of the placebo condition patients would experience "success"
independent of their biofeedback performance. The effect of the
perceived control may maintain the patient's motivation in
regular treatment session attendance.
Finger temperature, temporal artery amplitude or heart rate were
then shown on a light emitting diode (tEI>) display on the MM. The
LED display of the MM was transmitted by a Pye Lynx automatic camera
to a TV monitor in the subject's room.
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PROGRESSIVE RELAXATION CONDITION
Patients in the Progressive Relaxation condition were presented
with relaxation exercises (abbreviated from Jacobson , 1938) over the
headphones from a pre-recorded tape on the cassette recorder. No




Assessment interviews were conducted in the Out-patient Depart—
ments of a General Hospital or in the University of Edinburgh Department
of Psychiatry. The aim of the interview was to obtain detailed
information about the characteristics of the patient's headaches using
a modified version of Waters (1970) headache questionnaire. The
completion of each questionnaire was supervised by the experimenter
thus ensuring the immediate clarification of any ambiguities concerning
the questions or the patient's responses. On completion of the
questionnaire, each patient was given the following information:
"A study into the treatment of headaches is being conducted at
the University Department of Psychiatry; inclusion in the study will
be based upon the results of the questionnaire."
Patients whose headaches were not considered to be of the type
under investigation were informed of the fact as soon as possible.
Their referring doctor was also informed and no further contact with
the patient regarding the study was made.
Patients whose headaches were diagnosed as being of the type
under investigation were informed of their inclusion in the study and
then assigned to one of two groups; a waiting list group or an experi—
mental group.
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The patients assigned to the waiting list group were asked to
continue with the treatment prescribed by their doctor and to keep
detailed records of their headache frequency, intensity, duration and
type and amount of medication taken. This recording procedure was
conducted for the period of one year, after which they were offered
a treatment for their headaches.
The patients assigned to an experimental group were also
required to monitor headache activity and medication consumption as
outlined above, and were offered a treatment which would necessitate
their attendance at the Department of Psychiatry on a regular basis
over a number of weeks. The treatment they were offered was a non-
drug and non-psychiatric form of treatment intended to supplement and
not replace any drug regime the patient was already using.
Each patient was then given a demonstration headache record
form and instructions of how to record headache intensity, duration
and medication consumed. (See Appendix 1.3).
The patients who did not want to be considered for inclusion
in the project were immediately removed from the list of potential
experimental patients. Those patients who expressed an interest in
participating in the project were informed that a letter providing
further details would be sent to them in due course. If their
headaches were diagnosed as being of the type under investigation, a
supply of headache forms accompanied the letter.
All patients were assured of the following; it was their
prerogative to withdraw from the study at any point should they so wish.
That the study was being conducted with the consent of their doctor
who would still maintain clinical interest and responsibility for them.
That no psychiatric treatment was involved and that attendance at a
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Department of Psychiatry did not imply that their headaches were in
any way unreal or imaginary.
Following the assessment interview, the headache questionnaires
were rated by the experimenter. Patients who did not receive a
diagnosis of classic migraine were informed that their headaches were
not of the variety under investigation and that no further contact
regarding the project would be made with them. (Appendix 1.2+).
The referring doctor was informed of the patients' exclusion from the
experiment, reasons for exclusion were also presented. The referring
doctor was offered suggestions regarding alternative treatment
approaches; including relaxation classes and individual counselling.
The alternative treatments were not carried out by the experimenter
and no evaluation of these treatments has been attempted in this study.
The patients included in the treatment conditions were randomly
allocated to one of the five experimental conditions (four treatment
and a waiting list condition). The patients allocated to the waiting
list condition were informed of their allocation by letter. (Appendix
1.5). The letter confirmed that the patient would be offered a treat¬
ment for their headaches after a period of one year but that during
the intervening year an accurate record of their headache activity
and medication consumption was of great importance. A second
demonstration headache form was enclosed along with eight headache
record forms for the patient's use. The patient was told that a
similar number of headache forms would be sent to them at monthly
intervals along with a stamped addressed envelope so that contact
with the experimenter could be maintained. The letter stressed the
importance of maintaining an accurate record of headache activity,
medication consumption and details of changes in medication should it
- 11*9 -
occur, and that notification of a headache free period was as important
as careful monitoring of headache activity.
The patients allocated to the treatment conditions were also
informed "by a letter outlining details of the study but not of the
treatments. An appointment and eight headache record forms were
included. (Appendix 1.6).
BASELINE PERIOD
During the three month baseline period, patients in the treat¬
ment conditions were requested to attend the Department at monthly
intervals (at the end of the first and second months). The aim of
the baseline sessions (acclimatisation sessions) was to acquaint the
patients with the Department, the type of equipment used in the
project and experimental procedures, in an attempt to reduce any
anxieties the patients may have had regarding inclusion in the study
and the treatments. Both "acclimatisation" sessions were of one hour
and followed the same standard format.
Patients were seated in the treatment room where a brief
discussion regarding completed headache forms preceded a description
of the functions of the light reflectance plethysmograph and the
thermocouple probes. The plethysmograph and the probes were then
attached to the patient who was asked to remain awake, relaxed and
still whilst a 20-minute recording phase was completed. On completion
of the recording phase, the MX6 recordings of the finger temperature,
temporal artery amplitude and heart rate recordings were shown to the
patient. Questions regarding the MX6 recordings were answered by the
experimenter, but no details of the relevance of the recordings for
treatment purposes were given to the patients. Biofeedback was not
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administered to any patient at any stage of the acclimatisation
sessions. Recordings taken during the session were used for demonstration
purposes only and were not included in the analysis. On termination
of both acclimatisation sessions, patients were given eight headache
forms and an appointment for their next attendance.
TREATMENT PHASE
At the end of the three month baseline period, patients were
given appointments for the treatment phase of the experiment. On the
first treatment session, patients were informed of the type of treat¬
ment they were to receive. Written rationales for treatment were
provided for each patient (Appendix 1.7). Apart from the first session
when discussion of the rationales.preceded the treatment phase of the
session, the following format was adopted on each treatment session:-
On arrival, the patients were seated in the experimental treatment
room. An initial discussion period of 15 minutes was allowed for
each patient prior to the administration of the baseline phase of the
treatment. The discussions were limited to 'headache1 related topics
and at no time were domestic or personal issues encouraged as topics
of conversation. After the initial discussion, the apparatus was
attached to the patient and the following instructions were given.
BIOFEEDBACK PATIENTS
"I want you to sit quietly for 20 minutes, after which time the
television screen in front of you will display your (finger temperature/
temporal artery pulse wave/heart rate). When you see the numbers on
the screen, I want you to try and (increase/decrease/decrease) them.
Don't be concerned if you are unable to obtain immediate control as
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it may take a little time before you see any effects. Please do not
move unnecessarily, touch the sensitive probes or change the way you
are breathing in an attempt to gain control as all of these strategies
will hinder your attempts. There is reason to believe that the skill
is best shown when calm and comfortable. Even if you have achieved
control, it is often difficult to maintain and you may find that you
lose the skill between sessions. At no time will you receive a
shock or unpleasant sensation. If you feel uncomfortable and have to
move, do so and change position but do not keep moving around longer
than is necessary. If the equipment slips, or you become uncomfortable,
or you would like to finish the session, then don't hesitate to call
me. I will be in the room adjacent at all times during the session."
PROGRESSIVE RELAXATION PATIENTS
"I want you to sit quietly for 20 minutes, after which time
you will hear a short tape of relaxation exercises played to you over
the headphones. Please carry out the relaxation exercises as instructed.
When the tape is ended, I will leave you to maintain a relaxed and
tranquil state for 10 minutes. At no time will you receive a shock
or unpleasant sensation. Please do not move unnecessarily, touch the
sensitive probes or fall asleep. If you feel uncomfortable and have
to move, do so and change position but do not keep moving around
longer than is necessary. If the equipment slips, or you become
uncomfortable, or you would like to finish the session then don't
hesitate to call me. I will be in the room adjacent at all times
during the session".
The 10 minute biofeedback-recording phase was thus started
after the patient had been seated in the experimental room for at
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least 35 minutes (15 minute discussion and 20 minutes adaptation
period). This procedure would fulfil Yates's (1980) stringent
criteria for minimising the effects of drift in the feedback-recording
phase of the session. For all patients, irrespective of the treatment
condition, finger temperature, temporal artery pulse amplitude and
heart rate was recorded for the last five minutes of the 20 minute
adaptation phase and for the 15 minutes of the treatment phase. A
pre-experimental baseline was thus established at the beginning of
every treatment session Jbr every patient in every treatment condition.
Patients were given no suggestions or instruction as to how
they might acquire feedback control. On completion of the first
treatment session, patients were instructed to practice methods of
complying with the treatment demands using mental rehearsal. It was
suggested that mental rehearsal should be practiced in the following
manner :
"Every day, sit down in a quiet, darkened room. Make sure that
you are comfortable, warm and are not going to be disturbed or
distracted for at least 20 minutes. Try to picture yourself in this
experimental room and reproduce those feelings of control which you
achieve whilst you are here". This suggestion was reinforced on
every visit to the Department and patients were informed that this
procedure may facilitate skill acquisition and enhance therapeutic
benefits of the treatment. At no time were domestic or personal
issues regarded as a means of therapeutic concern and although general
conversation was encouraged as an aid to reducing anxiety, all possible
consideration was taken in maintaining the above format. Patients
were however encouraged to discuss the treatment with their families
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and parents of younger patients were invited to attend the sessions
with their children in an attempt to allay any anxieties present in
the parents which may have been transmitted to their children.
Each experimental condition patient was expected to complete
ten treatment sessions within ihe three month treatment period. The
treatment sessions were thus offered on a once weekly basis, at times
convenient to each patient but within normal working hours. Lunch
time attendance was discouraged.
FOLLOW-UP PERIOD
On completion of the three month treatment period (ten treat¬
ment sessions) all patients were reminded of the importance of
continued contact with the experimenter over the six month follow-up
period. Emphasis was placed on the need for continued home rehearsal
of the treatment on a regular daily basis, and the need for the accurate
recording of headache activity and medications used. Patients were
asked to inform the experimenter of months when headaches were absent.
The patients were sent eight headache record forms, and a stamped
addressed envelope every month for the duration of the six month
follow-up period. At the end of the six month follow-up period,
patients were informed that contact with them would be terminated.
MEASURES OF THERAPEUTIC BENEFIT
Seven indices of change were employed:
Headache frequency : The number of headache forms returned per month.
Headache intensity : The maximum intensity of pain experienced during
the headache attack (rated on a 5-point scale).
Headache duration : The length of time the headache was experienced.
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If a headache lasted for more than 21+ hours "but less than 1+8 hours,
the two headache forms were treated separately for frequency, intensity
and duration measures. If the headache lasted for more than 1+8 hours
but less than "J2 hours, the three headache forms were treated separately
for frequency, intensity and duration measures, etc.
Index of headache activity : Frequency of headaches per month x maximum
intensity of each headache x duration of each.headache.
Analgesic score : Analgesic potency was rated in the following way:
Aspirin (score 1), paracetamol (score 2), combination analgesics;
aspirin and/or paracetamol and/or codeine (score 3), distalgesics
(score 1+), codeine, morphine and cyclyzine (score 5).
Thus if a patient takes two aspirin (2 x 1), two combination
analgesics (2x3) a&cL a codeine (1x5) during the course of a
headache, the analgesic score = (2 x 1) + (2x3) + 0 x 5) =13.
Vasoconstrictor medication : As vasoconstrictor drugs can be taken
orally, parenterally or as suppositories; alone or in combined forms,
the exact dosage on each administration is difficult to determine
accurately, hence frequency of administration rather than amount was
used as an index of measurement.
Prophylactic medication : The number of tablets taken as a prophylactic
measure for the prevention of migraine attacks.
Although the use of Valium and a range of anti-emetic drugs
were observed during the experimental period, only the categories of
drugs mentioned above were used in the analysis.
The above method of collecting follow-up information and the
means of evaluating the information were employed to fulfil the
criteria for evaluating therapeutic change as proposed by Bakal and
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Kaganov (1976) and Adams, Feuerstein and Fowler (1980).
An index of headache activity was devised to indicate the
degree of overall discomfort experienced by the patient during each
headache. Blanchard, Theobald, Williamson, Silver and Brown (1978)
■used a 'Headache Index' of weekly headache ratings to measure changes
in headache activity. They stated that it was a sensitive measure of
headache activity and similar to the 'headache index' reported by
Budzynski, Stoyva and Adler (1970). It was however an average of
rated intensity and consequent incapacitation caused by the headache,
and not as in this study a score of frequency x intensity x duration
of headaches. There are no reports of an 'index of headache activity'
as used in this study, in previous work.
Sargent, Green and Walters (1972, 1973aand 1973b)used a 7-point
analgesic scale to record analgesic consumption, which
Blanchard et al (1978) also adopted as being a "more sensitive measure
of change than a mere pill count". The criterion of rating analgesic
potency is however not specified and in the absence of such a scale
the above 5-point scale was used in this study. The 5-point scale
was constructed under the supervision of a pharmacist (Boots Pharmacy
Department). The scale was intended to be a conservative measure of
change more sensitive than pill counting, as used by Turin and
Johnson (1976), Mitch, McGrady and Iannone (1976), Stambaugh and House
(1977) and. Warner and Lance (1975).
SUMMARY
The design of the study involved the collection of a group of
headache patients from which classic migraine headache patients were
diagnosed. The collection and assessment was carried out over the
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period of a year (January 1979 to January 1980). The diagnosed
classic migraine headache patients were randomly allocated to one of
the four treatment conditions and a waiting list control condition.
The conditions consisted of a finger temperature biofeedback condition,
a temporal artery pulse amplitude biofeedback condition, a progressive
relaxation condition and a heart rate biofeedback condition. The
patients in the finger temperature biofeedback condition were given
feedback of finger tip temperature and instructions to increase the
temperature; the patients in the temporal artery pulse amplitude
biofeedback condition were given feedback of pulse artery amplitude
of the superficial temporal artery and instructions to decrease the
amplitude. The progressive relaxation condition patients were given
no feedback but were administered abbreviated relaxation instructions.
The heart rate biofeedback condition (placebo condition) received
feedback of heart rate and given instructions to decrease heart rate.
The waiting list control condition patients received no treatment.
On initial contact with the patients and prior to allocation
to the treatment and waiting list condition, patients were given an
assessment questionnaire. The waiting list condition patients were
informed that treatment would be offered to them after the period of
a year, but that during the waiting period regular checks on their
medication consumption and headache activity would be made. For the
remaining subjects, allocation to the treatment conditions preceded
a three month baseline, three month treatment and six month follow-up
period.
At the end of the first month and the second month of the
baseline period, patients in the four conditions attended for baseline
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recording sessions. The patients were not informed about the treatment
they would receive until the start of the treatment period. On each
of the baseline visits, patients were familiarised with the apparatus
and recording equipment that was to be used during the treatment
sessions. Treatment was started at the beginning of the fourth month.
The treatment was given on a regular weekly basis, at times convenient
to the patient but within regular hours of the working week. Patients
were discouraged from lunch hour attendance. The six month follow-up
period was started on conclusion of the treatment period. During the
12 month experimental period, indices of headache activity and
medication consumption were recorded for patients in all treatment





RESULTS OF PHYSIOLOGICAL DEFORMATION
Data Reduction
Statistical analysis of the physiological information was
undertaken for the 32 patients who completed the ten treatment
sessions. Of the 32 'completers®, eight were in the finger temperature
condition, eight in the temporal artery amplitude condition, seven in
the relaxation condition and nine were in the heart rate (placebo)
condition.
Within every treatment session, a 20 minute stabilisation phase
was followed by a 15 minute treatment phase. Baseline physiological
recordings were taken during the last five minutes of the stabilisation
phase (pre-experimental baseline)♦ Recordings obtained during the
pre-experimental baseline phase were used to evaluate the magnitude
and direction of change that occurred during the 1 5 minute treatment
phase of the session.
Finger temperature data
For the purpose of statistical analysis, data from the 15
minute treatment phase was divided into three five-minute periods.
During the five minute pre-experimental baseline phase and
the 15 minute treatment phase (composed of three five-minute periods),
finger temperature was examined every 30 seconds and the changes from
the 'stability point* finger temperature calculated. Stability point
finger temperature was taken as that temperature achieved by the
patient at the end of the 20 minute stabilisation phase. The ten
30-second temperature values (five minute pre-experimental baseline
phase) were summed algebraically, as were each of the ten 30-second
temperature values in each treatment period. The pre-experimental
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baseline phase value was then subtracted from each of the three five-
minute period values of the treatment phase. Thus for each treatment
session, three values were obtained, each representing the magnitude
and direction of the temperature change from the pre-experimental
baseline occurring during the three five-minute periods of the treat¬
ment session. All finger temperature information is expressed as
the mean change observed at each 30 second interval of the treatment
phase.
Temporal artery amplitude data
As with finger temperature data, the 15 minute treatment
phase was divided into three five-minute periods.
Temporal artery amplitude recordings were examined every 30
seconds throughout the pre-experimental baseline phase and the
treatment phase (composed of three five-minute periods). At each
of the 30 second intervals, pulse waves were examined over a five
second epoch. During each five second epoch, the maximum and the
minimum pulse amplitude were recorded. The maximum and minimum
pulse amplitudes were summed algebraically over the pre-experimental.
baseline phase and the three five-minute treatment phase periods.
Mean and standard deviation values of the temporal artery pulse
waves were thus calculated for the pre-experimental baseline phase
and the three five-minute periods during the treatment phase.
As has been stated, slight variations in pulse amplitude size
across subjects and within subjects across sessions meant that pulse
amplitude recordings had to be taken at different plethysmograph
light intensities to gain clear signals. The light intensity control
of the Devices 3&11 Pulse monitor preamplifier provides only a coarse
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control of gain. As there is no indication that a direct relationship
exists between recordings taken on different lamp intensity settings,
relative difference scores were calculated for the three five-minute
treatment periods with respect to the pre-experimental baseline
phase. This form of transformation gives an index of change
independent of initial levels by treating the differences as relative
to the level of score (Bromley, 1971 )• All temporal artery
information is expressed as the mean change observed during within
session periods.
Heart rate data
Heart rate (beats per minute (bpm)) were obtained for each of
the five minutes in the pre-experimental baseline phase and each of
the three five-minute periods of the treatment phase. Magnitude and
direction of heart rate changes were calculated for each five minute
period within the treatment phase with respect to the pre-experimental
baseline. All heart rate information is expressed as mean change in
beats per minute (bpm).
The dependent variables were;
Changes in finger temperature (°C), relative difference (RD)
changes in mean temporal artery pulse amplitude, relative difference
(RD) changes in the standard deviation of temporal artery pulse
amplitude, and heart rate changes (bpm).
Changes during the within session periods relative to the
pre-experimental baseline were calculated for every patient in every
session of the four treatment conditions.
Analysis of physiological information
Physiological data was analysed using a 1; x 10 design (I).
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between treatment conditions and 10 within treatment sessions) with
repeated measures on the within (treatment session) variable. Since
three within session period measures were obtained, a 3 Way Analysis
of Variance was computed for each of the above dependent variables,
1+ between (treatment conditions) x 10 within (treatment sessions)
x 3 within (treatment periods), in which there were repeated measures
on the last two factors.
Computations were completed using the B.M.I).P. (Biomed) and
S.P.S.S. programmes. All raw, mean and standard deviation scores are
contained in Appendix 2.
FINGER TEMPERATURE INFORMATION
Table 1
Table 1 is a summary table from the 3 Way Analysis of Yariance
examining the effects of treatment conditions, sessions and periods
on finger temperature change. (Appendix 2.2)
Table 1
Finger temperature changes for all subjects between treatment
conditions, across treatment sessions and within treatment
session periods
Sum of Degrees Mean in 2 Tail
JDOUlTCe
Squares of Freedom Square Probability
Treatment 1106.21+ 3 368.75 0.75 0.53
Error 13728.77 28 1+90.31
Period 292.67 2 11+6.33 3.76 0.03
Period x Treatment 185.27 6 30.88 0.79 0.58
Error 2178.1+0 56 38.90
Session 3398.56 9 377.62 1.50 0.15
Session x Treatment 805U-9U 27 298.33 1.19 0.21+
Error 63273.1+8 252 251.09
Session x Period 595.92 18 33.11 1.01 0.1+1+
Session x
Period x 1798.75 51+ 33.31 1.02 0.1+1+
Treatment
Error 16I+72.09 5ol+ 32.68
3 Way Analysis of Variance
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The results from Table 1 show that there was no significant
treatment effect upon finger temperature change. The finger
temperature feedback condition demonstrated no greater change in
finger temperature than the other treatment conditions. Previous
research has suggested that the 'skill' of finger warming can be
acquired easily; within three to four sessions (Gardner and Keefe
1976, Ohno, Tanaka, Tayeka and Ikemi 1977)» thus a gradual increase
in temperature change over sessions would be expected. A 'learning'
effect of this type may cause a treatment x session interaction.
As a treatment x session effect was not apparent, it would appear
that there is no indication that a learning process was taking place.
A significant within period effect (F = 3.76, 2df., p<0.03)
suggests that the finger temperature changes during the three five-
minute within session periods differed significantly. The within
period difference was however a feature of all treatment conditions
and all sessions, as the period x treatment and period x session
effects failed to reach significance. Finger temperature feedback
therefore does not appear to have produced significant changes in
finger temperature.
Table 2
Mean finger temperature changes within treatment sessions
(per 30/ epoch)
Finger Temp Temp Art Amp Relaxation Heart Rate
+0.10°C -0.08°C -0.19°C +0.03°C
Although the finger temperature condition displayed a higher
mean change, the treatment condition differences failed to reach a
level of significance.
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The results from the Pilot Study (Chapter 8) suggest that
downward 'drift' of finger temperature may take place in an ambient
temperature of 22±1°C. The decreases shown by the temporal artery
amplitude and progressive relaxation conditions may have been due
to the effects of drift. The greater decrease evident for the
progressive relaxation condition may have been due to the combined
effects of drift and the 'abbreviated progressive relaxation*
exercises that preceded the 15 minute treatment phase. (Lynch and
Schuri 1978).
The slight increase in temperature shown by the heart rate
condition may also be within the limits of drift; this however is a
speculative point in the absence of supportive evidence.
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Graph 1
Mean temperature changes for the 3 within session periods.
MEAN TEMPERATURE CHANGES FOR THE 3 WITHIN SESSION PERIODS





x x Finger Temperature Condition
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• • Progressive Relaxation Condition
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It is evident from Graph 1 that the significant 'periods'
effect was due to a general tendency for finger temperature to
decrease during the third period, relative to the second. This
decrease may he due to the effects of drift, as it was a constant
effect across all treatment conditions. Although the finger tempera¬
ture condition showed an increase from baseline across all periods,
feedback does not militate against the 'drift' effect during the third
period even though there is a considerable mean increase in finger
temperature during the second within session period.
Graph 2
Graph 2 shows the mean finger temperature changes (30 second
epoch) across treatment sessions for each of the treatment conditions.
FINDER TEMPERATURE CHANCES I PER 30 SECOND EPOCH) WITHIN TREATMENT SESSIONS
"~i Finger Temperature Condition Temporal Artery Amplitude
Condition
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Stability point finger temperatures
Stability point finger temperature was that temperature
attained by each patient at the end of the 15 minute stabilisation
and five minute pre-experimental baseline phase, prior to the 15
minute treatment phase. It represented the stable level of responding
for the patient within the session. Thus for each patient a stability
point temperature was recorded within every session at the start of
every treatment phase. As the non-significant treatment effect
(Table 1) may have been due to group differences in stability point
temperatures, rather than an inability to increase finger temperature
during the feedback session, stability point finger temperatures were
investigated to determine whether the finger temperature condition
showed elevated temperatures in anticipation of feedback.
Table 3 is a summary table of a 2 Way Analysis of Variance,








































Two Way Analysis of Variance.
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The 2 Way Analysis of Variance (repeated measures) between
treatment conditions and across sessions showed no significant
condition, sessions or condition x session effects. If a treatment
condition effect were apparent, it may have indicated that finger
temperature stability point values were different across conditions,
suggesting that temperature changes were taking place prior to the
onset of feedback. A treatment x sessions effects may have indicated
that changes prior to the onset of feedback were taking place across
sessions, perhaps as a function of the practice afforded by earlier
sessions. As neither a treatment nor a treatment x session effect
was observed, it appears that no pre-feedback finger temperature
changes occurred in any treatment condition.
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TEMPORAL ARTERY FtJLSE AMPLITUDE DEFORMATION
The temporal artery amplitude information was analysed as
Relative Difference (RD) change scores. The RD scores enabled
relative changes to be measured, independent of absolute values
(Bromley 1971)• An RD score was calculated for each of the three
five-minute within session periods with respect to the pre-experimental
baseline. A positive RD score indicated an increase in the treatment
period pulse amplitude relative to the pre-experimental baseline.
Conversely, a negative RD score indicated a decrease in the treatment
period pulse amplitude relative to the pre-experimental baseline.
(Appendix 2. J4.).
Table 1 is a summary table from a 3 Way repeated measures
Analysis of Variance examining the effects of treatment conditions,
sessions and periods on mean temporal artery pulse amplitude (RD scores).
Table 1
Temporal Artery Pulse Amplitude (relative difference scores)
between treatment conditions, within treatment sessions and
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The results from Table 1 show that there was no treatment
condition effect upon changes in mean temporal artery amplitude (Eh
scores). The temporal artery feedback condition therefore
demonstrated no greater change than the other treatment conditions.
There was a highly significant across session effect (F = 6.05»
9df., p<C0.0l) which indicated that mean changes in amplitude
differed across the treatment sessions. A lack of a significant
treatment x session effect would suggest that the changes were not
attributable to a particular treatment condition, but were constant
across all treatment conditions.
Table 2.
Mean temporal artery amplitude changes within treatment sessions
Finger Temp Temp Art Amp Prog Eel 'n Heart Rate
+0.05 +0.12 +0.16 +0.15
Table 2 shows that all treatment conditions showed slight
increases in mean artery amplitude during the treatment phase in
comparison to the pre-experimental baseline phase of the sessions.
The slight increases in artery amplitude suggest reduced levels of
arousal, and the observed increase for the relaxation condition may
support this view. Whilst it appears that feedback does not prevent
slight temporal artery amplitude increases, it may facilitate a
reduction in the amount of vasodilation that would normally occur as
a result of relaxation. The change shown by the finger temperature
condition cannot however be explained with current information.
In the absence of a treatment effect, it was considered
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necessary to confirm the accuracy of the relationship between the
pulse wave tracings and the presented feedback information (see page
172).
Graph 1
Mean temporal artery pulse amplitude changes (BP scores) for
the 3 within session periods
MEAN TEMPORAL ARTERY AMPLITUDE CHANGES.
(RD SCORES) FOR THE WITHIN SESSION PERIODS.
+ 0*20-1
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Graph 1 shows the mean period changes across sessions. The
finger temperature condition was the only condition to show a
slight decrease in mean amplitude, albeit small and non-significant.
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Graph 2.
Graph 2 shows the mean changes across sessions for each
treatment condition.
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TEMPORAL ARTERY AMPLITTJLE ; ACCURACY OF FEELBACK
The results show that the temporal artery amplitude condition
failed to demonstrate a change in mean amplitude In previous
studies binary feedback had been used; in the present study, however,
analogue feedback was presented to the patients. Although there is
no information on the comparative efficacy of these two approaches,
analogue feedback would on a priori grounds be expected to produce
more efficient learning (Hume 1977). As there was no evidence to
suggest that the presence of feedback afforded greater control of
temporal artery activity, an investigation into the relationship
between changes in artery amplitude and the feedback display was
conducted.
Three subjects - one male and two female - took part in this
study. Their ages ranged from 21+ - 31 years (mean 26.3 years). All
were from University staff and were free of peripheral vascular
abnormalities. Hone of the subjects had been involved in any other
part of this study.
Each subject was seated in the experimental room for a period
of 1+5 minutes. The light leflectance piethysmograph was placed on the
left temporal artery at the point of maximum beat engorgement (approx¬
imately 1 cm above the zygomatic arch). Finger temperature and heart
rate were not recorded during the session. The subjects did not
receive feedback of temporal artery amplitude (which was displayed
on the LVM at six second intervals) but the display was recorded by
the experimenter. Luring the 1+5 minute experimental period, temporal
artery amplitude was recorded on 'low' intensity gain for 15 minutes,
'medium1 gain for 15 minutes and 'high' gain for 15 minutes. The
- 173 -
intensity of gain was counterbalanced across the three subjects.
Apart from the above modifications for experimental purposes, the
presentation and computation of the temporal artery information was
the same as in the main treatment study.
The coefficient of correlation was calculated for the two
measures (display and permanent record) for each intensity gain sample
and across all intensity gain samples. (Appendix 2.7).
The following table shows the coefficients of correlation for
each subject on each intensity gain.
Subject 1 Subject 2 Subject 3
Intensity gain n = 10 n=10 n=10
Low r=+0.9 (p<0.01) r=+0.9 (p 4.0.01) r=+0.8 (p<10.01 )
Medium r=+0.8 (p<0.0l) r=+0.9 (p<0.0l) r=+0.9 (p<0.0l)
High r=+0.9 (p<0.0l) r=+0.9 (p<0.0l) r=+0.9 (p 4.0.01)
An overall correlation across all subjects and all intensity
gains (n = 90) was r = +0.9 (p4_0.00l).
The results indicate that there is a high correlation between
mean temporal artery amplitude (permanent record) and the feedback
display. This would show that the feedback was an accurate
representation of change and the degree of change that occurred
during the treatment session.
The light reflectance plethysmograph is a sensitive transducer
and detection can be influenced by movement and muscle tension. For
this reason patients in the main study were instructed to remain as
still as possible and not to disturb the plethysmograph. Although
movement and muscular 'artifacts1 may have interfered with the feed-
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back display, the length of the 'stabilisation' period and the
instructions to remain still would reduce the frequency of artifact
interference. The present evidence would indicate that the feedback
display was an accurate analogue signal of the mean size of temporal
artery amplitude.
The inability of the temporal artery amplitude condition to
demonstrate a significant decrease in amplitude may therefore
indicate one of two things: firstly, feedback did not enable control
of temporal artery amplitude to be gained. Secondly, the amount
of change that occurred during the feedback presentation could not
be further effected with the aid of feedback. These are however
points for further discussion.
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TEMPORAL ARTKKY PULSE AMPLITUDE (RD of standard deviation scores)
As stated in the introduction, mean and standard deviation
changes in temporal artery pulse amplitude were obtained for the
pre-experimental baseline and each of the three five-minute within
session periods. The mean values were obtained to show changes in
the 'central tendency' of the amplitude and, as has been stated, there
is a high correlation between the means calculated for analysis and
the feedback information presented. Previous research has however
implied changes in cerebral blood flow levels from the number of
artery pulses which exceeded pretrial criteria. The pretrial criterion
was not a fixed level but adjusted at frequent intertrial intervals.
(Koppman, McDonald and Kunzel 197U» Peuerstein and Adams 1977 and
Christie and Kotses 1973)* Frequency counts may not, however, reflect
mean amplitude changes, but may reflect a change in the variability
(standard deviation) of the pulse amplitudes.
The standard deviation (SD) values were thus obtained to
investigate the amount of variance, and changes in variance that
occurred in the pulse amplitude during the treatment phase of each
session. (Appendix 2.5).
Table 1 is a summary table of the results from a 3 Way repeated
measures Analysis of Variance of standard deviation changes (RD
scores) in temporal artery pulse amplitude between treatment
conditions, across sessions and within periods.
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Table 1.
Standard deviation changes in temporal artery pulse amplitude
(ED scores) between treatment conditions, across sessions and
within periods
Temporal Artery Pulse Amplitude Information. Relative Difference









































































3 Way Analysis of Variance
The results from Table 1 showed that as with mean changes in
temporal artery amplitude, there were no significant treatment
condition effects. The temporal artery amplitude feedback group
therefore failed to demonstrate significant changes in artery
amplitude variability. There was a significant period effect
(f = 3.63, 2df., p<0.03), but in the absence of a period x treatment
or period x session effect, it would appear that the differences
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within the periods was constant between all conditions and across all
treatment sessions.
Graph 1 shows the standard deviation changes in temporal
artery amplitude (RD scores) for all subject within the treatment
periods.
Graph 1
Mean standard deviation changes in temporal artery amplitude
(RD scores) for subjects within the treatment periods
MEAN STANDARD DEVIATION CHANGES IN TEMPORAL ARTERY
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It is evident that the temporal artery amplitude condition
showed the greatest reduction in variability during the first within
session period. The reduced variability was not however maintained
and slight increases within the second and third periods were noted.
As with the mean changes, the relaxation condition showed the
greatest increase in variability across the periods.
Table 2.
Mean standard deviation changes in temporal artery amplitude
within all session (BP scores!
Finger Temp Temp Art Amp Prog Rel'n Heart Rate
+0.01+ +0.05 +0.11+ +0.08
Although, as Table 2 shows, the mean standard deviation
changes in the finger temperature and temporal artery amplitude
conditions are very similar, neither group showed a change below
the pre-experimental baseline.
Graph 2 shows the mean standard deviation changes (RD scores)
in temporal artery amplitude across sessions for each treatment
condition. The finger temperature and temporal artery amplitude
conditions showed similar changes across the treatment sessions.
As with 'mean1 changes, the standard deviation changes observed
across the treatment sessions are increased for the Progressive
Relaxation condition. The increases observed for the relaxation
condition may be consistent with a reduction in arousal, although
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Table 1 is a summary table of the 3 Way repeated measures
Analysis of Variance of heart rate changes, between treatment
conditions, across treatment sessions and within periods. (Appendix
2.6).
Table 1.
Mean heart rate changes across treatment conditions, treatment
sessions and within treatment session -phases
Source ^Um 0"^ Degrees Mean Tail































































3 Way Analysis of Variance.
The results from Table 1 show that a significant treatment
effect occurred (F = 3«10, 3 df., p<0.0l+). This indicated significant
differences in heart rate changes between the treatment conditions.
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As a significant treatment x session effect also occurred (F = 1.76,
27 df, p<O.Ol) the differences in .treatment conditions was not
constant, hut varied over the treatment sessions. There was also a
significant period effect (F = 9-58, 2 df., p<0.0l) showing that
changes within the periods also occurred. As there were no period x
treatment or period x sessions effects, it can he assumed that the
changes within periods were constant between each treatment condition
and within each session.
The significant treatment x session effect was investigated
further to determine which treatment conditions were responsible for
the significant heart rate changes, and within which sessions the
changes occurred.
A One Way Analysis of Variance was carried out on each of the
ten treatment sessions, investigating the between treatment condition
heart rate changes for each session. The ten One Way ANOYA?s were
calculated to identify the extent of between treatment condition
differences for each treatment session. The results of the ten One
Way ANOVA's showed that significant treatment effects occurred for
session 1 (F = l+.l+l, 3 df, p-^0.03) and session 10 (F = 3.U9, 3 df,
p<0.03). There were no significant treatment effects in any of the
intervening eight sessions.
Table 2 is a summary table of the results of the One Way
ANOVA for between treatment condition heart rate changes.
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Table 2.
Mean heart rate changes between treatment conditions on session 1
Source Degrees of Sum of Mean F F






3 3019.60 1006.53 3.U1 0.03
28 8260.61+ 295.02
1 Way Analysis of Variance.
A Posteriori Contrast Test, (least significance difference test.
Alpha level 0.05) ~~~
Mean TAC HR FT RED
-15.1+9 Temporal artery pulse amplitude condition (TAC)
-10.1+1 Heart rate condition (HR)
1.36 Finger temperature control condition (FT)
9.97 Progressive relaxation condition (EEL) * *
(*) Denotes pairs of groups significantly different at the
0.05 level)
The *a posteriori contrast test* shows that the changes were
due to the mean heart rate values for the temporal artery and heart
rate conditions being lower than for the progressive relaxation
condition. (See Graphs 1A, 1B.)
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Graph 1.
Relaxation, temporal artery and heart rate condition, heart rate
changes between session 1 and 2
RELAXATION,TEMPORAL ARTERY AND HEART RATE CONDITION,HEART RATE



































In the absence of a significant treatment effect (1 WAY AEOYA)
for session 2, it is indicated that there was a significant change in
heart rate for the Progressive Relaxation condition between sessions
1 and 2.
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Table 3 is "the summary table of the results of the 1 Way
























1 Way Analysis of Variance.
A Posteriori Contrast Test (least significance difference test.
Alpha level 0.05)
Mean EEL BR TAC FT
-21;.09 Progressive relaxation condition (EEL)
-13.13 Heart rate condition (HR)
-09.20 Temporal artery pulse amplitude condition (TAC) *
-00.80 Finger temperature control condition (FT)
(*) Denotes pairs of groups significantly different
at the 0.05 level.
The ®a posteriori contrast test1 shows that the differences
were due to the mean heart rate values for the progressive relaxation
condition being lower than the finger temperature condition and the
heart rate condition being lower than the temporal artery amplitude
condition. (See Graphs 2A, 2B.)
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Graphs 2 (A_&JB)
Heart rate changes for the finger temperature, temporal artery.
heart rate and relaxation conditions between sessions 9 and 10.
HEART RATE CHANGES FOR THE FINGER TEMPERATURE, TEMPORAL ARTERY,

























In the absence of any other significant condition effects
within sessions 2 through to 9> it can be asspmed that the treatment
x session effects took place on session 1 and 10. The significant
changes in heart rate were due to the progressive relaxation and heart
rate conditions. In session 1, heart rate for the relaxation condition
was significantly higher than for the other conditions; it however
decreased on session 2. During session 10, significant decreases in




Mean heart rate changes within treatment sessions (bum)
Finger Temp Temp Art Prog Rel'n Heart Rate
+0.09 -1.67 -2.01 -2.10
Table 1; indicates that sessions 1 and 10 reflect the general
superiority of progressive relaxation and heart rate biofeedback in
effecting decreases in heart rate. The non-significant treatment
effect suggested that feedback did not produce greater changes
than were achieved by the Progressive Relaxation condition. There
was therefore no incremental utility in feedback over relaxation in
producing heart rate decreases.
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Graph 3 shows the mean changes in heart rate within session
periods. a slight decrease in heart rate is noted for all conditions
within periods. However the greatest decrease was achieved by the

























—x Finger Temperature Condition
-o Temporal Artery Amplitude Condition
$ 9 Progressive Relaxation Condition
a a Heart Rate Condition
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Graph U.
Graph I4. shows the mean changes in heart rate (bpm) across

















MEAN HEART RATE CHANGES WITHIN TREATMENT SESSIONS
Finger Temperaiure Condition
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RESULTS OF THERAPEUTIC CHANGE
Data Reduction
Seven indices of therapeutic change were recorded over the
three month baseline period, three month treatment and six month
follow-up periods. The indices were: frequency of headaches per
month, maximum intensity of each headache, the duration of the
headache, an index of headache discomfort (frequency x intensity x
duration), an analgesic index per month, frequency of use of vaso¬
constrictor drugs per month and the number of prophylactic drugs
taken per month. All raw, mean and standard deviation scores are
contained in Appendix 3«
Initial observations of 'headache frequency* during the three
month baseline period showed that a reduction occurred; across all
treatment conditions, during the second month (Appendix 3^)«
This reduction was preceded by the patient's first visit to the
Department (for the first acclimatisation session) during which no
treatment was administered and was followed by an increase in
•headache frequency' during the third month. A Two Way Analysis of
"Variance between the four treatment conditions and within the three
baseline months revealed a significant difference in frequency
within the baseline months (F = i+. 6I+, 2 df, p<O.Ol).
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Table 1.
Sum of Degrees of ' Mean p 2 Tail
Squares Freedom Square ~ Probability
Treatment 193*86 3 61}.. 62 3*07 0. 0i+
Error 576.51* 27 21.02
82.51+ 2 1*1.27 1+.61+ 0.01






A 'treatment1 condition effect was also observed (P = 3.07,
3 df, p<.0.0l+). In the absence of a treatment x month interaction,
the differences in headache frequency during each 'baseline month'
were assumed to remain constant. Therefore within month changes are
constant for each treatment condition.
Table 2.
Finger Temp Temp Art Prog Rel'n Heart Rate
99 136 3k 111+
Graph 1 shows the mean frequency of headaches over each base¬
line month for patients in all treatment conditions.
Graph 1.
MEAN NUMBER OF HEADACHES FOR ALL










It was hypothesised that the decrease in headache frequency
observed during the second month of the baseline period was due to
non-specific treatment effects of attending for the first 'acclimat¬
isation' session. It was therefore concluded that month three would
be representative of a stable level of headache activity; the un¬
controlled effects of the acclimatisation sessions, and of self
monitoring having the least influence at the end of the baseline
period. Month three was therefore used as the baseline month to
evaluate the clinical change during the following months.
As the initial baseline levels of responding differed between
the treatment conditions for frequency of headaches (j? = 3.07, 3 df,
p<.O.Ol|.), relative difference (ED) scores were calculated for each
of the seven indices of change. The relative difference scores
indicated relative changes over the follow-up months with respect to
baseline, the scores being independent of between treatment condition
differences in baseline values.
In order to assess changes in headache activity for each
treatment condition and the waiting list control condition, the
following approach was adopted:
Indices of change for month three (end of the baseline period)
were compared with the indices recorded from month seven (immediately
on completion of treatment), month 10 (four months after the completion
of treatment) and month 12 (six months after the completion of
treatment). Relative Difference scores were therefore obtained for
each of the follow up months to assess the immediate effects of
treatment, the effects after four months and after six months. A
positive relative difference value indicated an improvement whilst
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a negative relative difference value indicated a worsening of the
symptom with respect to "baseline. The amount of the value related
to the magnitude of change.
Since measures of therapeutic change were calculated for three
follow-up months relative to "baseline values, change was represented
as five between (treatment conditions) x three within (months)
design with repeated measures on the within (months) variable.
Statistical analysis of clinical information was undertaken
for the 29 patients who had completed the ten treatment sessions and
had notified the experimenter of headache activity on every month of
the 12 month duration of the study. Of the 29 patients, eight were
in the finger temperature condition, eight were in the temporal
artery amplitude condition, five were in the progressive relaxation
condition, five were in the heart rate condition and three were in
the waiting list condition.
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FREQUENCY OF HEADACHES
For the purposes of statistical analysis and. for the graph¬
ical presentation of the results, 'MONTH 1' is the relative difference
value for the changes recorded on month 7 (immediately after treat¬
ment) compared with the baseline. 'MONTH 2' is the relative
difference value for the changes recorded on month 10 (four months
after the completion of treatment) compared with the baseline and
'MONTH 1', the relative difference values recorded on month 12 (at
the end of the study).
Table 1.
Table 1 is a summary table of the results of a 2 Way repeated
measures ANOVA frequency between treatment conditions and within the
three follow-up months. (Appendix 3«2).
Frequency of headaches between treatment conditions within the
follow—up months
S urn ^um Degrees of Mean Tail
Squares Freedom Square Probability
Treatment 1+5.13 1+ 11.28 6.1+7 0.00
Error 1+1.86 21+ 1.71+
Month 1.30 2 0.65 0.79 0.1+6
££Lent 2'52 8 °-81 °-88 °-«
Error 39*57 1+8 O.83
2 Way Analysis of Variance
There was a significant difference between the treatment
conditions. As there was no difference between the follow-up months
- 19k -
and there was no month x treatment interaction, it would appear that
the difference in treatment conditions was constant over the follow-
up months.
In order to establish which treatment conditions differed
over the follow-up period, One Way Analyses of Variance were computed
between each of the five conditions for each of the three follow-up
months.
Graph 1.
Graph 1 represents the mean relative difference values in
frequency of headaches at month 1 (end of treatment period with respect
to baseline).
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Table 2 is the summary table for the One Way Analysis of
Variance between the treatment conditions at month 1.
Source ^Um °"^ Degrees of Mean Tail
Squares Freedom Square Probability
Eauality
of cell 23.39 k 5.81+ ' 7.0991 0.0I
means
Error 19.77 21+ 0.82
A significant difference between the treatment conditions
occurred during month 1. Table 3 is a table of probabilities for
the T values between the treatment conditions on month 1.
Table 3.
Condition FT TA RL HR
Finger temperature (FT) 1.00
Temporal artery (TA) 0.02 1.00
Relaxation (RL) 0.00 0.22 1.00
Heart rate (HR) O.67 0.02 0.00 1.00
Waiting list (Wl) 0.00 0.05 0.37 0.00
WL
1.00
Table 3 shows that the significant differences in headache
frequency found at month 1 were due to the finger temperature and
heart rate treatment conditions showing significantly greater improve¬
ment over the relaxation and temporal artery amplitude condition and
the waiting list condition. However there was no difference in the
improvement (reduction in headache frequency) between the heart rate
and the finger temperature treatment conditions.
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Graph 2.
Graph 2 represents the mean relative difference values in
frequency of headaches at month 2 (four months after the end of
treatment with respect to baseline).






Finger Temporal Relaxation Heart Rate Waiting List




Table 1+ is the summary table for the One Way Analysis of
Yariance between the treatment conditions at month 2. No significant
difference between the treatment conditions was found.
Source Stun o:f Degrees of Mean ^ Tail
Squares Freedom Square Probability
Equality
of cell 10.26 k 2.56 1.71 0.18
means
Error 35.95 21+ 1.1+9
Graph 3.
Graph 3 represents the mean relative difference values in
frequency of headaches at month 3 (six months after the end of
treatment with respect to baseline).





Finger Temporal Relaxation Heart Rate Waiting List




Table 9 is the summary table for the One Way Analysis of
Variance between the treatment conditions at month 3«
Sum of Degrees of Mean F Tail
Squares Freedom Square Value Probability
Equality
of cell 13.99 h 3.U9 3.25 0.03
means
Error 25.80 21+ 1.08
A significant difference between the treatment conditions
occurred during month 3. Table 6 is a table of probabilities for the
T values between the treatment conditions on month 3»
Table 6
Conditions FT TA EL HR WL
Finger temperature (FT) 1.00
Temporal artery (TA) 0.07 1,,00
Relaxation (RL) 0.05 0,.68 1 .00
Heart rate (HR) 0.36 0..01 0.01
Waiting list (WL) 0.09 0..72 1.00
1.00
0.03 1.00
Table 6 shows that the significant differences in headache
frequency found at month 3 were due to the heart rate condition
showing significantly greater improvement over the temporal artery
amplitude, the relaxation and the waiting list conditions. Although
the heart rate condition showed a greater improvement than the finger




Graph 1+ shows the mean relative difference values for
frequency of headaches over the three follow-up months for the
finger temperature, temporal artery amplitude, relaxation, heart
rate and waiting list conditions respectively.









































Table 1 is the summary table of a 2 Way repeated measures







































2 Way Analysis of Variance.
There was a significant difference between the treatment
conditions. As there was no difference between the follow-up months
and no month x treatment interaction, it would appear that the
difference in treatment conditions was constant over the follow-up
months.
In order to establish which treatment conditions differed
over the follow-up period, One Way Analyses of Variance were computed




Graph 1 represents the mean relative difference values in the
intensity of headaches at month 1 (end of the treatment period with
respect to baseline).










Relaxation Heart Rate Waiting List
Condition Condition Condition
Table 2
Table 2 is the summary table for the One Way Analysis of
Variance between the treatment conditions during month 1.
Sum of Degrees of Mean Tail
Squares Freedom Square Probability
Equality
of cell 12.26 k 3.07 3.58 0.02
means
Error 20.57 21; 0.86
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A significant difference between the treatment conditions
occurred during month 1. Table 3 is a table of probabilities for
the T values between the treatment conditions on month 1.
Table 3.
Condition FT TA RL HR WL
Finger Temperature (FT) 1.00
Temporal artery (TA) 0.12 1.00
Relaxation (RL) 0.27 0.78 1.00
Heart rate (HR) 0.27 0.02 o.o5 1.00
Waiting list (WL) 0.01 0.16 0.13 0.00 1.00
Table 3 shows that the significant differences in headache
intensity found at month 1 were due to the heart rate treatment
condition showing significantly greater improvement over the temporal
artery amplitude and waiting list conditions. The heart rate
condition however does not differ significantly from the finger
temperature condition and just fails to reach statistical significance
over the relaxation condition.
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Graph 2,
Graph 2 represents the mean relative difference values in
intensity of headaches at month 2 (four months after the end of
treatment with respect to baseline).
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Table I4. is the summary table for the One Way Analysis of
Variance between the treatment conditions at month 2.
Source °"^ Degrees of Mean F Tail
Squares Freedom Square Value Probability
Equality
of cell 17.01 k 1+.25 1+.05 0.01
means
Error 25.20 2k 1.05
One Way Analysis of Variance.
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Table 5.
Table 5 is the table of probabilities for the T values between







FT TA RL HR WL
1 .00
0.01 oo•T—
0.02 1 .00 . oo
0.87 0.01 0.02 1 .00
o.oi+ oo• • oo 0.01+ 1.00
Table 5 shows that the significant differences in headache
intensity found at month 2 were due to the finger temperature and
heart rate treatment conditions showing significantly greater
improvement over the relaxation, temporal artery amplitude and
waiting list condition. However, there was no difference in improve¬
ment (reduction in headache intensity) between the heart rate and the
finger temperature treatment conditions.
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Graph 3.
Graph 3 represents the mean relative difference values in
intensity of headaches at month 3 (six months after the end of
treatment with respect to baseline).
INTENSITY OF HEADACHES. MONTH 3. BETWEEN TREATMENT CONDITIONS
+ 2-j
+ 1-
Finger Temporal Relaxation Heart Rate Waiting List




Table 6 is the summary table for the One Way Analysis of Variance
between the treatment conditions at month 3«
Source Degrees of Mean F Tail
Squares Freedom Square Value Probability
Equality
of cell 11.81 1+ 2.95 3.02 0.01+
means
Error 23.50 21+ O.98
One Way Analysis of Variance.
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A significant difference between the treatment conditions
occurred during month 3» Table 7 is a table of probabilities for
the T values between the treatment conditions on month 3.
Table 7.
Condition FT TA EL HR WL
Finger temperature (FT) 1.00
Temporal artery (TA) 0.02 1.00
Relaxation (RL) 0.1+3 0.17 1.00
Heart rate (HR) o.5U 0.01 0.21
Waiting list (WL) 0.07 1.00 0.28
Table 7 shows that the significant differences in headache
intensity found at month 3 were due to the heart rate condition
showing significantly greater improvement over the temporal artery
amplitude and waiting list conditions. However, the improvement
found in the heart rate condition was not significantly greater than
found in the finger temperature and relaxation conditions.
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Graph U.
Graph 1+ shows the mean relative difference values for
intensity of headaches over the three follow-up months for the
finger temperature, temporal artery amplitude, relaxation, heart
rate and waiting list conditions respectively.














































Table 1 is the summary table of the 2 Way repeated measures
ANOVA between treatment conditions and within the three follow-up
months. (Appendix 3.i|).
Duration of headaches between treatment conditions, within
the follow-up months
Source ^Um °"^ Degrees of Mean ^ Tail"
Squares Freedom Square Probability
Treatment 38.61 Ij. 1+.65 7-0Q 0.00





2 Way Analysis of Variance.
There was a significant difference between the treatment
conditions. As there was no difference between the follow-up months
and no month x treatment interaction, it would appear that the
difference in treatment conditions was constant over the follow-up
months. In order to establish which treatment conditions differed
over the follow-up period, One Way Analyses of Variance were computed
between each of the five conditions for each of the three follow-up
months.
0.31 2 0.16 0.23 0.79














Relaxation Heart Rate Waiting List
Condition Condition Condition
Table 2.
Table 2 is the summary table for the One Way Analysis of






















A significant difference between the treatment conditions
occurred during month 1. Table 3 is a table of probabilities for the
T values between the treatment conditions on month 1.
Table 3.
Condition IT TA EL HE WL
Finger temperature (FT) 1.00
Temporal artery (TA) 0.05 1 .00
Relaxation (EL) 0.00 0.19 1.00
Heart rate (HR) 0.3b 0.01 0.00
Waiting list (WL) 0.18 0.89 0.25
Table 3 shows that the significant differences in the headache
duration found at month 1 were due to the heart rate condition
showing significantly greater improvement in headache duration than
the temporal artery amplitude and relaxation conditions. However, no
significant differences were found between the heart rate, the finger
temperature and the waiting list conditions.
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Graph 2.
Graph 2 represents the mean relative difference values in
duration of headaches at month 2 (four months after the end of
treatment with respect to baseline).









Heart Rate Waiting List
Condition Condition
Table 1+.
Table 1+ is summary table for the One Way Analysis of Variance
between the treatment conditions at month 2.
s Sum of Degrees of Mean F Tail^our._e
Squares Freedom Square Value Probability
Equality
of cell 12.07 h 3.02 3.1+1 0.02
means
Error 21.21+ 21+ O.89
One Way Analysis of Variance.
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Table 5.
Condition FT TA RL HR WL
Finger temperature (FT) 1.00
Temporal artery (TA) 0.03 1.00
Relaxation (RL) 0.02 0.65 1.00
Heart rate (HR) 0.68 0.02 0.01
Waiting list (WL) 0.12 0.89 0.63
Table 5 shows that the significant differences in headache
duration found at month 2 were due to the heart rate and finger
temperature conditions showing significantly greater improvement
over the temporal artery amplitude and relaxation conditions.
However, there was no difference in improvement (reduction in head¬




Graph 3 represents the mean relative difference values in
duration of headaches at month 3 (six months after the end of the
treatment with respect to baseline).













Table 6 is the summary table for the One Way Analysis of
Variance between the treatment conditions at month 3.
Source Degrees of Mean 3? Tail
Squares Freedom Square Value Probability
Equality
of cell 1U-13 b 3.53 3.17 0.03
means
Error 26.70 21+ 1.11
One Way Analysis of Variance.
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A significant difference between the treatment conditions
occurred during month 3» Table 7 is a table of probabilities for
the T values between the treatment conditions on month 3.
Table 7.
WLCondition FT TA KL HR
Finger Temperature (FT) 1.00
Temporal artery (TA) 0.03 1.00
Relaxation (Kb) 0.05 1.00 1.00
Heart rate (HR) 0.57 0.01 0.02 1.00
Waiting List (WL) 0.09 1 .00 1.00 0.05 1.00
Table 7 shows that the significant differences in headache
duration found at month 3 were due to the heart rate condition
showing significantly greater improvement over the temporal artery
amplitude, the relaxation and the waiting list conditions. The
improvement found in the heart rate condition was not significantly
greater than found in the finger temperature condition.
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Graph U,
Graph I4 shows the mean relative difference values for
duration of headaches over the three follow-up months for the finger
temperature, temporal artery amplitude, relaxation, heart rate and
waiting list conditions respectively.









































INDEX OF HEADACHE ACTIVITY
Table 1.
Table 1 is a summary table of the results of a 2 Way repeated
measures ANOVA of relative changes in the 'index of headache activity'
between treatment conditions and within the three follow-up months.
(Appendix 3.5).
Index of headache activity between treatment conditions, within
the follow-up months
Sum of Degrees of Mean ^ Tailource
Squares Freedom Square Probability
Treatment 37.92 1+ 9.1+8 5.53 0.00
Error 1+1.18 2lj. 1.72
Month 3.08 2 1.51+ 2.16 0.13
Month x
treatment 3.22
8 o.l+o 0.56 o.8o
Error 3U.29 1+8 0.71
Two Way Analysis of Variance.
There was a significant difference between the treatment
conditions. As there was no difference between the follow-up months
and no month x treatment interaction, it would appear that the
difference in treatment conditions was constant over the follow-up
months. In order to establish which treatment conditions differed
over the follow-up period, One Way Analyses of Variance were computed




Graph 1 represents the mean relative difference values in
'index of headache activity' values at month 1 (the end of the
treatment period with respect to baseline).
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Table 2 is the summary table for the One Way Analysis of
Variance between the treatment conditions during month 1.
Source Degrees of Mean j, Tail
Squares Freedom Square Probability
Equality
of cell 19.11 U U.78 5.71 0.00
means
Error 20.07 21; 0.81;
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A significant difference between the treatment conditions
occurred during month 1. Table 3 is a table of probabilities for
the T values between the treatment conditions on month 1.
Table 2.
Condition FT TA RL HR WL
Finger temperature (FT) 1.00
Temporal artery (TA) o.ou 1.00
Relaxation (Rl) 0.00 0.22 1 .00
Heart rate (HR) 0.51 0.02 0.00
Waiting list (WL) 0.00 0.15 0.69
Table 3 shows that the significant differences in the 'index
of headache activity' values found at month 1 were due to the finger
temperature and heart rate conditions showing significantly greater
improvement than the temporal artery amplitude, the relaxation and
the waiting list conditions. There was however no significant




Graph 2 represents the mean relative difference values in
•index of headache activity' values at month 2 (four months after
the end of treatment with respect to baseline).





Finger Temporal Relaxation Heart Rate Waiting List




Table 1+ is the summary table for the One Way Analysis of
Variance between the treatment conditions at month 2. No significant
differences were found to exist between the treatment conditions.
Source ^Uin °"^ Degrees of Mean F Tail"
Squares Freedom Square value Probability
Equality
of cell 10.12 1+ 2.53 2.13 0.11
means
Error 28.57 21+ 1.19
One Way Analysis of Variance.
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Graph 3.
Graph 3 represents the mean relative difference values in
•index of headache activity' values at month 3 (six months after the
end of the treatment with respect to baseline).










Relaxation Heart Rate Waiting List
Condition Condition Condition
Table 3.
Table 5 is the summary table for the One Way Analysis of
Variance between the treatment conditions at month
Sum of Degrees of Mean F 2-Tail
k~ n' "
Squares Freedom Square Value Probability
Equality
of cell 11.92 h 2.97 2.66 0.06
means
Error 26.81; 21; 1.11




Graph 1+ shows the mean relative difference values for 'index
of headache activity' over the three follow-up months for the finger
temperature, temporal artery amplitude, relaxation, heart rate and







































ANALGESIC INDEX PER MONTH
Table 1.
Table 1 is the summary table of the 2 Way repeated measures
ANOVA of relative changes in 'analgesic index' values between
treatment conditions and within the three follow-up months.
(Appendix 3.6). No significant differences on any of the levels
was found.
Source ^Um Degrees of Mean ^ Tail
Squares Freedom Square Probability
Treatment 17.31 U ^«3 1.^- 0.27
Error 7U-35 2k 3-09
2.01 2 1.00 2.33 0.11






Two Way Analysis of Variance.
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EEEQ.UEflCY OF THE USE OF VASOCONSTRICTOR DETJGS
Table 1.
Table 1 is the summary table of the 2 Way repeated measures
ANOVA of relative changes in 'frequency of use of vasoconstrictor
drugs' between treatment conditions and wit hin the three follow-up
months. (Appendix 3.7)•
Source °"^ Degrees of Mean Tail"
Squares Freedom Square Probability
Treatment 10.71 U 2.68 2.30 0.09
Error 27.96 2k 1.16
2.23 2 1.12 3.29 0.09






Two Way Analysis of Variance.
Table 1 shows that there was a difference in the frequency of
the use of vasoconstrictor drugs over the three follow-up months
(P = 3.29, 2 df, p-C0.05). In the absence of a treatment or treatment
x month effect, it can be concluded that the changes over the follow-
up months was constant for all groups.
Table 2.
Mean changes in the use of vasoconstrictor drugs (RD scores)
for the three follow-up months
Month 1 Month 2 Month 3
+0.07 0.00 +0.07
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Table 2 shows that the frequency of use of vasoconstrictor
drugs, increased slightly from the baseline levels, on months 1 and
3. On month 2, a return to baseline frequency was observed.
NUMBER OF PROPHYLACTIC DRUGS TAKEN PER MOUTH
Table 1♦
Table 1 is the summary table of relative changes in 'number
of prophylactic drugs taken per month' values between treatment
conditions and within the three follow-up months. (Appendix 3.8).
No significant differences on any of the levels was found.
q Sum of Degrees of Mean Tail
Squares Freedom Square Probability
Treatment 1.1+9 1+ 0.37 0.77 0.56
Error 11.66 2l| 0.1+9
0.25 2 0.12 0.67 0.51






2 Way Analysis of Variance.
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MULTIPLE REGRESSION ANALYSIS
The results of this study show that no treatment condition
effected significant changes upon any of the physiological variables.
It may therefore be concluded that biofeedback did not enable patients
to change the physiological response under observation. There were
however significant differences between the treatment conditions on
the measures of clinical outcome. As a result of this anomaly an
investigation into the relationship between the clinical changes and
the changes in physiological measures for each individual patient was
undertaken.
A multiple regression analysis was used to determine the
effects, and the magnitude of the effects of more than one independent
variable (physiological changes) on the dependent variable (clinical
outcome), (Kerlinger , 1973)•
Information from the 26 patients to have completed the ten
treatment sessions, and to have maintained continuous contact over the
12 month experimental period was used for analysis. Of the 26
patients, eight were in the finger temperature condition, eight were
in the temporal artery amplitude condition and five were in each of
the heart rate and progressive relaxation conditions.
The dependent variable.
The dependent variable was a clinical outcome measure for each
patient. As the 'index of headache activity' score provided a
sensitive measure of overall clinical change, a mean change score was




As significant 'period' effects occurred more frequently than
'session1 effects for changes in the four physiological variables,
the mean change for each of the three within session 'periods' was
calculated for each patient on each physiological variable. Thus
FD 1, FT 2 and FT 3 were finger temperature changes during periods 1,
2 and 3 respectively, across the ten treatment sessions. Mean temporal
artery amplitude (TM) changes, standard deviation of temporal artery
amplitude (TS) changes and heart rate (HR) changes were similarly
estimated. The age of each patient (AGE) and the length of time
they had suffered from migraine headaches (DTJRl) were also included
as independent variables.
Details of each patient's age and length of illness were
obtained from the assessment questionnaires (Appendix 1.1). The
questionnaires were used primarily for diagnostic purposes, although
they also contained some personal information about the characteristics
of each patient's headaches. The stringent screening procedure used
to select patients for the present study resulted in the patient's
showing a specific range of diagnostic characteristics. As there
was only a small amount of variability in the range of symptoms,
diagnostic information was not included in the multiple regression
analysis. Also, due to the small number of patients used in the
multiple regression analysis, the inconsistencies in the rate of
reporting some aspects of personal information, and the questionable
accuracy of retrospective information, no further 'personal character¬
istics' information was included for analysis.
The multiple regression analysis was used to analyse the
- 227 -
relationship between the dependent variable (clinical outcome) and a
set of independent variables (physiological changes, age of patient
and duration of illness). (Appendix 3»9).
Used as a descriptive tool, multiple regression analysis allows
the linear dependence of one variable on others to be summarised and
decomposed. Thus instead of focusing on prediction of the dependent
variable and its overall dependence on a set of independent
variables, the relationship between the dependent variable and
particular independent variables can be made. Multiple regression
techniques can then be used to determine the magnitude of direct and
indirect influences that each variable has on other variables.
The test of statistical significance of the multiple regression
analysis is based upon the comparison of variances (or mean squares).
S.P.S.S. provides the following information in the computation of the
multiple regression analysis. Firstly, a matrix of the correlation
coefficients between all variables included for analysis; secondly
analyses of variance based on the individual independent variables
with the dependent variable. Each analysis of variance is ordered in
a step-wise sequence, the highest F values positioned at the
beginning of the procedure. Each F ratio gives the level of
association between the regression of the dependent variables on the
independent variable. Thirdly, a matrix .of the multiple correlation
coefficients (R) is provided between all variables. The multiple
correlation co-efficients (R) show the highest possible correlation
between a least squares linear composite of the independent variables
and the observed dependent variable. The symbol 'Rl can be inter¬
preted like any ordinary coefficient of correlation, except that
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the values of ®R® range from 0 to 1.00, unlike 'r* which range from
-1.00 through to 1.00 (Kerlingerf 1973).
The sign of 'R* indicates the direction of the relationship,
whether positive or negative, while the absolute value of 'R® can be
used as an index of the relative strength of the relationship.
2
However, since R indicates the proportion of the variation in the
dependent variable explained by each independent variable, it has a
clearer interpretation than 'R* as an index of the strength of the
relationship. Thus for example if R =0.28, this would indicate
that 28% of the variance in the dependent variable is explained by




Table 1 is the matrix of correlation coefficients for temporal
artery amplitude/mean changes (TM1), temporal artery amplitude/
standard deviation changes (TS1), heart rate changes (HR1) and finger
temperature changes (ST1) compared with clinical outcome (HUT). The
changes in physiological variables were the average of all 'period 1'
changes over the ten treatment sessions.
1T1 TM1 TS1 HR1 HUT
iT1 1.00
TM1 -0.21+ 1.00
TS1 0.03 0.1+6 1 .00
HR1 0.25 0.01+ 0.02 1.00
HUT 0.21+ -0.1+0 -0.30 0.26 1.00
Table 2 is a summary table of the linearity of regression for
each independent variable on the dependent variable. The 'step-wise'
multiple regression procedure gives the coefficient of determination
2
values (R ) for each independent variable alone and in combination.
2
The R values show the amount of variance in the dependent variable
2
accounted for by the independent variables. The 'change in R ' values
show the effects and the magnitude of the effects of each independent
variable upon the dependent variable.
2 2
R Change in R Beta
TM1 0.16 0.16 -0.31
HR1 0.21+ 0.07 +0.25
TS1 0.26 0.02 -0.16
IT1 0.27 0.01 +0.10
Table 2 shows that 26.5% of the variance in clinical outcome
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can be accounted for by the combined effects of the four physiological
variables during period 1. However, of this, 16.2% can be accounted
for by TM1 alone (i1 = 1+.65, 1 df, p<0.05). The remaining 10.3%
the variance of HIN can be accounted for by the combination of the
remaining three variables, none of which reach statistical signifi¬
cance.
PERIOD 2
Table 1 is the matrix of correlation coefficients for TM, TS, HR
and IT compared with clinical outcome (HUT). The physiological
variables were the average of all 'period 2' changes over the ten
treatment sessions.
IT2 TM2 TS2 HR2 HUT
IT2 1.00
TM2 -0.25 1.00
TS2 -0.01+ 0.63 1 .00
HR2 0.36 -0.28 -0.16 1.00
HUT 0.16 -o.5U -0.1+1+ 0 • -g- -A • OO
Table 2 is a summary table of the coefficient of determination
2
values (R ) for each independent variable alone and in combination.
2
The 'change in R ' values show the magnitude of the effects of each
independent variable upon the dependent variable.
2 2
R Change in R Beta
TM2 0.29 0.29 -0.36
ER2 0.37 0.07 +0.30
TS2 0.39 0.02 -0.18
FT2 0.39 0.00 -0.05
Table 2 shows that 39.2% of the variance in HUT can be accounted
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for by the combined effects of the four physiological variables
during period 2. However, 29.6% of this variance is accounted for
by temporal TM2 alone. (F = 10.07, df = 1 , p<0.0l). The remaining
9.6% of the variance of BIN can be accounted for by the combined
effects of the three remaining variables. No effects of the three
remaining variables reach statistical significance.
PERIOD 3
Table 1 is the matrix of correlation coefficients for TM, TS, FT
and BE compared with HUT. The physiological variables were the aver¬
age of all 'period 3' changes over the ten treatment sessions.
FT3 TM3 TS3 ER3 HIN
FT3 1 .00
TM3 -0.31+ 1 .00
TS3 -0.08 0.1+9 1 .00
HR3 0.02 -0.25 0.01+ 1.00
HIN 0.0I+ -0.61 -0.39 0.35 1.00
Table 2 is a summary table of the coefficient of determination
2 2
values (R ) and the 'change in R ' values for each independent
variable upon the dependent variable.
R2 2Change in R Beta
TM3 0.37 0.37 -0.53
HR3 0.1+1 0.01+ +0.23
FT3 0.1+1+ 0.03 -0.15
TS3 0.1+6 0.02 -0.15
Table 2 shows that 1+5.5% of the variance in clinical outcome can
be accounted for by the combined effects of the four physiological
variables. As with periods 1 and 2, TM changes account for the
- 232 -
greatest proportion of the variance associated with clinical outcome
(37.02%, F = U4.ll> 1df, p<0.0l). _ The remaining 7.U9% of the
variance is accounted for by the combined changes of the other
independent variables, none of which reach levels of statistical
significance.
During the three within session periods, the coefficients of
2
determination (R ) are consistently greater for mean temporal artery
amplitude changes (TM) than for the other physiological variables.
This would show that changes in clinical outcome are largely accounted
for by changes in TM. The correlation coefficient matrices show that
the association between TM and clinical outcome (HEN) is negative;
thus an improvement in HEN is associated with decreases in mean
temporal artery amplitude. There is no other physiological variable
which approaches levels of significance to account for the variance
in clinical outcome.
Mean temporal artery amplitude change from period 3 (TM3) was
included in a multiple regression analysis with age of the patients
(Age) and duration of illness scores (DURl). Although heart rate
changes (HR) failed to reach levels of significance in the three
within session period analyses, HR3 was included as the fourth independent
variable on the basis of being the second largest contributor to the
variance of HEN. The dependent variable was HEN.
Table 1 is the matrix of correlation coefficients for TM3, HR3,
AGE, DTJRI and HEN.
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DTJRI -0.18 0.00 1.00
HR3 -0.11 -0.25 0.02 1.00
hut 0.27 -0.61 -0.23 0.35
Table 2 is a summary table of the coefficients of determination
2 2
values (R ) and the 'change in R 1 values for each independent
variable upon the dependent variable.
2 2
R Change in R Beta
TM3 0.37 0.37 -0.52
3JDRI 0.1+2 0.05 -0.22
HR3 0.1+7 0.05 +0.21+
AGE 0.1+8 0.01 +0.08
Table 2 shows that 1+7.5% of the variance in clinical outcome
can be accounted for by the combined effects of the four independent
variables. TM3 changes account for 37% of the variance associated
with clinical outcome. (E = 11+.11, 1 df, p<h0.00l). The remaining
10.5% of the variance is accounted for by the combined changes of




The results will be summarised in terms of the hypotheses
outlined in Chapter 9.
1. Finger temperature changes in the finger temperature control
condition do not reach a level of significance. Finger
temperature elevation is not demonstrated across the treatment
sessions and feedback fails to modify a tendency, displayed by
all conditions, for temperature to rise and fall over the
within session periods.
2. Temporal artery amplitude (mean and standard deviation) changes
are not significantly effected by the presence of feedback.
Although the mean and standard deviation changes are slightly
increased in the Progressive Relaxation condition, they do not
reach significance.
3. Heart Rate changes also fail to reach levels of significance
across all sessions for the heart rate condition.
1;. For the Progressive Relaxation condition, heart rate decreases;
temporal artery amplitude (mean and standard deviation) shows
slight increases and finger temperature decreases. None of these
changes however reach levels of significance. The decrease in
finger temperature may be due to the combined effects of the
isometric exercises that preceded the treatment phase, and drift.
5. Clinical improvement cannot be related to a 'group' analysis of
physiological changes. A multiple regression analysis of
individual physiological changes, age of each patient and duration
of illness (independent variables) and mean change in 'Index of
headache activity' (dependent variable), showed that mean
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temporal artery amplitude changes accounted for the greatest
proportion of variance in clinical outcome. A decrease in
mean temporal artery amplitude was associated with clinical
improvement.
6. The comparative clinical benefits of finger temperature and
heart rate feedback was greater than the benefit associated
with temporal artery amplitude feedback. The relaxation






The discussion will he divided into four sections. Section 1
(physiological information) will compare the physiological results
obtained from each experimental condition with results from previous
studies. Section 2 (clinical outcome) will compare the clinical
changes observed during the follow-up with the clinical changes
reported in previous studies. Section 3 (multiple regression analysis)
will present a multiple regression analysis of the relationship
between physiological changes and clinical outcome. The concluding «
section will relate the results of this study to theories of migraine
headache and methodological aspects of biofeedback. Points of
departure for future research will be suggested throughout all
sections of the discussion.
PHYSIOLOGICAL INFQBMATION
1. Finger temperature condition.
The results of this study show that the finger temperature
condition patients failed to demonstrate significant increases in
finger temperature compared with the other treatment conditions. As
there were no differences in 'stability point' temperatures between
the treatment conditions, it is concluded that the non-significant
results were due to the inability of the patients to increase finger
temperature, rather than that finger temperature changes were taking
place in anticipation of finger temperature feedback.
The present study has attempted to overcome some of the method¬
ological deficiencies apparent in earlier studies. For example, some
previous studies - notably those of Sargent, Green and Walters (1972,
1973a and 1973b) - investigated differential temperature changes
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between the forehead and fingers. It was however -unclear whether
temperature changes were due to changes in both forehead and finger
blood flow or predominantly one or other of these sites. Although
Sargent et al (1973"b) and Keefe (1975) established that differential
temperature changes were primarily due to increases in finger
temperature rather than forehead temperature decreases, some subsequent
studies have investigated temperature control using instructions to
increase and decrease finger temperature on successive within-trial
sessions (Keefe, 1975; Keefe and Gardner, 1979). Significant changes
were however found to be largely due to temperature decreases during
'decrease* instruction trials, rather than temperature increases and
decreases when instructed. It was therefore difficult to establish
whether control had been achieved at all, given the influences of
uncontrolled factors, such as drift. The present study investigated
'unidirectional' finger temperature control to overcome the above
difficulty, and is consistent with the recommendation of Yates (1980)
who suggested that before differential control is investigated, com¬
prehensive studies of 'unidirectional* control should first be under¬
taken.
A second major difficulty is obtaining information of physio¬
logical change which is relatively free of uncontrolled influences.
In order to minimise the influences of uncontrolled factors during
feedback, a stabilisation period is usually incorporated before any
measurements are taken. In the present study a 20 minute stabilisation
period preceded every feedback/recording period. Many studies have
neglected to include details of the length of stabilisation periods
or have used short stabilisation periods. Hunter, Russell, Russell
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and Zimmerman (1976) used a three minute baseline period from which
to investigate experimental period .changes; the baseline period was
also used as the stabilisation period. Hunter et al (1976) instructed
children to increase finger temperature while holding the thermometer
bulb between thumb and forefinger. Although small increases in
temperature were observed, given the short stabilisation period, the
effects of naturally occurring variations cannot be excluded. It
should also be mentioned that although the children were discouraged
from rubbing and pressuring the thermometer bulb, insulation effects
and movement artifacts cannot be ruled out.
The lack of properly controlled procedures when investigating
finger temperature control, and the absence of control groups, may be
responsible for the wide range of reported results. Taub and Emurian
(1976) reported large increases and decreases in finger temperature
with the aid of feedback. Attempts to replicate Taub et al's (1976)
findings have however been unsuccessful. Lynch and Schuri (1978)
found that subjects showed reliable decreases from baseline tempera^-
tures, which persisted following instructions to reverse temperature
changes. Roberts, Schuler, Bacon, Zimmerman and Patterson (1975)
reported large and reliable performance and learning effects for
differential hand-hand temperature feedback, but Lynch and Schuri
(1978) stated that attempts to replicate Roberts et al (1975) study
had also been unsuccessful. Despite giving the subjects four times
as much training than in the original experiment, processing and
computing the information by identical methods,.control was not
demonstrated.
In the present study, the finger temperature condition demon-
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strated a mean increase in temperature of 0.1°C above baseline.
■While many studies have neglected to include details of temperature
changes Reading and Mohr (1976) regarded a rise of 0.1°C as a
demonstration of successful control. The Reading et al (1976) study,
as with many others, was uncontrolled.
Surwit , Shapiro and Peld (1976) stated that a mean decrease
of 2°C was shown by subjects instructed to decrease finger tempera¬
ture. Subjects instructed to increase finger temperature were unable
to do so. These experimenters considered that the failure to obtain
voluntary control of temperature increases may have been due to a
•ceiling effect' since the average starting temperature of their
subjects was 33-3U°C, and hence little opportunity for temperature
increase was available. In a second study of the same report, Surwit
et al (1976) attempted to overcome the ceiling effect by reducing
room temperature from 22.5°C, as in their first study, to 19.5°C.
However, once again, subjects were unable to increase finger temperature,
even though the average starting temperature had been decreased to
around 30°C. In the present study, the average starting temperature
of all patients was 33«U°G, and was 33« 7°G for the finger temperature
condition patients. As the room temperature was similar to Surwit*s
et al (1976) original experimental temperature of 22.5°C, decreases
in finger temperature may have been anticipated. The small temperature
increases demonstrated in this study may therefore suggest that some
volitional control had been achieved (at least by Reading and Mohr's
1976 criterion); this must however remain speculative.
In summary, the results of the present study show that biofeed¬
back has little effect upon finger temperature changes. As stated,
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the high stability point finger temperatures, and the small capacity
for further increases displayed by finger temperature, may account for
the results. In the light of the pilot study findings that feedback
may counteract the effects of drift, small increases in finger
temperature may still indicate a degree of volitional control.
2. Temporal artery amplitude condition (CVMR).
In the present study, maximum and minimum temporal artery pulse
amplitude measurements were taken at 30 second intervals over the
five minute pre-experimental baseline and the three five minute periods
of each session. From these recordings, measurements of central
tendency of the amplitude (mean) and the spread or variability of the
amplitude changes (standard deviation) were obtained.
The results show that there were no significant changes due
to treatment effects in either the means or the standard deviations.
The results therefore suggest that temporal artery amplitude feedback
did not enable volitional decreases in temporal artery amplitude to
be achieved.
As previously mentioned, little is known about the reactivity
of the temporal artery. An increase in sympathetic nervous system
activity is assumed to cause vasoconstriction, whilst a decrease in
sympathetic activity is assumed to cause vasodilation of the temporal
artery. This would appear to be a rather simplistic model of temporal
artery reactivity as Sokolov (1963) stated that vasoconstriction may
occur when a stimulus is novel or alerting. The relationship between
the different types of stimuli in terms of their effects upon
sympathetic arousal, and the consequent changes in temporal artery are
still to be elucidated. However given the above information, it may be
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the case that the state of passive concentration encouraged during
biofeedback may facilitate vasodilatation of the temporal artery.
Vasodilatation is however antagonistic to the change required during
temporal artery feedback.
There are only a small number of experiments concerned spec¬
ifically with changes in temporal artery amplitude; some studies
infer a direct relationship between temporal artery amplitude changes
and blood volume changes in the forehead (Friar and Beatty, 1976;
Zamani, 197^-1-) • Given the possible influence of arteriovenous shunts
(Heyck, 1971) and the lack of significant association between fore¬
head blood volume changes and temporal artery amplitude changes
(Attfield and Peck, 1979)> "the generality of forehead blood flow
changes to temporal artery activity is questionable. One point of
interest is that Friar and Beatty (1976) controlled for the effects
of forehead blood flow feedback using a group of migraineurs given
pulse amplitude feedback from the fingers. The fingers were considered
to be an irrelevant site of control. The results showed that the
experimental condition subjects demonstrated a decrease in forehead
blood flow, whilst at the same time a decrease in finger pulse
amplitude occurred (and probably finger temperature). Headache
activity for the experimental group was found to improve. This result
would appear to contradict the results of Johnson and Turin (1975)
and Turin and Johnson (1976) who found that a decrease in finger
temperature was accompanied by a significant worsening of headache
activity.
Other studies of CVMR have placed the plethysmograph over the
temporal artery at a point above the zygomatic arch (as in this study).
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At this point, artery pulsations are easily detectable and the
relationship between temporal artery activity and migraine can be
more appropriately investigated.
Feuerstein and Adams (1977) measured blood volume pulse changes,
blood volume changes and frequency of vasospasms; the origin of the
vasospasm is not made clear in this study. Results showed that
changes in one measure were not always associated with changes in the
others. It was also noted that one subject gained control over
temporal artery responses by contracting forehead muscles. As there
were only two migraine headache patients in this experiment, the
generality of the results about CVMR control would appear limited.
Feuerstein, Adams and Beiman (1976) gave CVMR feedback and IMG feed¬
back to an elderly patient with a history of both tension and migraine
headaches. The frequency of vasospasm activity was found to decrease
during IMG feedback. When CVMR feedback was presented, the frequency
of vasospasm activity further decreased and a decrease in pulse
amplitude was noted. The decrease in pulse amplitude occurred in one
session only (session 5of 6 sessions given). It was therefore concluded
that changes across trials were not systematic. The lack of a
significant session x trial interaction would also limit conclusions
regarding the demonstration of a learning effect. Feuerstein et al
(1977) concluded that 'idiosyncratic responses' characterise the
results of CVMR feedback, and that a minimum of 15 treatment sessions
should be employed during feedback. However, Sturgis, Tollison and
Adams (1978) used 1|? treatment sessions and found that a reduction in
temporal artery amplitude was associated with the termination of feed¬
back and that no changes were found while feedback was being given.
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The variable results of these studies would, indicate the need
for further research into the responsivity of the temporal artery,
especially in the light of the number of vascular responses which
have been observed. It is also proposed that the effects of the
feedback stimulus and the methods of measuring changes in artery
responses should be investigated further. In the present study,
changes in the central tendency (mean) of the artery amplitude and
changes in the variability of the temporal artery amplitude (standard
deviation) were analysed separately. In previous studies a 'window
discriminator* has frequently been used to monitor changes in artery
amplitude. The temporal artery wave form is displayed on a recording
device (an oscilloscope has frequently been used) and the window
discriminator is placed over the display. The upper limit of the
window is crossed by the increases in amplitude of the systolic peak
of the waveform, while the lower limit of the window is set at the
diastolic limb of the blood volume pulse. Feedback is presented to
the subject if the artery amplitude fails to fall within the limits
of the discriminator window. The limits of the discriminator window
are then increased or decreased so that a progressive shaping of the
artery responses can be achieved. However, Feuerstein and Adams (1977)
stated that this type of measurement procedure may not give an accurate
index of blood volume level but can be considered a measure of blood
volume pulse variability. The following hypothetical example
illustrates this point:
If, during a feedback trial the maximum height of the artery
amplitude is 19 millimeters, the height of the window discriminator
would be set accordingly. If during the trial period, some pulses
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have a maximum amplitude of 20 millimeters and others an amplitude of
11+ millimeters, a mean amplitude measurement of 17 millimeters would
he obtained, and pulse beats exceeding the criterion would be
observed. If after feedback, the amplitudes changed to 18 millimeters
and 16 millimeters respectively, the mean size of the amplitude would
remain 17 millimeters, however a reduction in the number of pulses
exceeding the criterion would be observed. Under these conditions
the variability of the amplitude responses would have decreased but
not the overall mean size of the amplitude. The results of the
present study would appear to support Feuerstein et al*s (1977)
observation. The mean artery changes shown by the temporal artery
amplitude condition during period 1 did not decrease below baseline,
while the standard deviation score did achieve a below baseline change
(the only condition to achieve a below baseline change). Thus
temporal artery amplitude feedback would appear to facilitate a
decrease in the variability of the artery amplitude rather than an
overall decrease in mean artery amplitude.
The second point concerns the effect of binary feedback as used
in previous studies, compared with the analogue feedback as used in
the present study. Although there is no evidence of the comparative
efficacy of one or other of these methods, Hume (1977) stated that
analogue feedback is, on a priori grounds, likely to produce more
efficient learning. If, for example, the presentation of white noise
(binary feedback) proved unpleasant to the subject, a transient
decrease in temporal artery amplitude may result (Sokolov, 19^3).
These are speculative comments, but serve to indicate the need for
further detailed research in this area.
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3. Progressive relaxation condition.
Progressive relaxation exercises have often been used in
combination with other procedures in the treatment of migraine, thus
there have arisen questions about the role of relaxation in combined
relaxation/biofeedback packages.
Mathew, Ho, Kralik Claghorn (1979) stated that there is
evidence to suggest that the therapeutic action of biofeedback is
mediated through a 'relaxation response'. The inclusion of a
progressive relaxation condition in the present study was designed
to investigate whether specific physiological changes could contribute
to the clinical changes of migraine headache patients. The results
of the study show that the relaxation condition patients showed
a slight decrease in heart rate and finger temperature and increases
in the mean and standard deviation changes in temporal artery
amplitude. None of the physiological changes reached levels of
significance. The fact that the decrease in finger temperature was
slightly in excess of the other treatment conditions may indicate
that the effects of drift were combined with the effects of the
isometric exercises which preceded the onset of the recording phase
of the session (^ynch and Schuri, 1978).
Although the observed physiological changes may be consistent
with the effects of reduced sympathetic activity, it may be
precipitant to conclude that a 'relaxation response' had been
demonstrated. Lacey and Lacey (1958) recorded changes in blood
pressure, skin conductance, heart rate and heart rate variability,
to various stimuli. They concluded that while measurements of a
single locus variable might be a useful indicator of the effects of
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different stimuli, there was a marked independence of various measures
characteristic of each response. Christoph, Kron, Luborsky and
Fishman (1978) measured heart rate, respiration rate and blood pressure
to investigate whether a specific relaxation response could be
observed. They concluded that there was no evidence to support the
concept of the relaxation response in terms of only an across measure
decrease in the physiological systems. Individual differences in the
amount of response, the direction of response and the inter¬
relationships between the physiological measures were observed. Even
within the most consistent measures, some subjects showed increases
rather than decreases. The findings are therefore considered con¬
sistent with theories emphasising individual patterns of relaxation
responses.
In a review of the effects of abbreviated relaxation instructions
(as used in the present study), Zing (1980) stated that a clear
picture fails to emerge with respect to the psychophysiological
effects of abbreviated progressive relaxation in stress and non-stress
situations. King (1980) further found that correlations between
subjective ratings of anxiety and relaxation, and measured physiological
variables during relaxation are low and non-significant. These low
and non-significant correlations would support earlier observations
by Hume (1977) who stated that there is little understanding of the
inter-relationship between the cognitive and somatic components of
relaxation.
Ij.. Heart rate condition.
In the present study the slight decreases in heart rate are
consistent with a decrease in sympathetic nervous system activity.
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The fact that the mean decrease in heart rate is only slightly in
excess of the decrease observed for the progressive relaxation
condition would support the observation by Yates (1980) that
decreases in heart rate are difficult to demonstrate, a factor
probably attributable to the fact that resting level heart rate is
close to the lowest physiological level attainable by normal subjects.
CLINICAL OUTCOME
The following is a brief summary of the clinical changes that
occurred during the follow-up period of this study. The clinical
changes for each treatment condition will then be related to the
results of previous studies.
Clinical change was measured on seven scales; frequency of
headaches, maximum intensity of headaches, headache duration, an index
of headache activity (frequency x intensity x duration), an analgesic
index, the frequency of vasoconstrictor drug administration and the
number of prophylactic drugs taken.
It is evident from the results that significant differences in
clinical change was obtained on four of the above seven scales;
frequency of headache, intensity of headache, duration of headache
and index of headache activity.
Frequency of Headache
The most consistently superior treatment conditions were the
finger temperature control and heart rate control treatment conditions.
The progressive relaxation and waiting list control conditions showed
no improvement at all over the follow-up months. Patients in both
conditions initially became worse during the first month of the
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follow-up period, and returned to baseline levels during the second
and third months. The temporal artery amplitude condition showed a
consistent but non-significant improvement throughout the follow-up.
Intensity of Headaches
Again the most consistently superior treatment conditions were
the finger temperature and heart rate treatment conditions. During
the follow-up month 1, the waiting list condition showed a worsening
in headache intensity; an improvement in all other treatment
conditions was observed. During the second and third months, the
temporal artery amplitude condition returned to baseline whilst the
relaxation condition, after returning to baseline levels on the
second month, showed a slight but non-significant improvement at the
third month.
Duration of Headaches
For the headache duration measures, values for the first
follow-up month indicated that a general improvement took place over
all treatment conditions except for the relaxation condition, which
became worse. Over the remaining follow-up months, the relaxation
condition patients reverted to baseline levels. The temporal artery
amplitude condition patients showed a slight improvement on the first
and second follow-up months, and returned to baseline levels during
the third follow-up month. The heart rate condition showed signifi¬
cantly greater improvement over all other conditions except for the
finger temperature condition.
Index of Headache Activity
The index of headache activity scores reflect the findings
observed in the frequency, intensity and duration measures. Finger
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temperature and heart rate conditions show the most consistent
improvement over the follow-up months. Temporal artery amplitude
patients showed a slight, consistent, but non-significant improve¬
ment over the follow-up months. The relaxation condition patients
tended to show a gradual improvement during the follow-up. In
month 1, there was a worsening of headache activity; month 2 showed
a return to baseline followed by a slight improvement in month 3.
The waiting list patients showed slight improvement in month 2 after
worsening on month 1; however this improvement was not maintained
during month 3«
Other Measures
There were no significant condition x month interactions on the
other clinical variables (medication indices) perhaps due to the
small amount of medication that was consumed during the experimental
period.
In summary, consistently greater improvement was shown for the
finger temperature and heart rate conditions in comparison with the
other treatment conditions over the follow-up months. Progressive
relaxation condition patients in general showed little improvement,
and even became worse during the first follow-up month (on intensity
and duration measures). The relaxation condition results could be
considered comparable to the waiting list control condition results.
The temporal artery amplitude condition showed a slight, non¬
significant improvement that was consistent over the follow-up period.
1. Pinger Temperature Condition
The finger temperature condition results would appear to be
consistent with previous clinical studies. However, a dearth of
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controlled studies makes accurate comparisons difficult.
Andreychuk and Skriver (1975) found 'handwarming' to be more
effective in reducing headache activity than hypnosis and EEG (alpha
wave) feedback; however there was no follow-up included. Diamond,
Diamond-Falk and De Yeno (1978) found that finger temperature
combined with autogenic phrases was superior to relaxation instructions.
The results of this study were however based on retrospective data,
and not upon continued monitoring of headache activity. Peck (1980)
found that finger temperature and EMG feedback provided some relief
in headache symptomatology after a 2k week follow-up period. After
73 weeks, the patients' headache activity had reverted to baseline
measures. Both finger temperature and EMG changes failed to reach
significance in this study.
The results of the present study would appear comparable with
the findings of Reading and Mohr (1976) who used a finger temperature
increase of 0.1°C as the criterion for successful elevation. Reading
and Mohr (1976) found that improvement was maintained over a two
month follow-up. This however was an uncontrolled study and
'expectancy* effects cannot be entirely excluded. The results of
the present study would also be comparable with the findings of
Mullinix, Norton, Hack and Fishman (1978) who showed that clinical
benefits were unrelated to significant increases in finger temperature,
although the absence of quantitive date makes further comparison
impossible. In the present study, clinical benefit was mainly
associated with the two conditions under which patients showed slight
mean increases in finger temperature, viz finger temperature and
heart rate conditions. However, the temporal artery amplitude
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condition showed a slight decrease in mean finger temperature, "but
demonstrated consistent clinical improvement over the follow-up,
albeit not significant.
2. Temporal artery amplitude condition (C1MR)
As with the finger temperature condition, a dearth of uncon¬
trolled studies limits the comparability of the present results with
previous work. Zamani (197U) stated that C17MR proved of greater
therapeutic benefit than relaxation in the treatment of migraine
headaches. Friar and Beatty (1976) compared an experimental group
given feedback of temporal artery amplitude and instructions to try
and reduce it, with a control group who received similar feedback but
from the pulse amplitude of an index finger. The results showed that
the experimental group demonstrated a significant reduction in artery
amplitude which was associated with a reduction in major headaches.
However neither study obtained information directly from the super¬
ficial temporal artery, but rather inferred artery changes from
ramifications of the artery at the site of the forehead. Although
the results of the present study would be consistent with the findings
of Zamani (197U)> Friar and Beatty (1976) gave no follow-up information.
Feuerstein and Adams (1977) and Feuerstein, Adams and Beiman
(1975) compared EMG and C7MR feedback with migraine and tension
headache patients and reported that CT7ME was most effective in
alleviating migraine headaches. As EMG feedback is aimed at
facilitating the 'relaxation' of specific groups of muscles in the
face, the results of these studies may be considered comparable to
that of Zamani (197I4.) and the results of the present study. However
as both Feuerstein and Adams (1977) and Feuerstein et al (1975)
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incorporated only nine and eight week follow-up periods respectively,
conclusions regarding the comparative effectiveness of the treatments
must remain open to question.
Bild (1976) concluded that CYME was more effective than EMG
feedback in the treatment of migraine headaches. Both treatment
conditions were found to be more effective than no-treatment although
a lack of diagnostic criterion and a limited follow-up (1+5 days)
would render the results equivocal. The lack of a placebo treatment
condition may also lead to speculation about the influence of
'expectancy1 effects.
In summary, conclusions regarding the clinical efficacy of
CYMR feedback are tentative. The above studies are characterised by
a number of methodological deficiencies, including the lack of
adequate controls, an absence of diagnostic criteria and short follow-
up periods.
3. Progressive relaxation condition
In contrast to the plethora of biofeedback literature, very
little work has been reported on the effectiveness of progressive
relaxation instructions as a treatment for migraine headaches. One
of the major reasons for this is that progressive relaxation has seldom
been used alone, but rather to supplement other treatment procedures
such as group therapy (Bay and Madders, 1971) and EEG and hypnosis
(Stambaugh and House, 1977). Progressive relaxation also has a
number of variants, some including a greater 'muscular relaxation'
component (Jacobson, 1938), while others have greater meditative
components (transcendental meditation; Benson, Klemchuk and Graham,
197U), and meditative and self instruction components (autogenic
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training; Schultz and Luthe, 1969).
Although relaxation training-of various kinds has shown
encouraging results, the lack of controlled follow-up studies limits
conclusions about its efficacy. Perhaps the main advantage of
progressive relaxation over other approaches is in terms of cost
effectiveness; since relaxation training can be conducted in groups,
it would seem a promising area for further research (Blanchard, Ahles
and Shaw, 1979).
In general, where progressive relaxation has been used as a
single independent variable controlling for the effects of biofeedback
treatments, it has shown inferior performance. Beasley (1976) found
that a combination of finger temperature and SEG feedback with auto¬
genic phrases and relaxation instructions was superior to combined
progressive relaxation with autogenic phrases. The single effect of
relaxation alone was not however investigated. Zamani (197U) compared
progressive relaxation with CVMR responses from the forehead. As
previously stated, Zamani (197U) found that feedback was superior
to progressive relaxation. Mitchell and Mitchell (1971) compared
relaxation with combined relaxation and desensitisation (single model
versus a multiple model approach) and found that the combined
relaxation and desensitisation package (multiple model) was superior
to relaxation alone (single model).
One of the few studies which have found relaxation to be of
comparable benefit to biofeedback was conducted by Blanchard, Theobald,
Williamson, Silver and Brown (1978). Although the progressive
relaxation condition showed a slight improvement over finger temperature
biofeedback during the last week of the treatment period, the difference
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was not maintained after one month. Blanchard et al (1978) incor¬
porated a 'no-treatment' control condition over the baseline and
treatment periods of the experiment. They did not include headache
information from the no-treatment group over the follow-up period.
As a general decrease in headache activity characterised all groups
during the baseline and treatment period of the experiment, it is
difficult to determine whether the treatment conditions eventually
-derived any greater benefit than was experienced by the no-treatment
control condition.
In the present study, the progressive relaxation condition
derived little clinical benefit from their treatment. This may be
due to the stringent selection procedure used to include patients
into the study. If headaches are viewed on a continuum of vascular
involvement, the patients in the present study may be seen as
representing the extreme of the continuum, having a high degree of
vascular involvement and a small tension component in their headaches.
The present findings would therefore be consistent with Reading and
Mohr (1976) who suggested that those subjects reporting tension-like
headaches found the handwarming technique largely ineffective in
controlling headaches.
ij.. Heart Rate Condition
The heart rate condition demonstrated an increase in clinical
benefit that was consistently superior to all other treatment
conditions except for finger temperature biofeedback. As a relation¬
ship between heart rate control and migraine has not previously been
demonstrated, the results of the present study cannot be compared with
any previous work in the area.
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The findings of the present study may he considered similar
to those of Mullinix, Norton, Hack_and Fishman (1978) who found that
false feedback of finger temperature increase facilitated clinical
improvement in migraine headache. The actual change in finger
temperature was not however significantly above baseline measures.
The same clinical improvement was found for a second group of migraine
subjects who demonstrated successful elevation of finger temperature
with the aid of true feedback. Mullinix et al (1978) concluded that
the results suggested that 'biofeedback techniques are useful in
treating patients with migraine, and the mechanism, presumably a placebo
effect, is independent of peripheral skin temperature'.
In the present study, placebo effects cannot be completely
excluded. Shapiro (i960) cited a number of examples in which placebo
effects produced significant clinical improvement in a variety of
ailments, and the effects were found to be maintained over considerable
periods of time. There are however a number of points which would
appear inconsistent with use of the placebo as an explanation for the
results of the present study. Firstly, the clinical improvement
shown by the attention placebo condition (heart rate feedback) is
inconsistent with hypothesis 6 chapter 9. This hypothesis stated that
clinical change expected for patients in the heart rate condition
would be similar to changes shown by patients in the no-treatment,
waiting list control condition. As this was not the case, the results
would therefore appear to be independent of any 'experimenter expectancy'
effects that may have been manifest during the experimental period.
Secondly, Wilkinson, Neylan and Rowsell (197U) stated that in any
clinical trial there will be about a placebo reaction, thus any
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new treatment for migraine must show an improvement rate in excess
of 50% before it can be considered'really satisfactory. In the
present study, the finger temperature condition and the heart rate
conditions showed clinical benefit in excess of 65% and 75%
respectively on follow-up measures of the 'index of headache activity'
scale. Although the design of the present study may minimise the
effects of non-specific treatment factors, the unknown effects of the
'differential placebo power' of the treatment conditions would make
this a vital area for further research.
In conclusion, the between condition analysis of the physio¬
logical results shows that biofeedback does not enable subjects to
gain significant control over the physiological parameter displayed.
The observed non-significance of the physiological changes however
presents an anomolous situation in the light of the clinical changes
obtained between the treatment conditions over the follow-up months.
It would therefore appear that some distinguishing feature, not shown
by 'group' analysis of the information, may be apparent that would
account for changes in clinical outcome. In order to investigate this
aspect of the results, a multiple regression analysis was carried out.
The multiple regression analysis was designed to evaluate the relative
influence of each independent variable (physiological changes, age of
patient and duration of illness) alone and in combination, upon a
clinical change score. The analysis also generated other useful data,
such as intercorrelations between the physiological changes.
MULTIPLE REGRESSION ANALYSIS
The average change for each of the three within session periods was
obtained for the ten treatment sessions and used for analysis.
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Period 1 (independent variables : finger temperature, mean
temporal artery amplitude score, standard deviation of temporal
artery amplitude changes and heart rate changes. Dependent variable :
Index of headache activity.)
In period 1, the physiological variables accounted for 27% of
the variance in clinical change. The mean temporal artery amplitude
change alone accounted for 16% of the variance, and was the only
significant factor of the four physiological variables.
Period 2l
In period 2 (variables as in period 1), the four physiological
variables accounted for 39% of the variance in clinical change. As
in period 1, the mean temporal artery amplitude changes accounted for
the greatest change (30%) and was the only independent variable to
attain significance.
Period 3
In period 3 (variables as in period 1), the four physiological
variables accounted for 1j.6% of the variance in clinical outcome. The
mean temporal artery amplitude change accounted for 37% of the clinical
outcome score, and was again the only independent variable to attain
statistical significance.
In the fourth multiple regression analysis the independent
variables consisted of mean temporal artery amplitude changes (Period 3)>
heart rate changes (period 3)» the age of the patient and the length
of migraine history of each patient. The dependent variable was again
the 'index of headache activity" score. The results showed that the
four independent variables accounted for 1+8% of the variance in
clinical change; the mean temporal artery amplitude score alone accounted
for 37% of the variance. The temporal artery amplitude score was again
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the only independent variable to attain significance.
The results of the multiple'regression analysis showed that
mean temporal artery amplitude changes accounted for the greatest
amount of variance in the clinical outcome. The consistently high
negative correlation coefficients between clinical change and mean
temporal artery amplitude change showed that an increase in clinical
benefit was associated with a decrease in mean temporal artery
amplitude.
CONCLUDING COMMENTS
Conducting a clinical research project has a number of
inherent methodological and ethical difficulties. The major diffi¬
culties apparent in the present study were:
Patient Selection
The inclusion of a relatively small patient population, due to
the availability of patients and the screening procedure adopted for
the selection of patients.
Patient Compliance
Maintaining the patients® motivation during the baseline phase
of the experiment to ensure accurate completion of the headache
record forms and willingness to undertake treatment. The two pre-
experimental baseline sessions (after months 1 and 2) were intended
to reduce the patients® anxiety regarding the treatment and engender
interest in completing the treatment phase of the experiment.
The ®change process® which takes place during biofeedback
consists of two separate components; the presentation of the physio¬
logical information and the ability of the individual to effect change
upon the physiological process. The physiological parameters under
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investigation in this study (finger temperature, temporal artery-
amplitude and heart rate) have relatively small capacities for
variation in the 'resting state8 normal individual. The relative
independence of within subject and across subject changes in
physiological responses (Lacey and Lacey, 19^8) may further add to
the difficulty in obtaining consistent across condition changes and
effect the patient's motivation for completing the treatment phase
of the experiment. Presenting each patient with a rationale of the
treatment at the beginning of the treatment phase of the experiment
was intended to emphasise the salience of the treatment, and maintain
motivation during the treatment phase of the experiment. An inability
to change the displayed phsyiological parameter, or to discriminate
changes, with or without the aid of feedback may have adversely
effected patient motivation, especially in the case of the progressive
relaxation patients who received no information regarding physio¬
logical changes throughout the treatment sessions.
Finally, patient motivation in maintaining regular contact
with the experimenter during the follow-up phase of the experiment in
order to accurately monitor headache activity. The use of 'postal
headache forms' with reminder letters and stamped addressed envelopes
was intended to maximise patient compliance during the follow-up.
The no-treatment control condition patients were also sent
headache forms, a reminder letter and a stamped addressed envelope
at monthly intervals for the.12 months of the study. Although all
patients were offered a course of treatment at the end of the
experimental period, the small number of patients to reply to this
offer (three patients) would indicate the unsatisfactory nature of
- 260 -
this arrangement.
Given the above criticisms of the present study, and the
nature of the present results, including the discrepancy between
a lack of significant across condition changes in the physiological
variables and significant clinical outcome change, there may be a
need for greater emphasis upon single case design studies (Barlow,
Blanchard, Hayes and Epstein, 1977) in biofeedback research.
Although changes in mean temporal artery amplitude were
correlated negatively with finger temperature changes across all
within session periods, the results failed to reach significance.
There is therefore no significant relationship between changes in
finger temperature and mean changes in temporal artery amplitude.
The finding that finger temperature consistently contributed low and
non-significant changes in clinical outcome supports the findings
of Mullinix et al (1978). Furthermore, the findings appear to be
contrary to Sargent et al's (1973b) rationale for finger temperature
control as a treatment for migraine headaches. Although finger
temperature may be a sensitive one variable index of autonomic
arousal, the specificity of such control appears to be independent
of the therapeutic benefit gained from the procedure.
Changes in heart rate and mean temporal artery amplitude
correlated positively, although to a low and non-significant degree.
The finding that changes in heart rate contributed small and non¬
significant changes in clinical outcome supports the inclusion of
heart rate feedback as an attention placebo condition in the present
study.
The differences in clinical outcome between the three biofeed-
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back conditions may be explained with reference to somatic mediation
aspects of biofeedback. Somatic mediation refers to the ability of
the patient to discriminate levels of, and changes in, autonomic
activity, related to the ability of the patient to bring these
activities under increased voluntary control with or without feedback.
Previous research on this aspect of biofeedback is small and mainly
concerned with changes in heart rate. Epstein and Miller (197U)
requested subjects to press a button whenever they thought their
heart rate was above or below an average level. It was found that
discrimination training (with biofeedback) led to successful
discrimination of heart rate changes on withdrawal of the feedback.
Similarly, Gainer (1978) found a marked improvement in headache
activity after a patient had been taught to discriminate finger
temperature changes which occurred prior to the onset of her headaches.
Before discrimination training, the patient had displayed an ability to
increase finger temperature, but had not managed to apply her 'skill'
in time to stop the onset of the headache. The evidence of this study
would suggest that although the patient may have been successful in
elevating finger temperature prior to the onset of the headache,
clinical outcome was independent of finger temperature change. It may
therefore have been the case that maintained attention upon effecting
change at the perceived site of control (fingers) may have mediated
change in other physiological responses (temporal artery amplitude).
There have been no studies of patient ability to discriminate
change in temporal artery activity. An inability to discriminate
small changes in artery activity may reduce the patient's incentive
to maintain attention during 'home rehearsal* and thus minimise the
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direct influence of control or the indirect influence of other factors.
Bakal (1978) stated that 'in general terms, the behavioural literature
has brought about a recognition that the patient must assume an active
role in his or her treatment1. An inability to discriminate changes
in temporal artery amplitude may reduce the 'active component'
necessary to effect change, whether the change is a direct or a
mediated effect of the patient's active involvement. This may explain
why the temporal artery amplitude demonstrated only slight improvement
over the follow-up, albeit non-significant in comparison with both
finger temperature and heart rate conditions.
The finding that the progressive relaxation condition
demonstrated small increases (non-significant) in mean temporal artery
amplitude, associated with little clinical benefit would support the
vascular theory of Wolff (19&3)• would also be consistent with
observations that migraine headaches are characteristic of periods of
relaxation and a reduction in the pressures of 'everyday life'
(Pearce, 1971). Hence, the terms 'holiday headache', 'Friday night
headache' and 'weekend headache' have become synonymous with migraine
as it is at these times that the opportunity for relaxation is available.
The emphasis placed upon 'facial' relaxation when using EMG feedback
may explain the comparatively poor therapeutic benefit evident when
treating migraine headaches. The vasodilatation consequent upon
relaxation would reduce any potential vasoconstrictory responses
facilitated by biofeedback.
In conclusion, given that 'migraine patients tend to respond
with vasoconstriction in the cerebral arteries when subjected to a
task situation (suggesting that the situation is a stressful one)
- 263 -
(Yates, 1980), further vasoconstriction may be difficult to achieve,
even with the aid of feedback. This observation would be consistent
with the results of the present study. It would also explain the
clinical benefit observed during finger temperature feedback studies
where non-significant increases in finger temperature are associated
with improvement in headache activity. A similar explanation might
also serve to account for the therapeutic benefits associated with
CVMR studies. However, these points remain speculative and future
studies should attempt to. clarify the situation using a variety of
feedback and sensitive measurement procedures concentrating upon
demonstrating an association between the type of feedback and one
specific vascular response at a time.
The results of the present study suggest the need to develop
more predictably effective ways of producing cerebral vasoconstriction,
and then to compare its effects with that of drugs. Investigations
of this nature would be desirable because of the specificity of the
locus of action shown by biofeedback in this study, and also observations
that biofeedback may compare favourably with the more diffuse and
undifferentiated action of vasoconstrictor drugs. It is also apparent
that less heed should be paid to diagnostic labels, but that measures
of physiological change for each patient, before, during and after
headache attacks should be taken and used to design biofeedback
treatments accordingly. A series of single case, multiple baseline




1. Between group analysis of the effects of finger temperature
biofeedback, temporal artery amplitude biofeedback and heart rate
biofeedback showed no significant changes in the physiological
variables.
2. Finger temperature and heart rate biofeedback conditions showed
significantly greater improvement than the other treatment
conditions. The temporal artery amplitude condition showed a
consistent, non-significant improvement during the follow-up.
The progressive relaxation and waiting list conditions demonstrated
little clinical improvement.
3. Multiple regression analysis showed no consistent correlation
between changes in the physiological variables. Mean temporal
artery amplitude change (decrease) accounted for the greatest
















1. Have you had a headache within the past year?
YES / NO (Please tick one )
□
□
IF YOU HAVE HAD A HEADACHE DURING THE PAST YEAR. PLEASE ANSEER ALL THE
QUESTIONS BELOW FOR YOUR HEADACHES DURING THE PAST YEAR ONLY. WE DO
NOT WANT DETAILS OF ANY HEADACHES THAT HAPPENED MORE THAN ONE YEAR AGO.
IF YOU HAVE NOT HAD A HEADACHE DURING THE PAST YEAR. PLEASE DO NOT
CONTINUE WITH THIS QUESTIONNAIRE.
2. Are your headaches usually mild or severe; or do you get both mild
and severe headaches?
Mild (Please tick one)
Severe
Both .
If you get BOTH mild and severe headaches
Are they different kinds of headache, that is can you clearly
distinguish b.tve.n then? '^ / N0 • (p1<saso ti(!k one)
a
D
IF YOU GET BOTH SEVERE AND MILD HEADACHES, PLEASE ANSWER ALL THE
QUESTIONS FOR YOUR SEVERE HEADACHES ONLY.
DO NOT CONTINUE WITH THIS QUESTIONNAIRE IF YOU GET MILD HEADACHES ONLY.
3. Which one of these statements is nearest the truth for you?
My headaches are quite severe
My headaches are very severe (Please tick one) f j
My headaches are terribly severe ' '
My headaches are almost unbearable
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CONSIDERING TOUR SEVERE HEADACHES ONLY
4. Vbich of these statements is nearest the truth for you?
I hardly notice my headaches at all. (Please tick
My headaches rarely inconvenience me. '
My headaches sometimes distract me from what I am doing
Sometimes I am unable to continue my normal activities
because of my headaches.
My headaches sometimes interfere a lot with what I am
doing.
I can hardly do anything when I have a headache.
I am absolutely fit for nothing when I have a headache.
□
How long do your headaches usually last? □
6. (a) When you have a headache, do you usually have to:-
lie down? (Please tick if
rest? applicable)
take things easy? □
IP YOU DO - Por how long is this usually? hrs.
(b) Have you missed work or SchOOl' DUfiWJIJRgbeca-
VASTS tSAS, because of a headache?
YES (Please tick
n
IP YES, for how many days ?
NO 0ne'
□
7. Do you get a headache:- (Please tick
About once a year? one)
Several times a year?
About once a month?
Several times a month (HOW MANY? ..)
About once a week?
Several times a week? (HOW MANY? )
(SEVERE fsEAjuACHES ONLY)








10. Bo your headaches usually make your nose run or feel
congested? i I
YES (Please tick one) | |
NO
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11. Do your severe headaches make you feel as though you have
a tight band around your head?




12. Are your headaches throbbing or thumping?




13. Where do you usually feel the headaches?





All over the head
If elsewhere, where
14. Are your severe headaches on one side only:-




15. Before you get a headache do you know that one is coming?
YES (Pl»ase tick one)
NO
IF YOU DO, Please describe briefly what you notice?
16. Before you get a severe headache do you have any
difficulties with speech? YES / NO
If so, describe
Numbness ox- -tingling sensations? YES / NO
xi' so, where
17. Do your severe headaches often last for more than two days?
YES / NO (Please tick one)
18. Are you. headache free for long periods and then experience
a number in a short space of time?
YES / NO (Please tick one)
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19. Before you have a severe headache do you notice any
changes in your sight?
YES /NO (Please tick one) □
IF YES, please describe briefly what you notice
2D. Vi 1 o 11 you havo a hoadacDS do yon■-
Lose your appetite? (Please tick any that
Feel dizzy? app | J
Feel sleepy?
Hear ringing in your ears ?
Find that light hurts .your eyes?
21. When you have a headache do you:-
Bver feel sick? (Please tick any that




22. Have you ever seen a doctor about the headaches?
YES / NO (Please tick one) □
IF YES, have you seen a doctor about the headaches
during the past year? |- j
YES / NO (Pleaso -t-Aoi* )
23. Over the years have your headaches become:-
□More frequent? (Please tick one)Less frequent?
or liav« you noticed no change?
24. Over the years have your headaches become:-
□More painful? (Please tick one)Less painful?
or- have you noticed no change?
25. Do you notice that your headaches come at a particular
time of the month / week /day.
YES / NO (Please tick one)
IF YES, please specify .
□
26. Do you think that your headaches have any connection with
your diet?
YES / NO (Please tick one) □
IF YES, please specify
27. Does anyone else in your family suffer from similar severe
headaches?
YES / NO (Please tick one) □
IF YES, please specify
WE ARE MOST GRATEFUL TO YOU FOR HELPING IN THIS WORK
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ABSTRACT
98 patients, who had received a diagnosis of migraine
from their general practitioners, completed the Waters
Headache Questionnaire. The data were subjected to a
Principal Components Analysis (with Varimax rotation).
13 factors were extracted, but none of them comprised those
variables regarded as constituting "migraine features".
The results are discussed in the context of recent studies
which have raised several questions concerning the
classification of headaches.
A considerable amount of clinical and research time has
been devoted to the topic of migraine headaches, particularly
in the last two decades. Friedman et al. (1 ) proposed a
classification system based on symptom patterns of headaches}
drawing on the experimental and clinical data available to them
at that time. Briefly, they proposed, inter alia, the following
headache entities: common migraine, classic migraine, cluster
headache, hemiplegic and opthalmoplegic migraine, muscle
contraction headache, and combined vascular and muscle
contraction headache . The earlier experimental data relating
to these entities were summarised by Dalessio (2).
Major advances in the study of headache have occurred
within several disciplines. Biochemical abnormalities,
particularly deficiencies in serotonin, have been observed (3);
cerebral blood flow changes have been recorded during the
prodromal and the headache phase of a migraine attack (4); and
new psychological methods of treatment have been developed (5).
However not all of the recent advances have been consistent with
the earlier clinical "conventional wisdom". For example, Blau (6)
was critical of the reports that the superficial temporal artery
pulse amplitude was larger during the headache phase of the
migraine attack, than during the non-painful phase. In a recent
review, Morley (7) claimed that because of major deficiencies in
experimental design and data dialysis, it is impossible to make
unequivocal interpretations of the evidence concerning cerebral
vasomotor dysfunction in migraine. Bakal & Kaganov (8) found
considerable overlap in the pathophysiology of migraine and
muscle contraction headaches. Finally, it has been suggested
that the varied headache symptom patterns may be simply a
2 .
function of differences in severity, rather than of differences
in clinical entities (9).
Xt appears from the above that the problem of headache
requires some rethinking and fresh analysis. One useful approach
may be to reduce the heterogeneity in the classification of
headaches, by examining how headache symptoms cluster
together. If symptoms are correlated and form consistent
patterns, the patterns so obtained may more precisely provide
the defining characteristics of headache syndromes.
The statistical technique of factor analysis is ideally
suited to examining the emergence and clustering of symptom
patterns. On the basis of a matrix of correlations amongst
variables (or symptoms), it simply attempts to examine what
would be the optimum combination of variables that could best
account for the variance in all the data. The combinations
which emerge suggest whether some underlying pattern of
relationship exists, such that all the data may be re-arranged
or reduced to a smaller set of factors or components. In
clinical applications, factor analysis may permit one to see
how far symptoms cluster together to form clinical entities.
If you start with a large number of variables (say, over thirty),
typically it would be found that only four or five factors could
sum up most of the information about the relative position of
individuals, on'the original variables. The factors extracted
each account for a decreasing proportion of the remaining
variance; at some point, further factors would account for very
little extra variance and no more are extracted. It should be
noted that factor analysis is a generic term for a large
number of related techniques. The technique based most explicitly on
3.
exact mathematical transformations of the original data, and
which is particularly suitable for examining symptom factors,
is that of principal components analysis. Often however this
mathematical approach produces factors which are statistically,
but not clinically, interpretable. In such cases, it is quite
legitimate to carry out further transformations, or rotations,
of the data, to produce simpler and more clinically intelligible
factors. Such rotated factors often "line up" more precisely
with the original variables, and this facilitates describing
and labelling the extracted factors. Yarimax rotation is the
most commonly used method, and is the one best suited to the
analysis of symptom patterns. Examples of the application of
factor analysis to medical research have been discussed by
Child (10) and factor analysis as a technique has been
succinctly reviewed by Kim & Mueller (11).
It appears that only one study has been published
describing a factor analysis of headache symptoms. Ziegler et
al. (12) obtained seven main factors from 27 headache variables;
no one factor comprised the expected "migraine features";
instead it was found that three distinct migraine factors emerged.
Their results further challenged commonly held beliefs in a
number of ways; for example, there was no strong evidence of a
separate "cluster headache" entity.
It would appear thatr despite these controversial findings,
no further factor analytic study of headache symptomatology has
I
been reported. The present study was intended to fill this gap.
A major difference between this study and that of Ziegler et al.,
however, is that this study utilised a standard questionnaire,
the Waters Headache Questionnaire, about which much is already
known. For example it has been found that, of subjects given a
diagnosis of migraine based on questionnaire responses, 90$
would also be diagnosed as having migraine in a clinical
interview (13)« Furthermore the items in the Waters Headache
Questionnaire are not identical to those used by Ziegler et al.
(12). For example, the Waters Headache Questionnaire obtains
more precise information concerning the location of the pain,
and enquires more closely into associated symptoms, such as
appetite changes, feelings of dizziness and sleepiness, light
hurting the eyes, etc. However the Waters Questionnaire does
not, unlike in the Ziegler et al. (12) study, include items
relating to family history of headaches, response to treatment
and precipitants of the headache. The items of the Waters
Headache Questionnaire are shown in the Appendix.
METHOD
Sub ,j e c t s
98 patients completed the Questionnaire; all were referred
to a headache clinic by their general practitioners. Because the
patients came from a variety of practices, it is impossible to
state the precise diagnostic criteria used; however all subjects
were referred with a diagnosis of migraine, and there is no
reason to suspect that these patients are not representative of
patients so diagnosed. There were 77 females, and 21 males;
mean age was 36.8 years, with a standard deviation of 13-5,
and a range of 10 to 64. They were predominantly from social
classes 1 (20.4$), 2 (39-8$) and 3 (24.5$); only 15-3$ were from
social classes 4 and 5>
Procedure
All patients were asked to complete the Questionnaire as
part of an assessment procedure, prior to commencing treatment
by a variety of psychological methods, including relaxation and
biofeedback. Only quantitative responses relating to
symptomatology were analysed; first by simply examining
frequency of endorsement of the items; second, by factor
analytic methods, using principal components analysis (without
iteration), and subsequently rotated by the Varimax method, with
Kaiser normalisation. The computer programmes used in this
analysis were part of the Statistical Package for the Social
Sciences (SPSS) (l4).
Results
1) The responses of the subjects to the items of the
Vaters Headache Questionnaire are shown in the Appendix.
2) Using Principal Components Analysis, factors were
extracted until additional factors accounted for little extra
until
variance; that is,/the eigen value reached a level of less than
1.0. Thirteen factors were found, which were then rotated accord¬
ing to the Varimax criterion (Kaiser Normalisation). After
rotation, it was found that the 13 factors accounted for 71-38$
of the total variance. Furthermore each of the 13 factors
accounted for a reasonably similar, albeit low, proportion of
the variance, with no large differences in ability to account for
variance between the first factor extracted (6,62$) and the
1
thirteenth (4.6$). Accordingly, all 13 factors are described
hei-e ; only those symptoms which load (i.e. correlate) with the
factor at +0.30 or above are reported. Both total variance and
common variance (i.e. variance due just to the factors extracted)
are reported for each factor. The details are shown in Table 1 .
Table 1 about here
DISCUSSION
Perhaps the most notable finding from the principal
components analysis was that no single factor emerged which
encompassed the three "migraine features" described by
Waters (l5): warning sign, unilateral headache, and nausea/
vomiting. This is quite consistent with the results of the
factor analytic study of Ziegler et al. (12), who also reported
that no factor emerged which contained the variables "ordinarily
thought of as particularly characteristic of migraine". However,
neither did the present study find any factors which closely
resemble those obtained by Ziegler et al. (12). This is
presumably because different variables were measured; neverthe¬
less there was sufficient similarity in the content of the
questionnaires to lead one to expect that some factorial
congruence might emerge.
The findings are not however totally at variance with
clinical lore. Factor 1 contained two of Waters' three migraine
features (unilateral headache and nausea/vomiting); the remaining
symptions loading on this factor are generally as expected: pain
in the forehead or behind the eyes; light hurting the eyes; and
low probability of pain being all over the head. The only
anomalous finding was that frequency of headaches had a
negative loading on this factor, although not substantially.
Of all the factors to emerge, this one most closely resembles
a "migraine" factor.
The second factor to emerge describes those headaches
which are not particularly troublesome, are located bilaterally
in the forehand and are without accompanying sensory or
perceptual disturbances. However such headaches may or may not
be severe (severity loading =+0.022). Of all the factors to
to emerge, this one most closely resembles a "muscle tension
headache" component. However, if this were the case, one
might expect that the variable "Are your headaches throbbing
or thumping?" would be negatively loaded on this factor;
but the loading was a mere -0.037- Also, it must be remembered
that all subjects in the study had already been diagnosed as
clearly suffering from migraine by their general practitioners.
However, given that there are notorious difficulties in making a
differential diagnosis between migraine and muscle tension
headaches, that mixed vascular and tension headaches may occur
(Friedman et al. (l )) and that subjects may suffer from both type
of headaches at different times, it remains a possibility that
this factor represents a muscle tension component in patients
with a diagnosis of migraine.
The remaining factors bear no obvious resemblance to
putative headache entities, but do raise some points of interest
In factor 3» the symptom of "Varning Signs" is not clearly
linked to other clinical features of headache, apart from
location and frequency; the presence of warning signs may
therefore not be as closely linked with "migraine features" as
others have suggested (16). Factor 7 describes an increase in
frequency and pain intensity over the last year, which is
independent of kind of headache. Of particular interest is
factor 11 which largely describes the severity of headaches, and
to a lesser extent the frequency. Severity appears to be
independent of kind of headache, and of other headache features,
since this is the only factor on which severity is highly
9.
It should be noted that the patients in this study formed
a reasonably homogeneous group in terms of chronicity, severity,
and symptomatology. Accordingly the variance in the scores
was necessarily restricted, and there remains the possibility
that, if a wider range of variance had been introduced by
using a more heterogeneous group of headache patients, a more
clear-cut migraine factor structure may have emerged.
Waters (16) reported that severity is significantly
associated with the presence of the three main headache
features of warning, nausea/vomiting and unilateral headache.
In order to test this, those patients reporting various
combinations of the three features were examined for severity
ratings. No significant differences emerged between any of the
combinations; for example there was no significant difference
between the mean severity (3-92) of those subjects reporting
all the three features, and the mean (3.8O) of those not
reporting all three features, (t *= 0.256, p * 0.80). Hie
range of severity ratings was very narrow, from a mean of
3*714 for patients with "vomiting" as the only migraine feature;
to a mean of 4.0 for patients with "warning sign" as the only
migraine feature. All other combinations of the three
migraine features vere between these values. These findings
are not consistent with the suggestion of Waters (15) that
headache severity correlates with the presence of the three
migraine features.
Walker (17) suggested that "psychogenic" headaches may
be distinguished from migraine, in that they tend to be of
longer duration. Ebwever others have found the opposite; that
is, non-migrainous headaches tended to be of shorter duration
(18). The present study found that duration was not closely
related to any headache "type", a finding consistent with the
results of Ziegler et al. (12). J
1 0.
It is clear that the results of studies on migraine
symptomatology do not form a consistent pattern, in terms of
the specific constellations of symptoms found. However there
is some agreement in that many workers now query whether
migraine is a separate clinical syndrome, with features clearly
distinct from those of other headache syndromes. The available
evidence is more consistent with the suggestion by Waters (15)
that "migraine might be an extreme in a continuum rather than
a completely distinct clinical entity". The underlying basis
of this putative continuum may be the degree of vascular
involvement, but more research is required before this can be
firmly established.
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APPENDIX'
Responses to the ¥aters Headache Questionnaire
Symptom Item Endorsement












(c) I hardly notice my headaches at all
My headaches rarely inconvenience me
My headaches sometimes distract me from
what I am doing
Sometimes I am unable to continue my normal
activities because of my headaches
My headaches sometimes interfere a lot
with what I am doing
I can hardly do anything when I have a
headache
I am absolutely fit for nothing when I
have a headache
(d) How long do your headaches last?
Less than half a day
One day
More than one day
























(e) When you have a headache,' do you usually
have to -
Lie down 72
Re s t 12
Take things easy 1 6
(f) Have you missed work during the past year gg
because of a headache?
(g) Do you get a headache -
About once a year 2
Several times a year 12
About once a month 12
Several times a month 33
About once a week 8
Several times a week 33





(i) Where do you usually feel the headaches?
Temples 27
Forehead/behind eyes 49
Back of head 20
Top of head 12
All one side 47
J
All over head 12
Elsewhere 6





(k) Before you get a headache, do you know
that one is coming?
(l) 'When you have a headache, do you notice
any change in your sight?




Hear ringing in your ears
Find that light hurts your eyes
Notice tingling, or any strange feeling
in any part of your body
(n) When you have a headache, do you






(o) Over the year, have your headaches become
More frequent
Less frequent
Or have you noticed no change
3.
(p) Over the years, -have your headaches become
More painful 44
Less painful , 8
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TELEPHONE No. 031-447 2011
Dear
Thank you for taking time to discuss your headaches with me.
Unfortunately your headache does not appear to be of the type which
would benefit from any of the treatments I am investigating. It has
therefore been decided that you should continue with your present
treatment and not take part in this research project. Dr. Price has
been informed of this decision.
I would, however, like to thank you once again for the time spent









TELEPHONE No. 031-147 2011
Dear
Thank you for taking the time to discuss your heaches with me.
This research project is concerned with comparing different forms of
treatment for migraine headache. It has been decided that you should
continue the course of treatment prescribed for you by Dr. Price.
You will find 8 headache forms enclosed with this letter, please
complete a form each time you have a headache. One form covers a 2k hour
period, so if your migraine lasts for more than 2k hours you will need to
complete 2 forms, and so on. A 'specimen' form is enclosed to refresh
your memory on how to fill them in. further forms will be supplied at
monthly intervals and with each set a stamped addressed evenlope will be
included to return completed forms. Please do not forget to inform me
of headache free months, as this is also important information.
As the project will last for one year, I will send you a supply of
forms every month for that period of time. When the study is complete,
you will be offered a course of the most effective form of treatment.
Finally, if you do not wish to be included in this study, please inform
me.












TELEPHONE No. 031-J47 2011
Dear
Thank you for taking time to discuss your headaches with me. This
research project is concerned with comparing different forms of treatment
for migraine headache. The project will last for one year and will
consist of the following three stages:
Stage 1. During the first three months a record of the frequency
Stage 5, during the final six months, I will again be recording
your headaches to see if there have been any changes.
At no time will I require you to stop taking prescribed or preferred
medication, I will however require you to keep accurate records of the
medication taken. The treatment is not painful and a minimum amount of
equipment will be used. The equipment that is used will be taped to the
surface of the skin and at no time will you experience anything unpleasant.
Although I will be seeing you for the treatment sessions, it is
important to remember that I will be supplementing any previously
prescribed medication and not replacing it. Please find enclosed eight
headache forms. Complete a form each time you have a migraine, one form
covers 2k hours, so if your headache lasts for more than 2k hours you will
need to complete two forms, and so on. Finally if you do not wish to be
included in this study, please inform me, otherwise I will be contacting
you to arrange an appointment.
and severity of your headaches will be kept. I will
see you on two occasions; at monthly intervals, so that
we can get to know each other better and so that you can
become familiar with the department.
Stage 2. The second three months will be the treatment phase of
the project. During this phase, I will see you for one





coittrol - should it tori:?
In the hunan body there is a large system of arteries, veins and smaller
blood vessels. light pints of blood are pumped around this system by the heart.
These vessels are not rigid, arteries have muscular walls which can expand or
contract slightly, regulating the amount of blood that flows through then to any
particular part of the bod;/. Apart from its many other functions, blood
carries warmth to all pants of the body. How we know that the pain of a
migraine headache is due to an abnormal increase in the amount of blood flowing
to the head. The blood vessels in the head therefore have to stretch to allow
this extra blood to flow and this stretching is thought to cause the pain.
Finger temperature control is thought to work in two main ways:
Firstly, learning to increase the flow of blood to th§ hands by increasing
one's finger temperature may decrease the amount of blood which is being directed
to the head, the arteries in the head will therefore no longer need to stretch
and the headache should disappear.
Secondly, we know that an increase in finger temperature is a sign of
a relaxed nervous system, at least that part of the nervous system that causes
blood to be unevenly distributed around the body. Learning how to raise your
finger temperature will relax the nervous system causing that redistribution
of the blood which should bring relief from your headache.
Of course, achieving this state will take time and practice, so try to
spend at least fifteen minutes a day, every day in practice.
APPENDIX 1.7
TEMPORAL ARTERY AMPLITUDE CONTROL - NHY SHOULD IT WORK?
In the human body there is a large system of arteries, veins and smaller
blood vessels. Eight pints of blood are punned around this system by the heart.
These vessels are not rigid, arteries have muscular walls which can expand or
contract slightly, regulating the amount of blood that flows through then to
any particular part of the body. There is a lot of evidence to show that
migraine headaches are associated with an abrupt increase in blood flow to the
head which is thought to stretch the arteries and cause pain. One of the
major arteries of the head associated with pain during a migraine headache
is the temporal artery; the one which runs up the side of your head, next
to your ear. During the headache the pulsations of this artery increase.
Temporal artery amplitude control is meant to work by helping you gain
some control over the size of these pulsations, making any changes a less
extreme and less abrupt action, thereby stopping or at least decreasing the
pain of the headache.
Of course, achieving this state will take time and practice, so try to
spend at least fifteen minutes a day, every day in practice.
APPENDIX 1.7
PROGRESSIVE R5IA.Di.TI0N 5X5RCI325 - ;.~£Y SHOULD TE5Y V/ORX?
In the human body there is a large system of arteries, veins and smaller
blood vessels. light pints of blood are pumped around this system by the heart.
These vessels are not rigid, arteries have muscular walls which can expand or
contract slightly, regulating the amount of blood that flows through them to
any particular part of the body. There is evidence to show that relaxation can
affect bodily functions in many different ways. Migraine headaches are often
associated with an increase in blood flow to the head and this can be caused
in a number of ways. Stress and tension can often start a headache by causing
an increase in blood flow to the head and at the first signs of the headache
the tension may often increase in anticipation of the headache, thus causing
more blood to rush to the head, more headache signs and consequently a headache
will result. I am not saying that tension is the only cause of your headaches
but it probably plays quite an important role in its appearance.
Progressive relaxation exercises can help you in two main ways:
Firstly, if you can teach yourself to feel mentally ana physically tranquil
during times of stress and these times include the periods either before or
during a headache, then you will be able to prevent further tension mounting
and eventually bring about relief from your headache.
Secondly, as stated above, relaxation is also associated with many bodily
changes such as a decrease in heart rate and a redistribution of the blood supply
in the body so that blood will be more evenly distributed around the body during
relaxation instead of being concentrated in the arteries of the head causing the
headache.
Of course, achieving this state will take time and practice, so try to
spend at least fifteen minutes a day, every day in practice.
APPENDIX 1 .7
CCIDROIIITQ- HH.HIT RATI - '.,":-:Y SHCIID IT IORX?
In the human body there is a large system of arteries, veins and smaller
blood vessels. Bight pints of blood are pumped around this system by the heart.
'These vessels are not rigid, arteries have muscular walls which can expand or
contract slightly, regulating the amount of blood that flows through them to
any particular part of the body. There is a lot of evidence to show that
mivraine headaches are associated with disturbances in blood flow to the head
and probably other parts of the body as well. It is reasonable to suppose
that the rate at which your heart beats will affect the rate at which blood
flows to the head, decreasing heart rate will in effect reduce the amount
of blood, flowing through the arteries in the head which are stretched and
cause pain during a migraine attack.
Heart rate is also an index of how anxious you feel, lower heart rate is
associated with a state of relaxation and this is probably something that you
don't feel when experiencing a migraine headache. So, learning to control
your heart rate will hopefully enable you to achieve two things:
Firstly, it will enable you to gain some control over how much blood is
carried to those arteries of the head that cause migraine headaches.
Secondly, it will help you to relax and counter those feelings of anxiety
that accompany the anticipation of a migraine headache.
Of course, achieving this state will take time and practice, so try to
spend at least fifteen minutes a dai^, every day in practice.
APPENDIX 2.
PILOT STUDY. EXPERIMENT 1 (APPENDIX 2.1)
FINGER TEMPERATURE (Mean'Change Per 30 Second Epoch)
CONDITION 1 2 3 1+ 5
Subject 1 -0.3 -1.5 -1.U -2.1 -1.8
2 +2.1 +3.5 +0.2 -l+.o -1+.8
3 +0.3 -0.1 -0.9 -0.8 -0.9
b -0.3 -3.2 -b.b -1+.7 -6.0
5 -0.1 +0.6 -0.3 -1.7 -1.1+
6 -0.5 -0.9 -3.2 -5.6 -8.3
7 -0.1 -3.7 -0.1 -3.6 -3.1
8 -0.1 +0.9 -0.1+ -1.6 -0.9
Means +0.1 -0.5 -1.3 -3.0 -3.5
TEMPORAL ARTERY AMPLITUDE (Mean Per 30 Second Enoch)
CONDITION 1 2 3 1+ 5
Subject 1 6.6 8.6 9.1+ 8.6 9.1+
2 18.1 18. b 17.7 17.1 16.9
3 3.0 3-5 2.3 3.6 3.0
b 13.9 16.3 11+.9 1+.1+ 6.0
5 18.1 18.7 18.6 18.9 19.3
6 8.7 19.3 16.8 11+.1+ 11+.3
7 8.7 7.9 7.0 6.8 6.9
8 16.5 17.2 16.2 16.1 5.0
Means 11.7 13.7 12.9 11.2 10.1
RESPIRATION DEPTH (Mean Per 30 Second Epoch)
CONDITION 1 2 3 1+ 5
Subject 1 33.5 3U-3 31+. 2 31+. 2 29.9
2 21.2 20.2 16.7 13.9 10.I+
3 16.8 16.7 18.2 18.2 18.1
b 30.8 21.8 19.8 22.3 19.9
5 11+. 2 16.3 9.1 8.7 9.2
6 3U.7 27. b 29.1+ 20.8 27.5
7 38.7 38.8 31.5 25.0 29.3
8 28.0 3J+.8 32.0 33-7 32.6
Means 27.2 26.3 23.9 22.1 22.1
RESPIRATION RATE ( Per Minute) (APPENDIX 2.1)
CONDITION 1 2 ■' 3 h 5
Subject 1 15.7 15.5 11.7 9.2 15.5
2 18.2 18.3 16.9 15.8 17.9
3 18.8 17.8 11+. 1 15.1 15.5
b 16.0 16.3 15.7 16.1 16.0
5 12.7 12.1 12.3 13.1 12.1
6 10.3 12.6 9.9 16.1 8.8
7 16.1 13.5 15.8 17.2 15.6
8 17.3 17.3 17.5 18.0 18.0
Means 15.6 15.1+ 11+. 2 15.1 11+. 9
PEARSON PRODUCT MOMENT CORRELATION COEFFICIENTS (Per 30 Second Epoch)
Temp = Finger temperature changes
T.A. = Temporal artery amplitude
R.D. = Respiration depth
SUBJECT 1 SUBJECT 5
Temp/TA Temp/RD RD/TA Temp/TA Temp/RD RD/TA
A -0.08 +0.18 +0.29 Cond A -0.03 • -0.17 -0.37
B +0.31 -0.12 +0.01+ C -0.39 -0.1+1 +0.16
A +0.01+ -0.01+ +0.05 A -0.37 -0.1+2 +0.09
C +0.I+5 -0.15 +0.01 B -0.23 -0.17 +0.11
A -0.33 +0.12 -0.03 A -0.13 +0.12 +0.02
SUBJECT 2 SUBJECT 6
Temp/TA Temp/RD RD/TA Temp/TA Temp/RD RD/TA
>nd A -0.05 -0.55 +0.35 Cond A -0.27 -0.08 -0.28
B - - - C -0.10 +0.25 -0.39
A -0.26 +0.11 -0.20 A +0.21+ -0.1+6 +0.22
C -.0.08 -0.21 +0.15 B +0.18 -0.10 -0.08
A •- - - A +0.01+ -0.05 +0.16
SUBJECT 3 SUBJECT 7
Temp/TA Temp/RD RD/TA Temp/TA Temp/RD RD/TA
A +0.03 -0.39 -0.23 Cond A +0.01+ -0.08 -0.12
B -0.53 -O.38 +0.27 C +0.02 -0.01 -0.02
A +0.08 +0.10 +0.11+ A -0.12 -0.52 +0.29
C -0.27 -0.12 -0.39 B -0.19 +0.06 -0.35
A -0.01 +0.09 +0.35 A -0.08 +0.36 +0.08
SUBJECT 1+ SUBJECT 8
Temp/TA Temp/RD RD/TA Temp/TA Temp/RD RD/TA
A -0.31 +0.21+ -0.16 Cond A +0.3^ +0.16 +0.01+
B +0.11 +0.62 -0.17 C -0.10 +0.30 +0.06
A -0.58 -0.1+1+ +0.15 A -0.61 +0.71 -0.60
C +0.07 +0.35 -0.08 B +0.22 +0.01+ +0.20
A -0.23 +0.33 -0.29 A -0.52 +0.30 -0.16
PILOT STUDY, EXPERIMENT 2 (APPENDIX 2.1)
Finger Temperature Changes (Mean Per Session)
(A) Progressive Relaxation
Veeks 1 2 3 1+ 5 6
Subject 1 -0.15 +o.5o -0.11 -0.11+ -0.10 +0.3h
2 -0.39 -0.65 -0.39 -0.10 +0.20 +0.87
3 +0.21+ +0.1+0 -0.02 +0.15 +0.22 -0.10
k +0.71 +1.12 +0.36 -0.82 +1.19 +0.20
5 +0.25 -0.11 +0.11+ +0.02 +0.11 -0.10
6 +0.06 +0.52 +0.18 +0.60 +0.01+ -0.12
+0.12 +0.29 +0.03 -0.05 +0.31 +0.18
(B) Concentration task
Weeks 1 2 3 1+ 5 6
Subject 1 -O.23 -0.36 -0.26 -0.32 +0.20 -0.05
2 +0.65 +0.1+3 0.00 -0.13 -0.I+6 -0.51+
3 +0.08 +0.02 +0.03 0.00 -0.08 +0.02
h +0.91 -1.1+8 -1.53 -1.85 -1.81 -0.1+6
5 +0.80 -0.01+ +0.20 -0.55 -0.16 -0.19
6 -0.12 -1.1+1 -0.68 -0.I+1 -0.30 -O.38
+0.35 -0.I+7 -0.37 -0.51+ -0.1+1+ -0.26
(C) Finger Temperature Biofeedback
Weeks 1 2 3 b 5 6
Subject 1 -0.30 +0.29 +0.08 +0.01 +0.17 +0.03
2 +0.1+1+ +2.01+ +1.29 +0.53 -0.35 +0.1+2
3 +0.07 -0.31 +0.15 +0.02 +0.0I+ +0.09
k +0.78 -0.56 -0.72 -0.35 +2.39 +0.59
5 -0.12 -0.06 +0.25 +0.01+ +0.68 +0.76
6 -0.13 -0.10 -0.1+3 -0.1+6 0.00 -0.10
+0.22 +0.22 +0.10 -0.01+ +0.1+9 +0.29
FINGER TEMPERATURE CONDITION (APPENDIX 2.2)
Finger temperature changes within -periods of each treatment
session
Sessions
Patient Period 1 2 3 U 5 6 7 89 10
1 1 -09.5 +02.8 -02.2 -0U.2 +10.3 +03.7 +19.0 +01.7 +01.U +07.2
1 2 -16.2 +13.2 +02.2 +07.5 +17.2 +07.6 +50.0 +08.U +01.5 +12.5
1 3 -12.2 +10.8 +01.6 -O6.I1. +12.7 +00.5 +61.1+ +10.8 -07.8 +09.1+
2 1 +02.2 +13.1 +00.0 -02.9 -26.3 -00.7 +02.9 +08.2 -17.2 +01+.2
2 2 +05.1 +18.1+ +03.5 -03.h -31.3 -01.2 +03.6 +17.1+ -36.9 -03.1
2 3 +07.8 +01+.7 +00.0 +08.3 +01+.1+ -02.9 +02.9 +12.9 -59.8 -15.5
3 1 -07.1 -00.7 +02.6 +02.7 +02.6 +00.1 +03.1 +02.1 -00.1+ -07.7
3 2 +03.1 +05.6 +05.1+ +05.7 +05.0 +00.2 +05.7 +03.9 -02.7 -06.9
3 3 -03.3 +13.3 +03.7 +01+.0 +05.9 -01.1 +00.^ -00.9 -07.6 +05.2
1+ 1 -10.6 -07.1 -03.5 +02.2 -Ol+.O -01.8 +11+.U +09.2 +01+.5 -01+.1+
1+ 2 -13.0 -05.1+ -09.3 +06.9 +07.9 -02.2 +20.2 +23.3 +08.2 -09.0
1+ 3 -11.0 -17.3 -13.U +07.0 -01.8 -03.3 +1U.6 +13.8 +13.3 -22.8
5 1 -00.1+ +00.3 +01+.7 -09.2 +01.5 -01.5 -03.0 +01.8 -00.2 +01.6
5 2 +00.7 +01.0 +06.6 -02.6 +01.5 -01.8 -02.7 -00.9 -00.8 +01.7
5 3 +01.5 -02.0 +01+.7 -0i|.1 +02.3 -02.1+ -02.1 -01.0 +01.0 +00.6
6 1 -01.8 -00.k +00.3 +00.6 -00.3 +03.2 +02.0 -01.3 +01.2 +00.3
6 2 -02.9 +00.6 +00.0 +00.9 -00.k +01+.6 +01.6 +01.5 +02.6 +01+.5
6 3 -03.8 -01.1 -00.6 +01.3 +02.1 +05.2 +02.9 +00.k +01+.2 +03.3
7 1 +00.6 +01.3 +01.6 +03.5 +00.1 +01+.2 +01+.8 +00.0 +00.8 +03.5
7 2 -ol+.6 -00.7 +02.3 +01+.1 -01.9 +05.7 +06.1 -00.6 +01.0 +03.8
7 3 -11.1 -01+.1 +02.6 +01.5 -05.3 +08.7 +09.3 -00.8 +01.9 +03.0
8 1 +03.8 -12.7 -00.8 -01.6 -05.5 +00.9 -05.7 +13.9 +00.9 -01.3
8 2 +01 .1+ -12.2 +00.6 +08.1 +01.0 +01 .u -00.1 +27.1+ +00.7 +02.1
8 3 -09.0 -26.6 +01.6 +08.1 -05.7 -11.6 -01.5 +17.0 +00.9 +02.8
TEMPORAL ARTERY AMPLITUDE CONDITION (APPENDIX 2.2)
Finger tenrperature changes within -periods of each treatment
session
Sessions
Patient Period 1 2 3 1+ 5 6 7 8 910
1 1 +00.2 +00.3 +03.2 +03.1
1 2 +00.6 +05.2 +06.7 +03.0
1 3 -00.8 +07.6 +08.8 +05.0
2 1 -01.1 +01.1+ +00.8 +00.8
2 2 -00.7 +02.0 +01.6 +00.9
2 3 +01.1 +01.1 +01.5 +00.5
3 1 +00.0 +01.1 -03.7 -00.5
3 2 +01.5 +01.3 -12.2 +10.6
3 3 +01.5 +00.1+ -20.1 +11.0
1+ 1 +03.9 +01.1 +03.6 +02.3
1+ 2 +05.0 +01.3 +05.0 +03.7
1+ 3 +05.8 +01+.1+ +03.5 +00.7
5 1 -12.0 +01.6 -06.1+ +01.8
5 2 -08.1+ +01.3 -15.8 +06.6
5 3 -06.7 +02.1+ -32.7 -00.6
6 1 -02.5 -03.7 -01.8 -10.8
6 2 +02.0 -11+. 2 +07.1 -15.1
6 3 +36.9 -15.8 +36.5 -10.7
7 1 -19.1 +02.9 +01+.0 +07.9
7 2 -30.0 +03.8 +03.8 +03.2
7 3 -32.1+ +01.7 +02.1+ +03.9
8 1 +02.0 -01+.7 +01.1 -05.5
8 2 +02.7 +00.3 +01.6 -08.9
8 3 +00.7 +01+.0 +00.3 -01+.5
+00.1 -03.0 +00.0 +03.1 +01.1+ +01+.7
+01.0 -03.9 +00.5 +03.6 +02.8 +07.5
-00.8 +02.5 -00.2 -00.3 +02.1 +07.5
+00.9 +02.9 +00.6 +00.6 +00.5 +01.0
+02.2 +01+.2 +00.2 +00.2 -01.7 +01.0
+02.1+ +03.0 -00.2 +00.1 -03.1 +00.3
-06.3 -01.5 +01+.2 +02.0 -07.3 -20.7
+06.7 -01.3 +02.9 +02.9 -15.2 -29.8
+08.5 -03.2 -01.5 +02.9 -20.0 -27.8
-01.2 -00.8 +01.5 +02.1+ +10.1+ -01.1+
+00.9 -02.1 +01.5 -01+.2 +13.1+ +00.7
-01.7 -01.9 +00.0 -03.1+ +10.3 +03.2
+00.3 +07.7 -08.3 -07.1 -00.1+ -18.9
-01+.5 -00.7 -13.9 -09.2 -03.8 -13.1+
-12.6 -08.2 -11.2 -13.8 -09.3 -11+.6
-03.3 +01.7 +01.5 -00.1+ +00.3 +10.9
+01.1 +02.7 +03.5 +00.8 -10.1 +09.3
-03.6 +02.7 +0I+.6 +01.9 -10.1+ -01.2
-06.3 +01+.1 +01.7 +02.8 +05.0 -00.6
-06.7 -02.2 +01.1 +03.5 +05.0 +00.1
+03.1 +01.0 -00.3 +03.5 +05.1 -03.2
-00.5 +00.3 -13.7 +01.0 -01.7 +01.8
+00.1+ +00.1+ -01.8 +06.7 +00.8 -00.7
+00.1 +00.1 -03.9 +10.9 -05.6 -07.0
PROGRESSIVE RELAXATION CONDITION (APPENDIX 2.2)
session
Sessions
Patients Periods 1 2 3 U 5 6 7 8 9 10
1 1 -03.7 -oi+.o -03.3 -01.5 +00.2 -03.h -08.1 -22.5 -13.6 -06.2
1 2 -02;.6 -03.7 +02.5 -0U.7 -00.3 -03.k -15.8 -52;. 7 -13.5 -05.8
1 3 -05.2 -03.h +10.6 -01.3 -01.2 -05.0 -1U.5 -71.7 -16.6 -01.8
2 1 -08.5 -08.8 +00.0 +0U.8 -10.7 +07-U -07.2 -03.1 +02+.7 -06.3
2 2 -10.8 -08.0 -00.7 +06.8 -07.2; +01;. 5 —07-2; -11.5 +02.9 -07-2;
2 3 -08.3 -08.0 -01 .1 +05.9 -00.3 +00.5 -12.9 -12.5 -02;.2; -02;.8
3 1 -02;. 1 -01.1 +02.1 +10.0 -01.0 +03-7 +02.9 +00.3 -10.2 +03.2
3 2 -05.8 -03.5 +01.2 +11.7 +01.1 +01;. 7 +05.8 -09.6 -16.6 +01.8
3 3 -09.2 -06.2; -00.1 +11.2 +03.9 +00.9 +05.9 -10.8 -19.2 -00.3
k 1 -01.5 +03.1 +0l|.6 +00.8 +10.2 +01;.8 +02.2 -01.6 +01.1 +02.8
2; 2 -01.2 +0U.U +07.2 +02.8 +13.6 +05.2; +06.1; -01.0 -00.1; +02;.0
1; 3 -00.2 +01;.8 +06.8 +01+.0 +13.8 +05.7 +09.8 +O3.3 -00.3 +02.1;
5 1 +11;.9 -21.8 +07.5 -01.5 -02.9 -01.1 +00.1 +16.1 +01.5 +10.1;
5 2 +22.8 -00.8 +13.7 +07.3 -03.3 -0l;.7 +05.7 +21.8 +00.3 +22.0
5 3 +23.3 +02.1 +15.3 +15.0 -10.5 -26.1 +02.7 +15.7 -01;.6 +06.0
6 1 -01.5 +02.2 +02.8 +02.9 +00.9 +02.5 -00.2 -00.1 -00.8 +02.0
6 2 +00.7 +01.8 +01;.2 +02.7 -00.1 —01;.2 -01.2 +00.3 -01.7 +01.6
6 3 +00.0 +01.6 +02.2 +00.1; -00.5 -00.1 -03.8 -00.1; -02.6 -00.1
7 1 +00.7 -52.9 -09.8 +00.9 -01;.9 +29.8 -01.0 -25.2 -09.6 -05.2
7 2 -00.2 -68.2 -15.2 +00.9 -05.8 +26.9 -00.7 -32.2; -09.0 -07.5
7 3 -00.2 -78.2 -20.1 +01.2 -06.7 +26.9 +00.5 -33.8 -08.5 -10.3
HEABT RATE CONDITION (APPENDIX 2.2)
Finger temperature changes within -periods of each treatment
session
Sessions
Patient Period 1 2 3 1+ 5 6 7 8 9 "10
1 1 -15.6-01.0-13.7+00.0-15.5+02.2+00.2-03.8+01.0-13.1
1 2 -37.1 +02.2 -25.6 -02.7 -28.6 +1+0.3 -01.0 -10.1 +01.6 -23.3
1 3 -SS.br -03.2 -36.5 -06.9 -l+o.o +78.9 -03.0 -20.1 -00.1+ -32.1+
2 1 -01.8 +00.2 -00.3 -01.3 +00.7 +00.1+ -01.1 +01.3 +01.8 +01.7
2 2 -00.2 +01+.7 +01.9 -01.7 +03.h +03.3 +05.7 +03.2 +02.9 +03.1+
2 3 -03.2 +07.6 +02.1 -03.7 +01+.7 +03.8 +06.2 +03.8 +05.2 +01+.3
3 1 +02.7 +02.5 +00.7 +00.7 +01.1 +01.3 +00.6 +00.9 -00.1 +01.7
3 2 +03.1 +03.8 +00.8 -01.1 -00.8 -00.1+ +00.8 -03.6 +02.1+ +02.9
3 3 +01+.1 +01+.0 +01.0 -01+.2 -05.2 -02.6 -00.2 -10.6 +03.3 +03.7
1+ 1 -02.8 +02.6 +01.1 +03.6 +01.2 +02.0 +01+.5 -00.2 +02.9 +13.8
1+ 2 +02.6 +07.8 +01.9 +01+.1+ +02.0 +01.6 +06.0 +00.9 +01+.6 +12.1
1+ 3 +03.1 +08.6 +02.1 +06.7 +02.0 +03.1 +07.5 -00.8 +01+.2 +16.9
5 1 +01.6 -00.1 -00.7 -07.7 +02.2 +00.8 +02.8 +00.9 +00.1+ +01.5
5 2 +02.0 +00.1+ -08.6 -03.7 +01+.7 +02.1 +02.7 +02.1 -00.1 +01.7
5 3 +02.2 +00.0 -03.6 -01+.1+ +06.5 +03.2 +02.2 -02.3 +00.8 -01.6
6 1 +05.7 -08.3 +12.0 -06.6 -00.8 +06.7 +00.2 +03.5 +00.6 +05.5
6 2 +08.7 +03.7 +27.1 -06.2 +00.9 +22.7 +01.0 +03.8 -00.2 +31.0
6 3 +03.0 -07.0 +28.7 +00.1 -05.9 +25.1 -03.5 +05.9 +01.1+ +25.6
7 1 -00.2 -00.6 -01.0 -02.6 +00.9 -00.1+ +00.1 -00.2 +02.2 -02.1
7 2 +00.1 +00.3 +01.5 -00.2 +02.1+ +00.3 +02.3 +00.8 +03.9 +00.5
7 3 +00.8 +00.3 +02.6 +00.1+ +02.8 +01.1 +02.6 +00.8 +01+.6 +01+.7
8 1 -02.7 +00.5 +09.3 -02.9 -07.6 -01.2 -01.2 +00.7 +00.7 -00.2
8 2 -03.0 -02.7 +27.9 -05.8 -11+. 1 -01.6 -02.7 -01.8 +00.6 -00.1
8 3 -05.0 -06.7 +18.9 -08.2 -21.3 -02.2 -02.2 -01.3 +00.3 +01.0
9 1 -02.2 +01.6 +01.9 +03.1+ -03.6 +00.2 +01.5 +02.9 -06.8 +03.0
9 2 +00.1+ -01+.9 -05.8 +01+.5 -05.7 +02.5 +01.5 +03.6 -13.1 +02.0
9 3 -05.7 -08.2 -07.3 +02.5 -05.9 -02.0 +00.7 +03.8 -19.2 +02.1+
FINGER 'TEMPERATURE (APPENDIX 2.2)
Cell Means Between Conditions, Across Sessions and Within Periods
Conditions
Session Period Finger Temp Temp Art Amp Prog Rel'n Heart Rate
1 1 -2.85 -3.55 -0.53 -1.70
2 -3.30 -3.45 +0.13 -2.60
3 -5.14 +0.59 +0.03 -6.23
2 1 —O.i+3 0.00 -11.79 -0.29
2 +2.56 +0.13 -11.14 +1.70
3 -2.79 +0.73 -12.50 -0.51
3 1 +0.34 +0.10 +0.56 +1.03
2 +1.41 -0.28 +1.84 +2.34
3 +0.03 +0.03 +1.94 +0.89
4 1 -1.11 -0.11 +2.34 -1.49
2 +3.40 +0.50 +3.93 -1.39
3 +2.46 +0.66 +5.20 -1.97
5 1 -2.70 -2.04 -1.17 -2.38
2 -0.13 +0.14 -0.31 -3.98
3 +1.83 -0.58 -0.21 -6.90
6 1 +1.01 +1.43 +6.24 +1.33
2 +1.79 -0.36 +4.17 +7.87
3 -0.74 -0.50 +0.40 +12.04
7 1 +4.69 -1.56 -1.61 +0.84
2 +10.55 -0.75 -1.03 +1.81
3 +10.99 -1.59 -1.76 +1.14
8 1 +4.45 +0.55 -5.16 +0.67
2 +10.05 +0.54 -3.19 -0.12
3 +6.53 +0.23 -15.74 -2.31
9 1 -1.13 +1.03 -3.84 +0.30
2 -3.30 -1.10 -5.43 +0.29
3 -6.74 -3.86 -8.03 +0.02
10 1 +0.43 -2.90 +0.10 +1.31
2 +0.70 -3.16 +1.214. +3.36
3 -1.79 -5.35 -1.27 +2.73
FINGER TEMPERATURE (APPENDIX 2.2)
Cell Standard Deviations between Conditions, Across Sessions
and Within Periods.
Conditions
Session Period Finger Temp Temp Art Amp Prog Rel'n Heart Rate
1 1 5.1+9 7.87 7.39 5.91+
2 7.67 11.51+ 10.75 13.33
3 7.08 18.87 10.98 18.80
2 1 7.U8 2.71 19.99 3.27
2 9.79 6.00 25.1+8 3.89
3 13.53 7.06 29.35 6.29
3 1 2.63 3.76 5.69 7.21
2 1+.87 8.76 8.88 16.72
3 5.70 20.37 11.37 17.99
1+ 1 1+.28 5.71 I+.06 3.95
2 1+.56 8.1+1 5.27 3.86
3 5.51 6.1+8 5.99 1+.77
5 1 10.66 2.92 6.37 5.80
2 13.99 1+.10 6.89 10.91
3 6.12 6.09 7.77 11+.98
6 1 2.39 3.1+5 10.99 2.29
2 3.73 2.69 10.99 11+.18
3 5.80 3.83 15161 26.1+6
7 1 8.27 6.12 1+.35 1.81+
2 17.36 5.56 8.23 2.82
3 21.11+ 1+.51+ 9.20 3.89
8 1 5.33 3.31 11+. 29 2.09
2 11.19 5.06 27.90 1+.1+9
3 7.79 7.02 29.09 8.22
9 1 6.67 5.12 7.12 2.83
2 13.91+ 8.89 7.57 5.29
3 22.1+6 9.66 7.22 7.1+9
10 1 1+.83 11.12 6.26 7.06
2 6.89 12.72 10.33 11+. 01+
3 11.21 11.21+ 5.21 15.76
FINGER TEMPERATURES (APPENDIX 2.3)
Stability point finger temperatures for all patients,
between conditions and across sessions
Sessions






1 34.0 32.5 35.6 3U.7 33.4 35.1 21+.9 22.1 35.0 2i*.5
2 32.0 35.5 35.0 36.0 32.0 36.0 36.1 33.2 34.1 34.8
3 35.0 35.5 35.1 36.1+ 35.8 35.5 34.0 33.2 34.0 3U.6
4 36.3 36.4 34.6 21.7 27.0 21.U 33.0 30.0 20.5 33.5
5 35.2 34.8 3I4-.6 32.8 34.4 3U.U 34.1 34.2 34.1 34.6
6 35.0 34.4 35.3 34.9 35.0 34.6 35.3 35.6 35.0 35.0
7 32.8 32.4 35.2 34.0 34.7 32.4 35.1 33.0 34.6 35.7
8 25.7 34.3 34.8 34.9 35.2 3U.9 33.8 35.3 35.2 35.2
1 36.5 36.5 35.3 33.0 34.5 33.5
2 35.6 35.5 35.5 35.8 35.2 32.3
3 36.0 36.5 36.5 36.7 37.3 36.6
4 36.6 36.7 36.0 35.5 34.0 34.7
5 35.2 32.8 32.8 32.8 33.3 32.2
6 23.3 34.8 31.0 35.2 30.4 20.1
7 28.9 34.3 35.4 34.0 33.8 34.2
8 35.0 35.4 36.3 35.5 36.0 35.6
33.9 34.8 35.2 34.9
35.7 35.5 34.5 35.5
36.0 32.5 33.4 35.2
35.4 34.4 33.1 35.5
33.0 33.0 35.1 34.8
19.4 35.0 34.5 35.2
34.9 34.8 35.2 35.6
35.0 33.0 31.0 31.8
Progressive
Relaxation
1 35.5 35.9 36.5 36.8 32.1 32.1
2 35.8 35.2 35.7 34.5 35.5 34.0
3 35.5 35.2 34.0 33.6 35.5 35.0
4 36.4 32.0 32.5 32.9 32.5 34.8
5 31.0 32.1 20.3 25.0 34.9 33.9
6 33.4 34.4 33.7 34.7 35.2 33.9
7 18.9 33.3 25.6 20.0 27.4 30.5
30.8 33.5 35.3 33.5
32.7 33.8 32.4 34.5
34.0 35.4 34.4 35.6
34.0 34.0 35.3 35.0
29.9 32.7 35.6 30.5
34.8 23.1 34.0 33.7
19.3 31.6 34.0 33.2
Heart
Rate
1 35.4 35.6 29.5 36.0
2 34.7 31.0 34.0 34.7
3 33.0 33.3 30,1 35.0
4 35.1 35.5 34.6 36.0
5 35.4 34.9 34.6 33.9
6 28.7 34.0 28.2 33.7
7 35.8 36.0 35.8 34.8
8 35.0 35.5 31.0 35.0
9 34.0 34.6 35.0 34.3
29.7 26.3 35.9 35.4 35.7 29.7
34.0 34.0 34.2 34.3 34.8 34.4
35.4 34.9 35.8 33.5 35.4 35.4
32.2 32.9 32.8 33.3 32.5 30.0
18.8 35.4 34.4 35.0 35.5 35.9
33.9 22.1 34.7 34.4 34.0 34.2
35.0 35.5 35.7 35.8 35.5 35.5
34.7 34.8 35.5 35.3 35.0 35.0
33.5 34.4 35.4 35.0 33.0 35.3
FINGER TEMPERATURE (APPENDIX 2.3)
Stability -point finger temperatures cell means and standard










1 34.44 33.86 34.33 33.24
2 35.22 32.21 31.16 33.49
3 33.25 33.39 32.36 34.12
4 34.47 35.31 34.01 34.49
5 35.02 31+. 85 31.19 32.53
6 33.18 34.81 31.07 34.82
7 33.14+ 34.31 33.30 31.91
8 33.01+ 32.39 33.46 32.26
9 33.29 32.91 30.79 34.93










1 1.62 1.59 1.10 5.19
2 0.58 5.07 5.66 3.29
3 3.35 4.77 6.22 2.20
4 1.1+2 1.33 1.57 1.56
5 0.35 1.93 5.98 2.82
6 1+.77 1.39 6.15 0.80
7 2.86 2.05 2.96 5.21
8 1+.82 5.19 1.60 4.75
9 3.53 5.55 5.37 1.01
10 1+.38 1.12 4.10 0.86
FINGER TEMPERATURE CONDITION (APPENDIX 2.1*)
each treatment session
Sessions
Patient Period 1 2 3 U 5 6 7 8 9 10
1 1 +0.13 -o.o8 -o.oi -0.15 -0.07 -o.o5 -0.02 +0.11 -0.02 +0.16
1 2 +0.01; -0.09 0.00 -0.02 +0.11; +0.13 +0.02 +0.23 +0.01; +0.15
1 3 +0.08 -0.07 +0.11 +0.09 +0.11; +0.18 +0.05 +0.18 +0.18 +0.15
2 1 +0.02 +0.39 -0.01; -0.01 +0.15 -0.07 -0.22 -0.09 +0.10 +0.07
2 2 -0.11; +0.15 +0.03 +0.08 +0.'ll; -0.11 -O.63 +0.22 -0.01 -0.07
2 3 -0.01 +0.30 +0.10 +0.02 +0.16 -0.11; -0.81; -0.08 +0.17 -0.01
3 1 -0.23 +0.01 -0.11 +0.30 -0.28 -0.03 +0.06 -0.23 +0.25 -0.11+
3 2 -0.33 +0.15 +0.01 +0.17 -o.5U -0.10 -0.25 -0.21 +0.37 -0.05
3 3 -0.29 +0.05 +0.09 +0.16 -0.55 -0.02 -0.21 -0.11 +0.50 -0.02
k 1 -0.08 +0.05 +0.02 +0.01; 0.00 -0.03 +0.01 +0.15 —0.11+ +0.09
U 2 +0.12 +0.11 +0.10 +0.11 +0.07 0.00 +0.05 +0.10 -0.08 +0.01;
1+ 3 +0.01; +0.31 +0.19 +0.11; +0.22 +0.12 +0.01; -0.06 -0.08 -0.06
5 1 -0.06 +0.18 —O.I48 +0.09 0.00 +0.19 +0.22 -0.53 +0.10 +0.09
5 2 -0.21 -0.03 -0.68 0.00 +0.07 +0.26 +0.31 -0.66 +0.19 +0.10
5 3 -0.U8 +0.15 -0.66 -0.21 +0.1 u +0.3U +0.50 —o.J+3 +0.33 +0.23
6 1 -0.09 -0.08 +0.11+ -0.12 -0.19 -0.30 +0.02 +0.22 +0.07 +0.30
6 2 -0.68 +0.10 +0.21; +0.U3 +0.03 -0.29 +0.28 +0.29 -O.69 +0.1;6
6 3 -0.65 +0.18 +0.35 +0.66 +0.28 -0.55 +o.l;9 +0.29 -0.57 +0.U5
7 1 +O.23 -0.28 -0.02 +0.31 -0.03 +0.09 +0.12 —O.Ol; +0.17 +0.25
7 2 +0.28 -0.11+ -0.01 +0.21; +0.08 +0.15 +0.20 +0.15 +0.01; +0.23
7 3 +0.29 -0.03 +0.05 +0.33 +0.20 +0.27 +0.27 +0.11 +0.1U +0.27
8 1 +0.23 +0.U8 +0.27 +0.11 +0.23 +0.16 -0.11+ +0.55 +0.06 +0.10
8 2 +0.11 +0.50 +0.1;8 +0.18 +0.1;0 +0.11; +0.11; +O.67 +0.09 +0.09
8 3 +0.15 +0.1;2 +0.55 +0.25 +0.1;8 +0.11+ +0.29 +0.52 +0.10 +0.08
TEMPORAL ARTERY AMPLITUDE CONDITION (APPENDIX 2.1*)
Tem-poral artery amplitude changes (means) within periods of
each treatment session
Sessions
Patient Period 1 2 3 U 5 6 7 89 10
1 1 0.00 -0.27 +0.03 -0.11 -0.07 -0.09 -0.17 -0.11 -0.01 +0.15
1 2 +0.02 -0.23 +0.16 -0.22 -0.10 —0.01+ -0.13 -0.12 +0.26 +0.22
1 3 +0.10 -0.28 +0.1*1* -0.11 -0.21* -0.02 -0.11 -0.12 +0.19 +0.13
2 1 +0.08 -0.01 -0.07 +0.03 -0.25 -0.05 -0.06 -0.01 -0.05 -0.17
2 2 0.00 -0.03 -0.15 +0.01* -0.13 -0.09 -0.09 +0.01 -0.07 -0.33
2 3 +0.16 -0.11* -0.37 +0.01 +0.07 -0.01 -0.08 +0.07 +0.01 -0.25
3 1 +0.12 -0.11* +0.10 +0.07 +0.02 +0.09 +0.01 +0.31 +0.01 +0.01*
3 2 +0.23 0.00 +0.35 +0.1*1 +0.1*9 +0.11* +0.11 +0.57 +0.01 +0.09
3 3 +0.28 +0.03 +0.1*8 +0.53 +0.73 +0.31 +0.22 +0.71* +0.21+ +0.02
^ 1 -0.31 +0.11 +0.16 +0.11* -0.10 0.00 -0.09 +0.18 -0.03 -0.21
1* 2 -0.1*2 +0.27 +0.21* +0.29 +0.11+ +0.06 -0.05 +0.12 -0.16 -0.27
1* 3 -0.38 +0.35 +0.31+ +0.30 +0.30 +0.15 -0.03 0.00 -0.12 -0.12
5 1 _o.29 -0.09 +0.22 +0.13 -0.05 +0.11* -0.01 +0.19 -0.11+ -0.05
5 2 +0.11 -0.08 +0.36 +0.15 0.00 +0.05 +0.07 +0.05 -0.15 +0.06
5 3 +0.32 +0.27 +0.26 +0.38 -0.01 +0.1*1 +0.32 +0.27 -0.10 +0.13
6 1 +0.23 +0.28 +0.19 +0.17 +0.17 +O.29 +0.19 +0.09 +0.05 +0.22
6 2 +0.31 +0.18 +0.39 +0.1*0 +0.26 +0.39 +0.20 +0.21 +0.22 +0.27
6 3 +O.37 +0.17 +0.1*8 +0.1*1* +O.23 +0.68 +0.31 +0.17 +0.30 +0.35
7 1 +0.12 -0.01* +0.07 +0.12 +0.06 +0.03 +0.08 -0.10 0.00 -0.06
7 2 +0.21 +0.33 +0.15 +0.11* +0.05 +0.01* +0.06 +0.06 +0.23 +0.12
7 3 +0.37 +0.38 +0.23 +0.32 +0.19 -0.03 +O.36 +0.20 +0.1*1* +0.21
8 1 +0.09 +0.22 +0.30 +0.22 +0.09 +0.35 -0.23 -0.11* +0.35 +0.11*
8 2 +0.31 +0.59 +0.59 +0.1*8 +0.1*2 +0.33 +0.12 -0.01 +0.13 +0.27
8 3 +0.1*7 +0.77 +0.69 +0.55 +0.98 +0.51* +0.07 +0.23 +0.22 +0.1*2
PROGRESSIVE RELAXATION CONDITION (APPENDIX 2.1+)
Tenrporal artery amplitude changes (means) within periods
of each treatment session
Sessions
Patient Period 1 2 3 1+ 5 6 7 8 9 10
1 1 +0.03 +0.23 +0.13 +0.39 +0.1+0 +0.16 +0.18 +0.18 +0.12 -0.13
1 2 +0.09 +0.29 +0.22 +0.1+8 +0.56 +0.28 +0.35 +0.19 +0.19 -0.16
1 3 +0.33 +0.35 +0.27 +0.59 +0.65 +0.32 +0.3I+ +0.12 +0.26 -0.26
2 1 +0.35 +0.36 +0.21+ +0.09 -0.06 +0.22 -0.01 +0.25 -0.27 +0.13
2 2 +0.10 +0.12 +0.35 +0.20 +0.10 +0.51 +0.23 +0.1+5 -O.36 +0.1+6
2 3 +0.22 +0.22 +0.32 +0.03 +0.26 +O.38 +0.1+6 +0.56 -0.35 +0.68
3 1 +O.38 +0.13 +0.06 -0.06 -0.05 +0.03 +0.08 +0.17 +0.13 +0.05
3 2 +0.37 +0.33 +0.27 -0.12 +0.21 +0.16 +0.19 +0.29 +0.18 +0.17
3 3 +0.35 +0.36 +0.3I+ +0.01 +0.07 +0.18 +0.31 +0.1+0 +0.17 +0.21+
1+ 1 -0.11 +0.10 -0.15 -0.21 +0.01 -0.75 +0.02 +0.03 0.00 +0.03
1+ 2 +0.02 +0.17 -0.01+ -0.12 +0.07 -0.68 +0.06 -0.06 +0.02 +0.03
1+ 3 +0.20 +0.22 -0.02 +0.07 +0.21 -0.61+ +0.11+ -0.12 +0.18 +0.06
5 1 -0.10 -o.ol+ -0.05 +0.98 +0.11 +0.02 -0.13 0.00 +0.15 +0.21+
5 2 -0.11 +0.07 -0.01 +1.03 +0.17 +0.10 -0.05 -0.03 +0.13 +0.27
5 3 -0.09 +0.20 +0.08 +1.16 +0.11 -0.02 -0.26 +0.09 +0.08 +0.10
6 1 -0.10 -0.18 +0.67 +0.27 -0.33 -0.11 -0.03 +0.16 +0.51 -0.23
6 2 -0.10 -0.1+2 +O.77 +0.12 -0.07 -0.01+ -0.07 +0.07 +0.76 -O.29
6 3 -0.18 -0.1+5 +0.67 +0.19 -0.09 +0.18 +0.12 +0.16 +0.96 -0.39
7 1 -0.21 +0.21+ +0.18 +0.09 +0.33 +0.20 +0.25 +0.37 +0.10 +0.16
7 2 -0.07 +0.1+7 +0.33 +0.22 +0.1+5 +0.16 +0.51+ +0.65 +0.23 +0.37
7 3 +0.06 +0.59 +0.51 +0.1+7 +0.77 +0.37 +0.71 +0.81 +0.1+5 +0.1+1
HEABT RATE CONDITION (APPENDIX 2.1+)
Tem-poral artery am-plitude changes (means) within periods of
each treatment session
Patient Period 1 2 3 U 5 6 7 8 9 "10
1 1 +0.13 -0.12 +0.05 +0.22 +0.18 +0.02 -0.05 -0.13 +0.17 -0.19
1 2 +0.25 -0.18 +0.21 +0.1+5 +0.33 +0.05 +0.20 -0.23 +0.11+ +0.06
1 3 +0.U1 -0.03 +0.30 +0.55 +0.37 +0.20 +0.13 -0.25 +0.19 +0.09
2 1 +0.05 +0.15 +0.02 -0.02 +0.07 +0.12 +0.07 -0.07 +0.23 +0.01
2 2 +0.12 +0.18 +0.02 +0.19 +0.21+ +0.17 +0.11+ +0.11 +O.36 +0.17
2 3 +0.21 +O.38 +0.09 +0.36 +0.13 +0.15 +0.13 +0.26 +0.1+9 +0.20
3 1 -0.18 -0.12 +0.25 +0.03 -0.01+ +0.17 0.00 -0.09 0.00 +0.08
3 2 -0.03 -0.05 +O.38 +0.21+ -0.01+ +0.15 +0.08 -0.19 -0.15 +0.06
3 3 +0.12 +0.02 +O.36 +0.1+2 -0.02 +O.3I+ +0.01+ -0.07 +0.26 +0.07
1+ 1 +0.15 +0.27 +0.08 +0.27 +0.32 +0.06 +0.06 +0.01 -0.01+ +0.16
1+ 2 +0.21+ +0.08 +0.19 +0.21+ +0.1+1 -0.05 +0.28 +0.05 +0.10 +0.18
1+ 3 +0.25 +0.36 +0.26 +0.39 +0.51+ -0.05 +0.36 +0.09 +0.20 +0.30
5 1 +0.19 +0.18 -0.03 +0.09 +0.01 +0.02 +0.06 +0.05 0.00 +0.16
5 2 +O.23 +0.90 +0.03 +0.21 +0.06 +0.01+ +O.25 +0.16 -0.13 +0.32
5 3 +0.27 +0.22 +0.07 +0.26 +0.12 +O.23 +0.29 +0.21+ +0.05 +0.1+0
6 1 +0.20 +0.29 +0.31+ +0.22 +0.31 +0.19 -0.06 -0.03 -0.09 +0.06
6 2 +0.21+ +0.25 +0.11+ +0.18 +0.1+0 +0.22 -0.16 +0.01+ -0.06 +0.01
6 3 +0.27 +0.1+0 +0.13 +0.11+ +O.36 +0.26 -0.08 +0.11 -0.07 +0.03
7 1 +0.13 +0.20 +0.31+ +0.26 +0.10 +0.03 +0.01+ +0.11 +0.19 +0.27
7 2 +0.16 +0.22 +0.32 +0.38 +0.31 +0.17 +0.15 +0.09 +0.31 +0.28
7 3 +0.30 +0.16 +0.35 +0.29 +0.1+0 +0.06 +0.1+1 +0.20 +0.16 +0.21
8 1 +0.09 +0.08 +0.10 +0.01+ +0.03 +0.10 +0.13 +0.12 +0.02 +0.05
8 2 +0.02 +0.07 +0.09 +0.05 +0.06 +0.11 +0.13 +0.13 +0.07 +0.16
8 3 +0.02 +0.19 +0.11 +0.11 +0.27 +0.27 +0.13 +0.32 +0.01 +0.22
9 1 +0.10 -0.06 -0.03 -0.03 +0.01+ +0.01 +0.1+6 +0.09 +0.08 -0.01
9 2 +0.16 +0.10 -0.21+ -0.12 +0.17 +0.05 +0.1+1 +0.16 +0.27 -0.08
9 3 +0.28 +0.06 -0.13 +0.16 +0.1+3 -0.03 +O.38 +0.08 +0.18 +0.11
TEMPORAL ARTERY AMPLITUDE (MEANS) (APPENDIX 2.1+)











1 1 0.02 0.01 0.03 0.09
1 2 0.08 0.01 0.12 0.09
1 3 -0.03 0.13 0.15 0.12
2 1 0.07 0.09 0.22 0.12
2 2 -0.02 -0.02 0.06 0.11
2 3 -0.01 0.09 -0.03 0.08
3 1 0.01 -0.01+ 0.05 0.08
3 2 0.02 0.05 0.17 0.01
3 3 0.07 0.02 0.10 0.06
k 1 0.12 0.01 0.01+ 0.05
h 2 -0.10 0.09 0.01+ 0.15
k 3 0.09 0.13 0.15 0.51
5 1 0.02 0.26 0.27 0.13
5 2 0.15 0.21 0.26 0.20
5 3 0.05 0.11+ 0.21 0.26
6 0.02 0.11 0.07 0.10
6 2 0.02 0.01+ 0.18 0.16
6 3 0.09 0.11 0.22 0.01+
7 1 -0.01 0.06 0.16 0.10
7 2 0.12 o.o5 0.12 0.13
7 3 -0.11 0.21 0.13 0.21+
8 1 0.16 0.19 0.21 0.19
8 2 0.09 0.32 0.31 0.17
8 3 0.18 0.30 0.36 0.29
9 1 0.13 0.23 0.28 0.29
9 2 0.01+ 0.25 0.11 0.16
9 3 0.07 0.13 0.26 0.19
10 1 o.o5 0.19 0.29 0.11
10 2 0.09 0.15 0.25 0.17
10 3 0.13 0.11 0.12 0.18
TEMPORAL ARTERY AMPLITUDE (MEANS) (APPENDIX 2.1;)
Cell standard deviations between conditions, across sessions
and within -periods.
Conditions
Session Period Finger Temporal Progress Heart
Temp Artery Relaxation Rate
Amplitude
1 1 0.17 0.19 0.21; 0.11
1 2 0.25 0.19 0.18 0.16
1 3 0.22 0.12 0.26 0.15
2 1 0.17 0.10 0.39 0.12
2 2 0.17 0.13 0.25 0.13
2 3 0.16 0.16 0.31+ 0.07
3 1 0.11; 0.13 0.13 0.16
3 2 0.32 0.17 0.13 0.09
3 3 0.12 0.11; 0.23 0.11
1+ 1 0.13 0.16 0.17 0.11;
b 2 0.31 0.21; 0.17 0.10
b 3 0.19 0.26 0.28 1.28
5 1 0.33 0.22 0.27 0.18
5 2 0.11; 0.23 0.39 0.17
5 3 0.26 0.23 0.22 0.16
6 1 0.18 0.17 0.37 0.09
6 2 0.32 0.11 0.22 0.16
6 3 0.39 0.21 0.26 0.15
7 1 0.31 0.17 0.33 0.19
7 2 0.17 0.23 0.28 0.13
7 3 0.33 0.27 0.20 0.11
8 1 0.17 0.33 0.32 0.16
8 2 0.35 0.31 0.21+ 0.16
8 3 0.25 0.21; 0.1+2 0.15
9 1 0.29 0.31 0.31 0.18
9 2 0.28 0.27 O.36 0.11;
9 3 0.14+ 0.19 0.30 0.17
10 1 0.29 0.26 0.32 0.18
10 2 0.32 0.19 0.39 0.16
10 3 0.17 0.23 0.36 0.12
FINGER TEMPERATURE CONDITION (APPENDIX 2.5)
•periods of each treatment session
Sessions
Patient Period 1 2 3 1-5 6 7 89 10
1 1 +0.03 -0.57 +0.05 -0.1*8 -0.37 -0.26 -0.16 -0.28 -0.01 +0.02
1 2 +0.03 -0.1*2 -0.25 +0.22 +0.51 -0.58 +0.12 -0.1*3 +0.06 +0.28
1 3 +0.12 -0.1*8 -0.11* +0.35 +0.07 -0.31* -0.10 +0.01* +0.16 +0.28
2 1 +0.32 +0.72 -0.11 -0.52 -0.1*6 -0.28 -0.09 -0.07 +0.31 -0.55
2 2 -0.25 +0.01 +0.03 -0.27 -0.29 -0.1*3 -0.31 +0.35 +0.13 -O.69
2 3 -0.1*0 +0.19 -0.22 -0.10 -0.22 -0.07 -0.71 +0.09 +0.21 -0.37
3 1 +1.28 +0.02 +0.21* +0.39 +0.22 +0.27 -0.10 -0.13 +0.10 +O.36
3 2 +1.31 -0.01 +0.15 +0.18 -0.10 +0.11* -0.65 -0.31 +0.27 +0.26
3 3 +1.27 +0.23 +0.06 +0.08 -0.56 +0.11 -0.1*1 +0.05 +0.01* +0.00
1* 1 +0.08 -o.oi* +0.03 -0.56 +0.03 -0.20 -0.17 +0.13 -0.13 +0.08
1* 2 +0.33 +0.30 +0.08 -0.10 +0.13 -0.03 -0.22 +O.57 -0.1*1 -0.01*
1* 3 +0.1*6 +0.1*6 +0.20 -0.19 +0.39 +0.07 -0.26 +0.22 -0.28 -0.09
5 1 +0.08 +0.01 -1.06 -0.13 -0.19 +0.07 +0.59 -0.33 +0.13 -0.05
5 2 -0.21* -0.03 -1.02 -0.17 -0.1*0 +0.07 +0.37 -0.12 +0.15 +0.05
5 3 -0.09 +0.35 -1.16 -0.21* -0.51+ -0.02 +0.52 -0.31 +0.50 +0.01
6 1 -0.93 +0.10 +0.35 -0.37 +0.17 -0.82 +0.29 +0.17 +0.3I+ +0.10
6 2 -0.81* +0.30 +0.91* +0.1*5 +0.32 -0.1*6 +0.37 -0.03 -0.67 +0.05
6 3 -0.66 +0.62 +0.79 -0.1*3 +0.21* -0.28 +0.1*9 +0.28 -0.07 +0.59
7 1 +0.11* +0.01* +0.16 +0.22 -0.35 -0.01 -0.39 -0.11 +0.39 +0.03
7 2 -0.08 +0.30 +0.02 +0.1*0 +0.21* +0.1*1 +0.08 -0.08 +0.21+ -0.52
7 3 +0.22 -0.31 +0.1*1* +0.53 +0.11 +0.1*2 -0.11* +0.25 +0.30 +0.02
8 1 +0.31* +0.81 +0.1*8 -0.08 +0.58 +0.56 +0.02 +0.1*7 +0.31 +0.25
8 2 +0.20 +0.07 +0.79 -0.11 +0.1*9 +0.22 +0.1I* +0.1*5 +0.53 +0.31
8 3 -0.1*0 +0.35 +0.96 -0.13 +0.61* +0.1*2 +0.35 +0.25 +0.13 +0.1*0
TEMPORAL ARTERY AMPLITUDE CONDITION (APPENDIX 2.5)
Temporal artery amplitude changes (standard deviations) within
periods of each treatment session.
Sessions
Patient Period 12 3 4 5 6 7 8 9 10
1 1 +0.06 +0.19 +0.23 -0.07 -0.52 +0.12 -0.16 +0.08 +0.09 +0.29
1 2 -0.03 +0.19 -0.03 -0.51 -0.28 +0.22 -0.21 -0.08 +0.84 +0.1U
1 3 +0.01 +0.10 +1.07 -0.56 -0.23 +0.16 -0.32 -0.15 +0.38 -0.06
2 1 +0.36 +0.10 -0.27 -0.04 -0.04 -0.59 -0.3b -0.10 +0.25 +0.09
2 2 -0.12 -0.17 -0.33 -0.29 -0.02 -0.44 -0.12 +0.15 +0.06 +0.04
2 3 +0.45 -0.06 +0.02 +0.11 +0.21 -0.19 -0.51 -0.05 -0.28 +0.11
3 1 +0.17 -0.25 -0.18 +0.39 +0.08 +0.35 -0.22 +0.62+ +0.40 +0.02
3 2 +0.39 +0.08 +0.56 +0.36 +0.55 -0.06 +0.14+ +0.62 +0.43 -0.04
3 3 +0.40 -0.33 +0.08 -0.70 +0.56 +0.49 +0.40 +0.61 +1.10 +0.14
4 1 -0.64 +0.18 -0.32 -0.06 -0.18 -0.42 -0.01 -0.21 +0.03 -0.11
4 2 -0.97 -0.05 -0.20 +0.08 -0.37 -0.34 +0.01 +0.09 -0.17 -0.11
4 3 -0.95 -0.01 -0.47 +0.38 -1.18 +0.10 +0.16 -0.08 -0.16 +0.01
5 1 -0.50 -0.37 +0.17 +0.49 -0.32 -0.07 -0.14 -0.11 -0.39 -0.37
5 2 +0.26 +0.07 +0.40 +0.22 -0.37 +0.09 +0.14 -0.03 -0.03 +0.12
5 3 +0.42 +0.35 +0.40 +0.74 -0.13 +0.05 +0.19 +0.36 -0.27 -0.21
6 1 +0.15 -0.24 +0.21 +0.25 +0.64 -0.20 +0.02 -0.03 -0.15 -0.49
6 2 -0.22 +0.28 +0.07 -0.21 +0.37 -o.o5 -0.23 -0.56 +0.20 -0.26
6 3 -0.26 -0.19 -0.35 -0.16 +0.52 -0.51 +0.38 +0.09 +0.18 -0.13
7 1 -0.36 +0.07 -0.04 +0.19 +0.26 -0.17 +0.01 -0.21 +0.03 +0.09
7 2 +0.02 +0.79 -0.33 +0.85 +0.00 -0.46 +0.17 +0.25 +0.11 +0.16
7 3 +0.26 +0.74 -0.24 +0.29 +0.14 +0.24 +0.64 +0.31 +0.11 +0.19
8 1 -0.10 +O.38 +0.19 +0.35 +0.32 +0.26 +0.10 +0.46 +0.12 -0.18
8 2 +0.46 +0.41 +0.40 +0.23 +0.57 +0.30 +0.35 +0.74 -0.07 +0.07
8 3 +0.29 +0.55 +0.29 +0.05 +0.54 +0.56 +0.30 +0.76 -0.02 +0.24
PROGRESSIVE RELAXATION CONDITION (APPENDIX 2.5)
Temporal artery amplitude changes (standard deviations) within
periods of each treatment session
Sessions
Patient Period 1 23I4.56789I
1 1 -0.03 +0.30 +0.18 +0.09 +0.11 -0.09 +0.1+1 -0.20 +0.35 -0.
1 2 -0.12 +0.51 +0.08 +0.35 +O.36 +0.30 +O.36 -0.06 +0.55 -0.
1 3 +0.26 +0.37 +0.15 +0.1+0 +0,14.3 -0.03 +0.1+0 -0.07 +0.1+8 +0.
2 1 +0.32 +0.33 -0.1+1 +0.21+ -0.31+ +0.79 +0.25 -0.10 +0.13 +0.
2 2 -0.29 -0.3U -0.37 +0.06 +0.02 +0.99 +0.31 +0.15 +0.18 +0.
2 3 -0.30 -0.39 -0.1+2 +0.06 +0.11 +1.01 +0.39 -0.01+ +0.10 +0.
3 1 +0.00-0.0I++0.33-0.15+0.17+0.3I++0.35 +0.05 -0.35 +0.
3 2 -0.29 +0.26 +0.65 -0.10 +0.53 +0.28 +0.73 +0.06 -0.21+ +0.
3 3 -0.72 -0.39 +0.1+5 +0.10 +0.55 +0.53 +0.71 +0.11 -0.30 -0.
1+ 1 +0.09 +0.1+1 +0.13 -0.18 -0.01+ +0.09 +0.33 -0.10 +0.52 +0.
1+ 2 +0.52 +0.30 +0.25 -0.07 -0.06 -0.10 +0.51 -0.07 +0.1+0 +0.
1+ 3 +0.1+7 +0.80 +0.27 +0.16 +0.07 +0.20 +0.29 -0.11 +0.52 +0.
5 1 +0.03 -0.25 -0.21+ +0.77 +0.02 +0.32 -0.06 +0.30 +0.11 -0.
5 2 +0.00 -0.03 +0.1+1+ +0.61 -0.1+7 +0.70 +0.75 +0.1+0 +0.38 +0.
5 3 -0.21 -0.28 +0.93 +0.91 -0.52 +0.30 +0.37 +0.28 +0.03 -0.
6 1 -0.52 -1.65 +0.69 +0.78 +0.31 +0.80 -0.3I+ +0.22 +0.33 -0.
6 2 +0.02 -1.21 +0.28 +O.59 +0.70 +0.51 +0.53 -0.11 +0.66 -0.
6 3 -0.28 -0.90 +0.1+5 +0.35 +0.06 +0.38 +0.68 +0.02 +1.02 -0.
7 1 -0.52 +0.17 +0.39 -0.27 +0.01 +0.03 +0.11 +0.61 -0.23 -0.
7 2 -0.35 +0.58 +0.1+9 -0.33 -0.07 -0.01 +0.1+9 +0.90 +0.05 -0.























HEART RATS CONDITION (APPENDIX 2.5)
Temporal artery amplitude changes (standard deviations) within
periods of each treatment session.
Sessions
Patient Period 1 2 3 1 5 6 7 8 9 10
1 1 +0.20 -0.13 -O.i+1 +0.32 -0.11+ -0.28 -0.23 -0.51 +0.12 -0.17
1 2 +0.1+1 -0.29 -0.21 +0.1+3 -0.26 +0.22 -0.02 -0.59 -0.03 -0.06
1 3 -0.1+1 -0.1+5 -0.1+8 +0.I+3 -o.l+o -0.23 -0.03 -0.82 +0.11+ +0.35
2 1 +0.1+1+ -0.01 +0.27 -0.09 -0.13 +0.07 -0.22 -0.02 +0.29 +0.07
2 2 +0.22 +0.01+ +0.1+6 -0.12 -0.39 +0.37 -0.15 -0.05 +0.06 +0.27
2 3 -0.01 +0.50 -0.08 +0.02 +0.01 +0.1+6 +0.16 +0.02 +0.06 +0.1+2
3 1 _0.58 +0.32 +0.51 -0.11 +0.06 +0.16 +0.22 +0.1+2 -0.01+ +0.11
3 2 -0.23 +0.1+7 +0.57 +0.29 -0.10 +0.12 +0.15 +0.23 -0.1+3 +0.07
3 3 -0.30 +0.33 +0.1+2 +0.17 +0.31 +0.1+1+ -0.07 +0.77 +0.75 -0.11
1+ 1 +0.21+ +0.15 +0.37 +0.72 +0.86 -0.27 -0.28 -0.56 -0.28 +0.65
I+ 2 +0.23 -0.78 +0.37 +0.1+1+ +0.15 -0.1+1+ +0.05 -0.03 -0.05 +0.31+
1+ 3 +0.11+ -0.69 +0.21 +0.30 +0.06 -0.82 +0.17 -0.08 -0.25 +O.36
5 1 +0.38 +0.25 +0.09 -0.18 -0.27 +0.63 +0.10 -0.01+ +O.23 +0.26
5 2 +0.37 +0.1+7 +0.21+ +0.05 -0.1+7 +0.1+6 +0.07 -0.13 +0.05 +0.66
5 3 +0.27 +0.38 -0.03 -0.09 +0.19 +0.57 +0.11 +0.25 +0.25 +0.39
6 1 -0.08 +0.1+2 +0.55 +0.51+ +0.03 +0.26 -0.01+ -O.25 -0.39 +0.03
6 2 +0.32 +O.38 +0.03 +0.15 +0.23+0.11 -0.27 -0.70 -0.21 +0.12
6 3 +0.12 +0.1+8 -0.11 +0.20 +0.18 +0.30 -0.01+ -0.28 -0.1+1 -0.1+0
7 1 +0.10 -0.13 +0.1+1 +0.28 +0.06 -0.09 -0.39 +0.08 +0.26 -0.18
7 2 -0.22 -0.07 +0.25 -0.82 +0.07 +0.13 -0.10 +0.05 +0.26 -0.21
7 3 -0.05 -0.51+ +0.28 +0.25 +0.31 -0.01 -0.38 +0.09 -0.07 -0.57
8 1 -0.03 -0.01+ +0.50 +0.01+ -0.11 +0.08 +0.32 +0.13 +0.65 +0.31
8 2 +0.19 -0.05 +0.28 -0.07 -0.01+ +0.1+7 +0.08 +0.03 +0.1+3 +0.1+3
8 3 +0.1+6 +0.02 +0.27 +0.30 +0.17 +0.51+ +0.10 +O.23 +0.28 +0.3I+
9 1 +0.05 +0.1+5 -0.11+ -0.39 +0.27 -0.21 +0.11 -0.10 +0.06 -0.11+
9 2 +0.10 +0.82 -O.38 -0.26 +0.01 -0.02 +0.15 +0.11 +0.02 +0.05
9 3 +0.01 +0.51 +0.09 -0.02 +0.1+3 -0.68 +0.23 -0.10 +0.00 -0.08
TEMPORAL ARTERY AMPLITUDE (STANDARD DEVIATIONS) (APPENDIX 2.5)
Cell Means Between Conditions, Across Sessions and Within Periods
Conditions
Session Period Finger Temp Temp Art Amp Prog Rel'n Heart I
1 1 0.17 -0.11 -0.09 0.16
2 0.06 -0.03 -0.07 0.01+
3 0.11 0.08 -0.08 0.07
2 1 0.11+ 0.01 -0.10 0.02
2 0.07 0.20 0.01 0.00
3 0.18 0.11+ -0.13 0.18
3 1 0.12 0.00 0.15 0.25
2 0.09 0.07 0.26 0.06
3 0.12 0.10 0.20 0.32
h 1 -0.19 0.19 0.18 0.01+
2 0.08 0.09 0.16 0.19
3 -0.02 -0.23 0.33 0.10
5 1 -0.05 0.03 0.03 -0.10
2 0.11 0.06 0.11+ 0.10
3 0.02 0.05 0.08 0.09
6 1 -0.08 -0.09 0.33 0.18
2 -0.08 -0.09 0.38 0.16
3 0.0I+ 0.11 0.30 0.08
7 1 0.00 • -0.09 0.15 -0.02
2 -0.01 0.07 0.53 0.00
3 -0.03 0.16 0.37 -0.02
8 1 -0.02 0.07 0.11 -0.15
2 0.05 0.15 0.18 0.02
3 0.11 0.23 -0.05 -0.01+
9 1 0.18 o.o5 0.12 0.01
2 0.01+ 0.17 0.28 0.09
3 0.12 0.13 0.28 0.09
10 1 0.03 -0.08 0.07 0.20
2 -0.01+ 0.02 0.16 0.09
3 0.11 0.01+ 0.05 0.11+
TEMPORAL ARTERY AMPLITUDE (STANDARD DEVIATIONS') (APPENDIX 2.5)
Cell Standard Deviations between Conditions, Across Sessions and
Within Periods
Conditions
Session Period Finger Temp Temp Art Amp Prog Rel'n Heart Rate
1 1 0.60 O.36 0.32 0.25
2 0.61 0.1+5 0.29 0.28
3 0.59 0.1+8 0.1+1 0.32
2 1 o.i+U 0.26 0.72 0.1+3
2 0.21+ 0.29 0.62 0.1+9
3 0.38 0.37 0.56 0.22
3 1 0.1+7 0.23 O.38 0.25
2 0.61 0.35 0.33 0.29
3 0.66 0.1+9 0.1+9 0.21+
1+ 1 O.36 0.22 0.1+1+ 0.1+1
2 0.27 0.1+3 0.36 0.17
3 0.32 1.07 0.29 0.38
5 1 O.36 0.37 0.20 0.25
2 0.31+ 0.39 0.1+1 0.23
3 0.1+3 0.58 0.35 0.35
6 1 0.1+1 0.32 O.36 0.29
2 0.36 0.29 0.39 0.1+8
3 0.28 0.35 0.1+1 O.29
7 1 O.31 0.15 0.27 0.11+
2 0.35 0.25 0.17 0.18
3 0.1+5 0.38 0.31 0.25
8 1 0.26 0.32 0.28 0.32
2 0.37 0.I+1 O.36 0.1+6
3 0.19 0.3I+ 0.21+ 0.29
9 1 0.19 0.21+ 0.32 0.26
2 0.39 0.33 0.31 0.36
3 0.21+ 0.1+5 0.1+3 0.31+
10 1 0.27 0.28 0.28 0.28
2 0.37 0.11+ O.38 0.39
3 0.30 0.16 0.55 0.27
FINGER TiinFiUKATTJEB CONDITION (APFENDIX 2.6)
Heart rate changes within periods of each treatment session
Patients Periods 1 2 3 k 5 6 7 8 9 10
1 1 +31 +00 -06 +01 +12+ +10 +02 -05 -01 +08
1 2 -0i| +20 +00 +16 +10 +0i| -07 -23 -15 +0i|
1 3 -13 +16 -22 -01 +08 +00 -26 -32 -28 +0i|
2 1 -08 +26 -11 +0i| -10 -13 -03 -02 -03 -12+
2 2 -08 +02 -16 -03 "05 -21 -Oil +08 -03 -23
2 3 -08 -08 +01 +0i| +09 -21 -Oil -13 -05 -32+
3 1 -05 -05 -06 -02 -06 -09 +00 +10 -11+ -08
3 2 +16 +16 +02 +17 +05 +0i| -17 +0i| -10 +00
3 3 +12 +12 +12 -03 +07 -11 -16 +00 -Oil +02
k 1 +01 -10 -02 -08 -01 -Oil -10 -13 -03 -09
k rt -09 -0i| -01 -05 -05 -01 -17 -11 -05 -09
k 3 -07 -16 -01 +02 -19 -01 -19 -05 -13 -09
r>
P 1 +10 +08 +00 +26 +07 +1 u -01 +08 +05 +05
5 2 +08 +0i| -02 +23 +07 +10 -11 -12+ -08 -li+
5 3 +08 +0i| -05 +20 +06 +02 -15 -23 -15 -16
6 1 +05 +0i| +05 +01 -12 -02 -o5 +o5 +03 +0i|
6 2 +03 +0i| -02 +01 -16 -11 +00 +00 -09 +06
6 3 +01 -06 +00 -03 -20 -12 +01 +03 -11 +12
7 1 +00 +o5 +17 -17 +10 +09 -08 -08 —12+ -01
7 2 -02 +02 +18 -1il +00 -08 -13 -03 -01 +01
7 3 -08 +0i| +1il -13 -12 -11 -27 -11+ -07 -05
8 1 +08 +52 +10 +03 -05 +1+1 +51 +26 +i|0 +i+i+
8 2 +01 +39 +13 +03 -07 +31 +i|6 +i|2 +52+ +19
8 3 +01 +22 +10 -02 -15 +10 +33 +39 +25 +15
TEMPORAL ARTERY AMPLITUDE CONDITION (APPENDIX 2.6)
Heart rate changes within periods of each treatment session
;ients Period 1 2 3 1+ 5 6 7 8 9 10
1 1 -86 -18 -20 -07 _08 -11 -09 +12 -05 -06
1 2 -85 -21+ -30 -05 -15 -13 -08 +02 +01+ -01+
1 3 -89 -22 -18 +1+8 _17 -13 _o5 -05 -05 -01+
2 1 -09 -11 -09 +03 +07 -08 -02 -08 +07 -18
2 2 -03 -09 -03 +09 +17 _o8 -02 -08 +03 -23
2 3 -08 -19 -08 +07 +21+ -08 -01+ -08 -09 -23
3 1 -02 -02 -15 -11 -09 -07 -02 -01 -11 -19
3 2 -03 -06 -27 -13 +01 -07 -21 -03 -16 -22
3 3 +07 -01 -27 -19 -01 -11 -28 +08 -13 -22
h 1 -05 "09 +07 +12 -01+ -02 -03 -03 -03 +00
h 2 +01 -09 +00 +09 -17 -02 +02 -06 -09 +02
h 3 +03 -06 -o5 +09 -16 +00 -09 -07 -06 -02
5 1 +02 +05 -02 -06 -03 -01+ -07 +00 -01+ -01+
5 2 +13 +09 -09 -03 +01+ -03 -02 +12 +01 -02
5 3 +15 +06 -05 +00 +10 +02 -07 +11+ -01 +06
6 1 -08 -01+ +02 -11+ -15 _03 -11 -19 -10 -12
6 2 -13 -08 -03 -16 -11+ -o5 -10 -11+ -03 -13
6 3 -18 -11 +00 -19 -15 -01+ -12 -18 -15 -15
7 1 -06 -07 -17 -02 +03 -01 +10 -11 -02 -09
7 2 -18 -07 -12 -05 +oo -oi -05 -11+ -18 -15
7 3 -21+ -10 -08 -11+ +01+ -08 -07 -18 -26 -19
8 1 -09 +05 -16 -23 -15 -18 -27 -11 -03 +01+
8 2 -13 -01+ -1+7 -32 -32 -23 -16 -30 -26 +03
8 3 -11+ -01+ -17 -51 -l+o -13 -25 -62 -22 -01+
PROGRESSIVE RELAXATION CONDITION (APPENDIX 2.6)
Heart rate changes within -periods of each treatment session
;ients Period 1 2 3 1+ 5 6 7 8 9 10
1 1 +30 —1 h -28 -63 -50 +00 -20 -30 -25 -35
1 2 +l+o -28 -05 -73 -56 -52 -25 -19 -27 -33
1 3 +ko -18 +00 -33 -60 +27 +03 -19 -07 -1+9
2 1 +08 -08 -1+5 -13 -16 -26 -15 -26 +00 -1+0
2 2 +20 +02 -09 -11 -18 -28 -16 -27 +00 -33
2 3 +20 -ol+ -31+ +02 -21+ -31+ -29 -27 -03 -15
3 1 +0l+ -26 -07 -13 -28 +03 -10 -18 -06 -29
3 2 -07 -30 -15 -01+ -18 +02 -08 -13 -02 -21
3 3 +02 -26 -13 -01+ -18 -15 -16 -20 +01 -31
1+ 1 +08 -20 +03 -25 -13 -01+ -20 -29 -13 -03
b 2 +06 -06 +08 -21 -09 -21 -16 -20 -12 -10
k 3 +12 -23 +15 _23 -21 -17 -22 -31+ -17 -17
5 1 +ok -01+ +05 -08 -05 -21 +21 -08 +05 -50
3 2 -07 +03 -12 -1+8 -09 -07 +25 -08 +01+ -37
5 3 +ol+ -37 -19 -1+9 -16 -01 +23 -01+ +01 -36
6 1 +ol+ +00 +13 +00 +1+8 +55 +06 -02 -12 -09
6 2 +18 +01 +12 +00 +00 +01 +25 -10 +01 -18
6 3 +17 -11+ vo01CO01p~\+ -03 +25 -02 +01 -16
7 1 -0I| +01 -08 -13 -09 +06 -11+ +01 -06 -03
7 2 -08 +o5 -08 -09 -07 +05 -12 +01+ -06 -09
7 3 +00 +01+ -08 -01 -08 +02 -12 +00 -03 -12
HEART RATE CONDITION (APPENDIX 2.6)
Heart rate changes within periods at each treatment session.
Sessions
itients Periods 1 2 3 1+ 5 6 7 8 9 10
1 1 -08 -09 -03 -16 -06 -19 -05 "30 -32 -1+7
1 2 -23 -21 -16 -21+ -10 +01+ -29 -13 -35 -39
1 3 -1+0 -38 -15 -32 -19 -20 -21+ -25 -61 -53
2 1 -01+ -03 -07 +00 +03 -02 -05 -01 -05 +00
2 2 -12 +00 -10 +o5 -05 -01 -06 -01 +00 -01
2 3 +02 +02 -20 -01 -02 -01+ -09 +08 -08 +01+
3 1 -09 -12 "15 -19 -03 -02 -05 +07 -07 +01+
3 2 -15 -15 -21+ -21 -01 +01 +01 +09 -11 -01+
3 3 -07 +08 -29 -23 -11 +06 -08 -05 -11+ -07
1+ 1 -19 -09 -11+ -02 -02 +00 -o5 -12 -03 +o5
h 2 -03 -11 -12 -29 +03 -10 -09 -30 -07 +00
h 3 -02 -32 -13 -3U -06 -22 -21 -36 -08 +00
5 1 -06 -21 -33 -01 -13 -30 -05 -08 +15 -19
5 2 -16 -23 -1+3 -09 -26 -38 -23 +00 -06 -39
5 3 -06 -27 -1+2 -13 -19 -1+8 -16 -20 -01 -5o
6 1 -01 -11 -06 -08 -09 +05 -11 -02 -07 -10
6 2 -12 -18 -09 -01+ -16 -09 -09 -15 -02 -11
6 3 -11+ -33 -20 -16 -25 -11+ -19 -08 -05 -17
7 1 +01 +09 +05 +10 +01 +02 +01+ +06 +00 +02
7 2 -03 +09 +02 +13 +01 +01+ +05 +07 -01 +o5
7 3 +02 +19 +05 +12 +01 +01+ +10 +03 +01 +00
8 1 -11+ +00 +11+ -15 -10 -11 -08 -17 -15 -12
8 2 "30 -20 +01+ -18 -22 -11+ -23 -30 -35 -15
8 3 -28 -21+ -13 -20 -20 -27 -22 -29 -36 -20
9 1 -11 -08 -01+ +01+ +18 -09 -21+ -06 -01 -17
9 2 +01+ -20 -27 -05 +27 +00 -31+ -12 +06 -13
9 3 -07 +02 -11+ +13 +17 +09 -21+ -13 -08 -01
HEART RATE (APPENDIX 2.6)
Cell Means between Conditions, Across Sessions and Within Periods
Conditions
Session Period Finger temp Temp Art Amp Prog Rel'n Heart Rate
1 1 5.25 -15.38 7.71 -7.89
2 0.63 -15.13 8.86 -12.22
3 -1.75 -16.00 13.57 -11.11
2 1 10.00 -5.13 -10.11+ -7.11
2 10.38 -7.25 -7.57 -13.22
3 3.50 -8.38 -16.86 -13.67
3 1 0.88 -8.75 -9.57 -7.00
2 1.50 -16.38 -l*.1i* -15.00
3 1.23 -11.00 -6.57 -17.89
1* 1 1.00 -6.00 -19.29 -5.22
2 1*.75 -7.00 -23.71 -10.22
3 0.50 -1*. 88 -15.71 -12.67
5 1 -0.38 -5.50 -10.1+3 -2.33
2 -1.38 -7.00 -16.71 -5.1*1*
3 -U.50 -6.38 -21.86 -9.33
6 1 -5.75 -6.75 1.86 -7.33
2 1.00 -8.38 -11*. 29 -7.00
3 -5.50 -6.88 -5.86 -12.89
7 1 3.25 -6.38 -7.1*3 -7.11
2 -2.88 -7.75 -3.86 -11*.11
3 -9.13 -12.13 -l*.oo -11*. 78
8 1 2.63 -5.13 -16.00 -7.00
2 0.38 -7.63 -13.29 -9.1*1*
3 -5.63 -12.00 -15.11* -13.89
9 1 1.63 -3.88 -8.11+ -6.11
2 0.38 -8.00 -6.00 -10.11
3 -7.25 -12.13 -3.86 -15.56
10 1 3.63 -8.00 -21+.11* -10.1+1*
2 -2.00 -9.25 -23.00 -13.00
3 -3.88 -10.38 -25.11* -16.00
HEART RATE (APPENDIX 2.6)
Cell Standard Deviations between Conditions, Across Sessions
and Within Periods
Conditions
Session Period Finger Temp Temp Art Amp Prog Rel'n Heart Rate
1 1 12.07 28.78 10.61 6.29
2 8.38 29.87 18.13 10.53
3 8.71 32.33 13.93 11+. 21
2 1 20.01+ 7.88 10.27 8.1+2
2 13.99 8.97 15.01+ 10.88
3 12.95 9.21 13.77 21.25
3 1 9.29 9.97 20.35 13.23
2 10.31 16.63 10.22 11+. 71
3 11.59 8.88 17.52 12.79
1+ 1 12.26 10.69 20.66 9.88
2 12.73 13.51 26.91+ 13.95
3 9.31+ 28.69 19.61+ 17.33
5 1 9.61+ 7.89 29.88 9.25
2 8.57 15.31; 18.1+1+ 15.87
3 13.08 19.77 18.01+ 13.29
6 1 17.17 5.65 26.39 11.27
2 15.61+ 7.96 20.73 13.29
3 9.93 5.72 19.03 18.59
7 1 19.71 10.50 15.3U 7.1+7
2 20.61+ 7.72 20.38 13.63
3 19.59 9.23 21.51 11.03
8 1 12.37 9.31+ 13.03 11.63
2 19.63 12.1+1+ 10.03 11+. 1+3
3 21.1+5 23.11 13.29 11+. 82
9 1 17.00 5.51 9.75 12.60
2 22.10 11.08 10.63 11+.90 '
3 15.09 8.63 6.52 20.17
10 1 18.01+ 8.16 19.08 16.1+5
2 13.03 10.39 11.1+7 16.12
3 15.98 10.76 13.83 21.68
TEMPORAL ARTERY AMPLITUDE: ACCURACY OF FEEDBACK (APPEMDIX
(Correlation Coefficients)
Low Intensity Medium Intensity High Intensity
Gain Gain Gain
Display Amp(nims) Display Amp(mms) Display Amp(mms)
1 1691 7 31+61 21 5592 32
2 1917 8 3169 19 1+523 27
3 1781+ 7 31+87 21 1+828 30
1+ 173U 7 31+56 21 5112 31
5 21+88 9 321+1+ 20 1+753 30
6 1938 7 2709 17 5263 30
7 2202 8 3528 22 5579 32
8 2033 8 3198 19 5052 29
9 2206 8 3621 22 1+707 28
10 2066 8 2957 18 1+757 30
r = +0.901+ r = 0.982 r = +0.835
1 1711 7 3388 19 7921+ 1+6
2 178U 8 3215 20 6779 39
3 1595 6 31+95 20 3271 20
1+ 167b 6 331+8 20 3595 22
3 1618 6 3809 23 31+62 21
6 17 61+ 7 1+091+ 25 3601 22
7 1621+ 7 381+7 21+ 3551 20
8 1606 6 31+78 22 3710 22
9 1923 6 3937 21+ 3318 19
10 1668 7 3715 23 3293 20
r = 0.782 r = +0.932 r = +O.998
1 2510 13 3021+ 17 1+925 30
2 2516 13 2782 17 3766 25
3 2028 10 3391+ 10 1+11+1+ 27
b 1970 9 5605 33 61+33 36
5 2350 12 291+3 20 1+035 25
6 2987 18 2758 17 51+88 31
7 2109 10 3716 22 1+188 26
8 1.2801 50 3091 20 3979 25
9 2990 18 3651 22 5033 30
10 291+8 18 292I+ 19 5205 30
r = +0.985 r = 0.978 r = +0.987
Correlation across all readings
r = +0.887
APPENDIX 3.
FREQUENCY OF HEADACHES (BASELDIE MONTHS) (APPENDIX 3.1 )
Between conditions
Conditions Fing Temp Temp Art Rel'n Heart R.
Months 1 231 231 231 23
05 00 02 06 02 11 02 01 00 07 05 01+
03 01 01 08 08 06 03 00 02 01 02 01
03 02 01+ 08 02 07 02 00 08 01+ 02 00
00 00 16 07 02 18 01+ 06 02 06 07 06
08 07 01+ 05 01 01+ 02 02 00 03 00 01+
05 02 02 03 01 01 00 00 00 05 03 02
00 00 03 13 01+ 16 00 00 00 01+ 02 05
16 08 07 01+ 00 00 01 03 03
FREQUENCY OF HEADACHES (BASELINE MONTHS)
Means for each condition
Cell Means
Month Treatment Fing Temp C. Temp Art Prog Rel'n Heart Rate
1 1 5.00 6.75 1.86 3.88
2 2 2.50 2.50 1.29 3.00
3 3 1+.88 7.75 1.71 2.75
FREQUENCY OF HEADACHES (BASELINE MONTHS)
Standard deviations for each condition
Standard Deviations
Month Treatment Fing Temp C. Temp Art Prog Rel'n Heart Rate
1 1 5.18 3.11 1.1+6 2.17
2 2 3.21 2.51 2.21 2.11+
3 3 1+.85 6.71 2.93 2.31
















































































































































































































FREQUENCY OF HEADACHES (APPENDIX 3.2)
Mean Changes (RD Scores) across Follow-up Months.
Cell Means
Fing Temp Temp A„A. Prog Rel'n Heart Rate Waiting List
Month 1 1.38 0.25 -O.I4O 1.60 -1.00
Month 2 1.13 0.38 0.00 1.60 0.00
Month 3 1.25 0.25 0.00 1.80 0.00
Standard Deviation Changes (RD Scores 1 across Follow-up Months.
Standard Deviations
Fing Temp Temp A.A. Prog Rel'n Heart Rate Waiting List
Month 1 0.92 0.89 0.89 0.89 1.00
Month 2 1.14-6 1.19 1.1+1 0.89 0.00
Month 3 1.01+ 0.1+6 1.1+1 0.1+5 2.00
INTENSITYOFHEADACHES






















































































































































































































































INTENSITY OP HEADACHES (APPENDIX 3.3)
Mean Changes (R.D. Scores) across Follow-up Months
Cell Means
Ping Temp Temp A.A. Prog Rel'n Heart Rate Waiting List
Month 1 1.00 0.25 o.uo 1.60 -O.67
Month 2 1.50 0.00 0.00 1 .60 0.00
Month 3 1.25 0.00 0.80 1.60 0.00
Standard Deviation Changes (R.D. Scores) across Follow-up Months
Standard Deviations
Ping Temp Temp A.A. Prog Rel'n Heart Rate Waiting List
Month 1 1.07 0.71 0.89 0.89 1.15
Month 2 0.93 1.07 1.1+1 0.89 0.00
Month 3 1.0U 0.00 1.09 - 0.89 2.00
,DURATIONOFHEADACHES































































































































































































































































DURATION OF HEADACHES (APPENDIX 3.1+)
Mean Changes (R.D. Scores) across Follow-up Months
Cell Means
Ping Temp Temp A.A. Prog Rel'n Heart Rate Waiting List
Month 1 1.13 0.25 -o.l+o 1.60 0.33
Month 2 1.38 0.25 0.00 1.60 0.33
Month 3 1 .25 0.00 0.00 1.60 0.00
Standard Deviation Changes (R.D. Scores) across Pollow-up Months
Standard Deviations
Ping Temp Temp A.A. Prog Rel8n Heart Rate Waiting List
Month 1 0.99 0.71 0.89 0.89 0.58
Month 2 0.92 0.71 1.1+1 0.89 0.58
Month 3 1.01+ 0.00 1.1+1 0.89 2.00
INDEX OE HEADACHE ACTIVITY (appendix 3.5)
Between treatment conditions
across baseline and follow-up months
PING TEMP COND
MONTH 1 MONTH 2> MONTH 3 MONTH 1+
0099.0 0121+.0 0000.0 0000.0
0015.0 0000.0 0001.0 0000.0
021+1.6 0108.5 0000.0 0000.0
1076.3 0000.0 0000.0 0000.0
0075.0 0012.0 0063.5 0051.3
0206.8 0000.0 0000.0 0338.1+
0090.0 0000.0 0000.0 0000.0
0388.1+ 0090.0 0093.0 0132.3
TEMP ART AMP CONT
0179.7 0070.2 001i+.0 0106.3
0360.0 01+30.0 0595.1 0306.6
Oi+90.6 0212.8 0105.0 0126.0
0262.8 oo63.O 0018.0 0025.0
0090.3 0000.0 0000.0 0255.0
0039.0 0202.5 0096.0 0108.5
075U.6 0618.8 0960.9 0252.8
0000.0 0000.0 0115.5 0000.0
PROG RED COND
0000.0 0321 .1 0000.0 0052.0
0180.0 0126.0 0151+.0 0231.0
0225.6 0363.3 0000.0 0000.0
0111+.0 0093.0 0111+.0 0126.0
000.0 0000.0 0072.0 0000.0
HEART RATE COND
0072.0 0060.0 0000.0 0000.0
0096.0 0000.0 0000.0 0000.0
0315.0 0000.0 0120.0 0000.0
011+1.1+ 0000.0 0000.0 0000.0
0115.8 0000.0 0000.0 0027.0
WAITING LIST COND
0060.0 0056.7 0027.1+ 0000.0
0190.1 0113.5 0063.0 0032.0
0000.0 0338.8 0000.0 0120.0
Relative difference













+1 .2 +1.7 +1.6
+2.0 +2.0 -0.9
-1.1+ -0.8 -0.9











+2.0 +2.0 +1 .2
+0.1 +1.1 +2.0
+0.5 +1 .0 +1.5
-2.0 0.0 -2.0
INDEX OF HEADACHE ACTIVITY (APPENDIX 3.5)
Mean Changes (R.D. Scores) across Follow-up Months
Cell Means
Ping Temp Temp A.A. Prog Rel'n Heart Hate Waiting List
Month 1 1.25 0.25 -o.l+o 1.60 -0.67
Month 2 1.50 0.25 0.1+0 1.60 0.67
Month 3 1 .25 0.38 0.00 1.80 0.33
Standard Deviation Changes (R.D. Scores) across Pollow-ur Months
Standard Deviations
Ping Temp Temp A.A. Prog Rel'n Heart Rate Waiting List
Month 1 0.87 0.89 0.89 0.89 1.15
Month 2 O.76 1.16 1.67 0.89 0.58
Month 3 1.01+ 0.52 1.1+1 0.1+5 2.08
ANALGESIC INDEX (APPENDIX 3.6)
Between treatment conditions
across baseline and follow-up months
FENG TEMP COND -
MONTH 1 MONTH 2 MONTH 3 MONTH l+
021; 006 000 000
002 000 000 000
000 000 000 000
180 000 000 000
019 006 027 021
000 000 000 000
021; 000 000 000
015 101 oou 012
TEMP ART AMP CONT
09U 026 01 u 031*
032 0bh 061; ouo
003 003 003 006
036 008 000 000
000 000 000 000
000 006 000 000
068 078 010 000
000 000 012 000
PROG REL COND
000 0U0 000 001;
021; 015 015 033
102 000 000 000
012 012 018 012
000 000 000 000
HEART RATE COND
030 012 000 000
000 000 000 000
014.1 000 012 000
03U 000 000 000
058 000 000 030
WAITING LIST COND
028 072 008 000
026 000 000 000






























-0.9 +1 .1 +2.0
+2.0 +2.0 +2.0
-2.0 0.0 -2.0
ANALGESIC POTENCY (APPENDIX 3-6)
Mean Changes (R.L. Scores) across Follow-up Months
Cell Means
Fing Temp Temp A.A. Prog Rel'n Heart Hate Waiting List
Month 1 1.00 0.00 0.00 1 .20 0.00
Month 2 1.13 0.25 o.l+o 1.1+0 1 .00
Month 3 1.00 0.50 0.00 1.20 0.67
Standard Deviation Changes (S.D. Scores) across Follow-up Months
Standard Deviations
Fing Temp Temp A.A. Prog Rel'n Heart Rate Waiting List
Month 1 0.93 0.93 1.1+1 1.09 2.00
Month' 2 0.99 1.16 0.89 0.89 1.00
Month 3 1.07 0.93 1.1+1 1.09 2.31
3 00 00 00 00 00 00 00 1U
TEMP 2
I.O l.O I.O l.O I.o l.O l.O l.O
.2
VASOCONSTRICTORMEDICATION



















































































































































































VASOCONSTRICTOR MEDICATION (APPENDIX 3.7)
Mean Changes (R.D. Scores') across Follow-up Months
Cell Means
Ping Temp Temp A.A. Prog Rel'n Heart Rate Waiting List
Month 1 0.25 0.13 -o.l+o 0.80 0.00
Month 2 0.13 0.25 0.00 0.80 1 .00
Month 3 0.00 O.63 0.00 • ro 0 1.00
Standard Deviation Changes (R.D. Scores) across Follow-up Months
Standard Deviations
Ping Temp Temp A.A. Prog Rel'n Heart Rate Waiting List
Month 1 0.71 0.3k O.89 1.09 2.00
Month 2 0.35 0.71 0.00 1.09 1 .00
Month 3 0.00 0.92 0.00 1.09 1.00
PROPHYLACTICMEDICATION






















































































































































































































































PROPHYLACTIC MEDICATION (APPENDIX 3.8)
Mean changes (R.D. scores) across follow-up months
Cell Means
Ping Temp Temp A.A. Prog Rel'n Heart Rate Waiting List
Month 1 0.00 0.00 o.l+o 0.00 0.00
Month 2 0.00 0.00 o.i+o 0.00 -0.67
Month 3 0.00 0.25 0.00 0.00 0.00
Standard Deviation Changes (R.D. Scores) across Follow-up Months
Standard Deviations
Ping Temp Temp A.A. Prog Rel'n Heart Rate Waiting List
Month 1 0.00 0.00 0.89 0.00 0.00
Month 2 0.00 0.07 0.89 0.00 1.15
Month 3 0.00 0.71 0.00 0.00 0.00
MULTIPLE REGRESSION ANALYSIS (APPENDIX 3.9)
Column 1. Finger temperature : mean change, period 1.
2. Finger temperature : mean change, period 2.
3. Finger temperature : mean change, period 3«
U. Temporal artery amplitude (RD means) mean change, period 1.
5. Temporal artery amplitude (RD means) mean change, period 2.
6. Temporal artery amplitude (RD means) mean change, period 3*
7. Temporal artery amplitude (RD standard deviations)
mean change, period 1.
8. Temporal artery amplitude (RD standard deviations)
mean change, period 2.
9. Temporal artery amplitude (RD standard deviations)
mean change, period 3«
10. Heart rate, mean change, period 1.
11. Heart rate, mean change, period 2.
12. Heart rate, mean change, period 3«
13. Mean 'Index of Headache Activity1 score.
1lj.-. Age of patient.
15. Duration of illness.
FINGERTEMPERATU ECO DITION
Column 1
2 3 h 9 6 7 8 9




3 h 9 6 7
8 9
10 11 12 13 1U 19
PATIENT1 +03.02 +10.1+0 +08.98 +00.00 +00.06 +00.11 -00.20 -00.09 +00.00 +09.30 +00.90 -09.1+0 +01.20 +23.70 +19.00 PATIENT1 -00.1+1+ +00.27 -00.19 -00.02 -00.07 -00.01 -00.09 -00.13 -00.10 +08.20 +00.30 -03.ho +00.70 +92.30 +28.00
PATIENT2 -01.69 -02.79 -03.72 +00.03 -00.03 -00.02 -00.07 -00.17 -00.16 -03.1+0 -07.30 -07.90 +01.90 +9U.60 999999 PATIENT2 +00.38 +01.30 +01.39 -00.01 +00.02 +00.09
,-00.06 +00.01+ +00.16 +00.80 -20.1+0 -03.90 +01.90 +1+9-90 +29.00
PATIENT3 -00.27 +02.90 +01.96 -00.01+ -00.08 -00.01+ +00.27 +00.12 +00.09 -ol+.9o +03.70 +01.10 +01.60 +99.80 999999 PATIENT3 +02.01+ +01.92 +00.17 +00.08 +00.12 +00.19 +00.01 +00.10 +00.18 -00.70 -02.00 -07.90 +02.00 +U3.90 +06.00
PATIENT1+ -00.11 +02.76 -02.09 +00.01 +00.06 +00.09 -00.08 +00.06 +00.11 -09.90 -06.70 -08.80 +02.00 +27.00 +19.00 PATIENT1+ -00.81 +03.01+ -02.1+0 +00.21 +00.28 +00.30 +00.31 +00.31 +00.30 +27.00 +21+.10 +13.80 +01.20 +33.30 +19.00
TEMPORALARTE YMPLITUDECONDITION
Column 1 2 3 h 5 6 7 8 9 10 11 12 13 1U 15 1 2 3 h 5 6 7 8 9 10 11 12 13 11+ 15
PATIENT1 +0.131 +02.70 +03.11+ -00.07 -00.02 +00.00 +00.03 +00.03 +00.Ol+ -15.80 -18.30 -13.00 +00.80 +51.80 +20.00 PATIENT5 -1+0.17 -06.18 -10.73 +00.01 +00.06 +00.23 -00.16 +00.05 +00.19 -02.30 +02.00 +01+.00 +01.60 +20.20 999999
PATIENT2 +00.81+ +00.99 +00.67 -00.06 -00.08 -00.05 -00.06 -00.12 -00.02 -01+.80 -02.70 -05.60 +01+.00 +1+2.00 +31.00 PATIENT6 -00.81 -01.29 +01+.09 +00.19 +00.28 +00.35 +00.02 -00.06 -00.01+ -09.1+0 -09.90 -12.70 -01.00 +50.30 +20.00
PATIENT3 -03.27 -03.26 -01+.83 +00.06 +00.21+ +00.36 +00.11+ +00.33 +00.28 -07.90 -11.70 -10.70 +01.10 +1+7.80 +3U.00 PATIENT7 +00.21+ -OI.87 -01.52 +00.03 +00.11+ +00.27 -00.02 +00.16 +00.27 -01+.20 -09.50 -13.00 +00.50 +21.08 999999
PATIENT1+ +02.18 +02.52 +02.09 -00.02 +00.02 +00.08 -00.17 -00.20 -00.22 -01.00 -02.90 -03.90 +01.50 +16.90 +08.00 PATIENT8 -01.99 +00.15 -00.63 +00.11+ +00.32 +00.1+5 +00.19 +00.35 +00.36 -11.30 -22.00 -21+.00 -07.00 +21.92 999999
Column 1 2 3 h 5 6 7 8 9 10 11 12 13 1U 15 Colujnn 1 2 3 1+ 5 6 7 8 9 10 11 12 13 11+ 15
PATIENT1 -06.61 -10.1+0 -11.01 +00.17 +00.25 +00.30 +00.11 +00.23 +00.25 -23.50 -27.80 -11.60 -01.30 +30.30 +18.00
PATIENT2 +02.69 -03.90 -01+.59 +00.13 +00.22 +00.28 +00.18 +00.11+ +00.21+ -18.10 -12.00 -11+.80 +00.00 +36.80 +11+.00
PATIENT1 -05.93 -08.1+3 -11.90 +00.03 +00.13 +00.20 -00.12 -00.01+ -00.19 -17.50 -19.60 -32.70 +01. +0 +60.08 +02.00
Peart




+00.58 -00.92 -02.1+1 +00.09 +00.21 +00.21+ +00.10 +00.21+ +00.05 -13.00 -11.60 -11+.00 +01.20 +15:60 999999
+02.65 +01+.12 +05.01 -00.10 -00.05 +00.03 +00.11+ +00.20 +00.33 -11.60 -10.10 -11+.70 +00.00 +1+0.10 999999
+02.32 +08.1+8 +03.89 +00.12 +00.16 +00.15 +00.19 +00.30 +00.11+ -01.60 -09.60 -13.1+0 +00.70 +22.70 +06.00
Condition PATIENT3 +00.17 +00.33 +00.30 +00.07 +00.21 +00.18 +00.15 +00.18 +00.23 -12.10 -22.30 -21+.20 +01.60 +51-20 +16.00
PATIENT1+ +01.85 +09.25 +07.31+ +00.11+ +00.13 +00.16 +00.11 +00.02 +00.00 +06.00 -10.50 -17.10 +02.00 +1+2.00 +10.00
PATIENT5 +00.19 -01.50 -03.89 +00.06 +00.09 +00.15 +00.00 +00.06 +00.01+ -05.80 -07.1+0 -03.60 +01.70 +1+9.60 +1+5.00
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Abbreviated Progressive Muscular Relaxation Exercises
"I want you to sit quietly - rest your hands on the arras of the
chair and sit with feet slightly apart. Do not fold your arras or
cross your legs.
Close your eyes and concentrate on your toes: Curl them down
toward the soles of your feet and hold the tension - then slowly
let the tension go. Notice the feeling of relief. As you r£lax,
repeat the word 'relax* to yourself.
With your eyes closed, concentrate on your calves, the lower
part of your legs; Point your toes up towards your face and
tighten your calves. Hold the tension - then slowly let the tension
go. Repeat the word 'relax* to yourself.
Now concentrate on your thighs, the upper part of your legs:
Push your feet on the floor and feel the tension in your thighs
and hold the tension - slowly let the tension go. Notice the feel¬
ings of relief and repeat the word 'relax' to yourself. Notice
the difference now between the feelings you are getting from your
legs as compared to the feelings from your upper body. Your legs
feel relaxed and heavy, and your toes may be tingling. Concentrate
on the differences you feel.
Concentrate on your stomach area: Tense your stomach muscles
and imagine you are protecting yourself from a punch - hold the
tension - then slowly let the tension go. Feel the relaxation.
Now I want you to concentrate on your upper body and shoulders:
Keep breathing steadily, regularly and calmly. Tighten your shoulders
by shrugging them, bringing your shoulders up around your ears.
- 2 -
Lift your shoulders and hold the tension - then slowly let it go.
Repeat the word 'relax* to yourself.
Notice what is happening to your "body now. It is feeling
more relaxed, heavier and perhaps you are feeling a tingling sen¬
sation over your body. Concentrate on your forehead, your eyes
and your mouth. Let the muscles relax, feel comfortable and warm.
Breath steadily and stay calm and quiet.
The patients receiving the progressive muscular relaxation
exercises reported them to be effective in producing feelings of
relaxation. However, no record of the patients* responses were
kept and no systematic attempt was made to determine the degree
of relaxation achieved by the patients. In fact no attempt was
made to assess any patients perceived success of their treatment
task. In this way all self report data related to clinical infor¬
mation only, in an attempt to minimize "performance" related
anxieties and thus maximize patient compliance.
Results
Finger Temperature Biofeedback
Graph I shows the mean change in finger temperature for each
subject (per 30 second epoch). Although subject I in the finger
temperature feedback condition achieved a mean temperature eleva¬
tion in slight excess of 0.7°c, the other subjects failed to demon¬
strate changes of a similar magnitude. In fact six subjects in the
Heart Rate feedback group displayed above baseline changes compared
with four subjects in the Finger Temperature feedback group.
A visual inspection of the results would suggest that finger
temperature feedback did not facilitate increases in temperature.
However, the number of finger temperature feedback subjects showing
only small decreases in temperature may suggest that feedback could
militate against the effects of downward 'drift*. This, however, is
speculative, and a point of departure for future research.
Temporal Artery Amplitude Biofeedback
Graph II shows the mean change in temporal artery amplitude, for
each subject across treatment periods. Those subjects receiving in¬
formation about temporal artery amplitude changes, were expected to
show decreases in amplitude, compared with the other groups. A
visual inspection of the results would indicate that temporal artery
amplitude feedback did not enable subjects to reduce the mean size
of artery pulses. The finger temperature feedback group has a
greater number of subjects displaying a reduction in artery amplitude -
than any other treatment group.
Heart Rate Biofeedback
Graph III shows the mean change in heart rate for each subject
across treatment periods. It was anticipated that the Heart Rate
feedback group would show greater decreases in heart rate than the
other treatment groups. A visual examination of the results would
suggest that the heart rate changes displayed by the Progressive
Relaxation and Heart Rate Groups are similar. The similarities
are in both, number of subjects achieving a decrease and the mag¬
nitude of decrease. The finger temperature group responses are
conspicuous by their general tendency to display reduced heart
rate change. They are also the only group with three subjects
showing increases in heart rate. The reason for these differences
in responses are still to be elucidated.
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